TradingFloor Mobile
2025-06-30 / ALL-MARKETS
Full desktop terminal available Open Full Site ↗
Guest Preview Active
Create an account after 17s to keep the mobile market desk live.
Create Account Login
TFAI Command Terminal

Full Market Intelligence

AI-powered RNS digestion, live interactive charts, insider flow and broker targets — all in your pocket.

Create Free Account
Market AI 812 headlines · 43 AI picks today Tap a ticker to open AI chart · Ask AI above -- AI
Find by ticker, company name or close match. Tap + to add alerts.
Loading market intelligence…
Quant BTC Blending

Crypto Dream Desk

BTC structure, AI forecast, macro event odds and listed crypto-beta names blended into one mobile cockpit.

BTC logo
Loading BTC quant blending from the main site engine...
Open full quant desk

Live RNS Feed

49 types
All Market News Today All digested RNS titles 812
CYN logo
All News 17:21
CYN

Holding(s) in Company

CQS Natural Resources Growth and Income plc

TR1 Buy
['Bank of America Corporation', '5.420847', 0]
CLAI logo
All News 17:16
CLAI

Director's Dealings

Cel AI PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
BVA logo
All News 16:33
BVA

BBVA's decision on the takeover bid for Sabadell

Banco Bilbao Vizcaya Argentaria S.A

Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resulting from the offer, with an additional condition to BBVAs previously submitted commitments. Despite having the right to withdraw the offer due to the additional condition, BBVA has decided not to withdraw and will proceed with the offer as planned. The merger control procedure in Spain is now complete, and the offer remains in effect.
Takeover
SBDS logo
All News 16:14
SBDS

Final Results for the year ended 31 December 2024

Silver Bullet Data Services Group PLC

Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million, with a gross profit of £7.13 million, representing a 12% increase. The companys services revenue increased by 8% to £6.0 million, while its 4D revenue grew by 20% to £3.37 million, driven by US demand. US and globally operating clients now account for over 60% of total group revenues. Silver Bullet also reported a positive EBITDA during Q4 of FY24 and a strong start to 2025. The company raised £3.3 million through the issue of new convertible loan notes and restructured its existing CLNs, simplifying its capital structure and aligning financing with its growth plans.
YearRevenueGross ProfitLoss Before TaxLoss Per Share
2024£9.37m£7.13m£3.04m£0.17
2023£8.36m£6.36m£3.45m£0.20
PR1 logo
All News 15:23
PR1

Half-year Report

Pri0r1ty Intelligence Group PLC

Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report reflects only three months of Pri0r1ty trading. During this time, they generated £37,000 in revenue, with 40 customers using their products and 20% paying for services. They also formed strategic partnerships, developed new revenue-generating products, and successfully integrated cryptocurrency payments. The company expects to see increased platform adoption in the second half of 2025 and remains on track to onboard at least 100 paying users by the financial year-end. The financial statements include details on the companys financial position, changes in equity, and cash flows for the period.
Financial YearRevenue (£)Cost of Sales (£)Gross Profit (£)Other Expenses (£)Earnings Before Interest, Tax, Depreciation, and Amortization (£)Interest Expenditure (£)Loss Before Taxation (£)Income Tax (£)Profit/ (Loss) for the Year (£)
31 March 2025 (unaudited)37,000037,000570,436-860,2670-860,2670-860,267
31 March 2024 (unaudited)000151,301-151,3010-151,3010-151,301

| Debt | 31 March 2025 (Unaudited) | 31 March 2024 (Unaudited) | | --- | --- | --- | | Trade and Other Payables (£) | 400,397 | 68,842 |
BBH logo
All News 15:17
BBH

Holding(s) in Company

Bellevue Healthcare Trust PLC

TR1 Buy
['Saba Capital Management, L.P.', '0.873177', '1.088320']
80M logo
All News 15:16
80M

Final Results for the year ended 31 December 2024

80 Mile Plc

80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue remained nil, while its cost of sales decreased to £35,887 from £213,523 in the previous year. 80 Mile Plcs administrative expenses increased to £2,262,385 from £1,629,273 in the previous year. The companys impairment of intangible assets decreased to £4,902,058 from £3,535,254 in the previous year. 80 Mile Plcs share of losses from joint ventures increased to £18,114 from £13,779 in the previous year. The companys other losses increased to £2,259,088 from a gain of £2,962,769 in the previous year. 80 Mile Plcs finance expense decreased to £1,663 from a finance income of £7,039 in the previous year. The companys other income increased to £116,844 from £320,925 in the previous year. As of December 31, 2024, 80 Mile Plcs total assets decreased to £34,153,950 from £40,520,554 in the previous year. The companys total liabilities decreased to £1,187,350 from £1,143,927 in the previous year. 80 Mile Plcs net assets decreased to £32,966,600 from £39,376,627 in the previous year.
YearFinancialsDebt
2024£34,153,950£1,187,350
2023£40,520,554£1,143,927
BRSC logo
All News 14:58
BRSC

Portfolio Update

Blackrock Smaller Companies Trust PLC

Here is a summary of the provided text
BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basis, while the benchmark index returned 7.3%. The share price performance was positive for the month, but underperformed the broader market. The largest detractors from performance were Bloomsbury Publishing, Ashtead Technology, and Tatton Asset Management due to stock-specific issues. However, holdings in Chemring, Boku, and Alpha Group International contributed positively to the portfolio.
The update also includes a commentary on the markets by Roland Arnold, representing the Investment Manager. Arnold notes that global financial markets experienced a strong rebound in May, with a boost in risk sentiment and easing geopolitical tensions. While the US Federal Reserve maintained its policy rate, the Bank of England cut rates citing domestic disinflation. Despite this, UK inflation surprised to the upside in April.
Arnold also provides an outlook for the UK equity market, highlighting several positive factors including falling mortgage rates, positive real wage growth, and a recovery in the housing market. Additionally, the pace of M&A activity remains robust, and UK SMID stocks are considered undervalued compared to large-cap stocks. The update concludes by expressing optimism about the attractiveness of the UK market for investors, given the uncertainty in the US equity market.
Financial MetricsOne MonthThree MonthsOne YearThree YearsFive Years
Net Asset Value6.5%3.7%-8.6%-7.2%24.5%
Share Price6.1%4.3%-10.6%-3.8%17.3%
Benchmark7.3%6.4%1.1%1.1%38.9%
Net Asset Value (Capital Only, Debt at Par Value)1,409.19p
Net Asset Value (Capital Only, Debt at Fair Value)1,473.13p
Net Asset Value incl. Income (Debt at Par Value)1,424.01p
Net Asset Value incl. Income (Debt at Fair Value)1,487.95p
Share Price1,296.00p
Discount to Cum Income NAV (Debt at Par Value)9.0%
Discount to Cum Income NAV (Debt at Fair Value)12.9%
Net Yield3.4%
Gross Assets£678.5m
Net Gearing including Income (Debt at Par)7.0%
WIZZ logo
All News 14:57
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

TR1 Buy
['The Capital Group Companies, Inc.', '8.058573', '9.951957']
JARA logo
All News 14:50
JARA

Final results for the year ended 28 February 2025

Jpmorgan Global Core Real Assets Ltd

Here is a summary of the text provided
JPMorgan Global Core Real Assets Limited has released its final results for the year ended February 28, 2025, announcing a managed wind-down of the company and a shift in its investment objective. The companys continuation vote failed to pass at the 2024 AGM, leading to a new strategy that involves liquidating assets and returning capital to shareholders. As of February 28, 2025, the company has realized its holdings in the Listed Real Assets Strategy, with the exception of Home REIT plc, and has made significant progress in redeeming its holdings in other strategies. The Board expects to have realized and returned over 55% of assets to shareholders by the end of 2025 and over 80% by the end of 2026. The companys return on net asset value was 5.2% for the year, while the return to shareholders was 36.8%. The Board has taken steps to reduce costs, including reducing directors fees and disbanding certain committees. The companys sixth AGM will be held on August 28, 2025, and the Board encourages shareholders to vote in advance. The Board acknowledges the challenges faced by the company since its launch in 2019 but remains focused on liquidating assets and returning proceeds to shareholders efficiently.
YearFinancialsDebt
2025£162,311,000£35,260,000
2024£196,411,000£3,682,000
CCH logo
All News 14:33
CCH

Director/PDMR Shareholding

Coca Cola HBC AG

<mark style="background-coloryellow">PURCHASE</mark> OF ORDINARY SHARES FOLLOWING THE RE-INVESTMENT OF DIVIDENDS PAID ON THE EMPLOYEES SHARES HELD UNDER THE COMPANYS EQUITIES PLANS
EAAS logo
All News 14:19
EAAS

Final Results

Eenergy Group PLC

eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and transitioned into profit with an Adjusted EBITDA of £0.6 million. The companys net debt was reduced to £2.4 million, and it was awarded a solar installation contract worth £5.2 million with Spire Healthcare. The companys outlook for FY2025 is optimistic, with a strong contracted forward order book and increased sales pipeline. The company expects to be cash positive in H1 2025 and further cash generative in H2 2025.
<>eEnergy Group Financials
YearRevenueAdjusted EBITDANet DebtCash
2024£25.1 million£0.6 million£2.4 million£2.3 million
2023£14.7 million-£6.4 million£8.0 million£0.6 million
HAYD logo
All News 14:15
HAYD

Holding(s) in Company

Haydale Graphene Industries

TR1 Buy
['Octopus Investments Limited', '9.720000', '10.920000']
VLG logo
All News 14:14
VLG

Final Results for year ended 31 December 2024

Venture Life Group PLC

Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported strong growth in its core business, with a revenue increase of 18.9% to £26.6 million and an underlying growth of 14.9% excluding acquisitions. The gross profit increased by 31.1% to £12.2 million, and the gross margin improved to 45.8%. The adjusted EBITDA rose by 26.1% to £6.2 million, and the adjusted profit before tax increased to £4.3 million. The company also announced the sale of its contract development and manufacturing operations and certain non-core products for €62 million in cash. The Board expects to complete the sale of its oral care brands, which are now considered non-core, by the end of 2025.
YearRevenueGross ProfitMarketing CostsAdjusted EBITDAAdjusted Profit Before TaxAdjusted EPSFree Cash FlowGroup Net LeverageGroup Net Debt
2024£26.6 million£12.2 million6.1%£6.2 million£4.3 million3.37p£4.3 million1.83x£18.7 million
2023£22.4 million£9.3 million3.9%£4.9 million£2.8 million2.60p£2.7 million1.30x£13.7 million
VRS logo
All News 14:04
VRS

Interim Results

Versarien PLC

Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March 31, 2025. Versariens strategy is to monetize its intellectual property and know-how by licensing its technology and brands as commercial traction for graphene develops. The company has a pipeline of commercial opportunities worth £2.1 million and is seeking additional funding to continue as a going concern. Versarien is also simplifying its corporate structure and seeking strategic partners for its 3D Construction Printing business. The Board expects the Groups ongoing costs to reduce with the simplified structure.
Financial MetricsFY 2025FY 2024Change
Group revenues£1.47 million£1.34 million10.45% increase
Graphene revenues£0.21 million£0.28 million25% decrease
Grant income£0.23 million£0.20 million15% increase
Adjusted LBITDA£0.77 million£0.67 million14.93% increase
Loss before tax£1.49 million£1.61 million7.45% decrease
Cash as of 31 March£0.85 million£0.15 million466.67% increase

Debt MetricsFY 2025FY 2024Change
Innovate UK Loan£5 million£4.5 million11.11% increase
Long-term borrowings£285£47539.99% decrease
Total debt£5,285£4,9756.23% increase
EQT logo
All News 13:27
EQT

Final Results

EQTEC plc

EQTEC plc announces its audited results for the year ended 31 December 2024.
YearRevenueOperating LossNet LossNet Assets
2024€2.2 million€3.6 million€19.4 million€13.7 million
2023€2.5 million€3.5 million€23.5 million€21.2 million
WATR logo
All News 11:01
WATR

Audited Results for Year Ended 31 December 2024

Water Intelligence plc

Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 10% to $83.3 million, with statutory profit before tax growing 2% to $6.4 million and statutory EBITDA growing by 11% to $13.1 million. The companys balance sheet remains strong, with cash of $12.1 million and a Total Net Debt to EBITDA Adjusted ratio of 1.1. The companys critical mass of sales and technology-driven foundation establish a scalable Technology Enabled Services (TES) platform. Between Q4 2024 and Q1 2025, Water Intelligence completed three strategic transactions, including reacquiring its Dallas franchise and establishing it as the headquarters for its core American Leak Detection business, forming a partnership with Chubb insurance and its StreamLabs Water business, and reaffirming its capital allocation guidance with acquisitions. The companys TES platform enables it to provide recurring Preventive Maintenance solutions and efficiently offer proprietary, technology-driven solutions to its customers. Based on its competitive strategy and the Dallas Template, the company expects to deliver higher organic revenue and profit trajectory.
YearRevenueProfit Before TaxNet Debt to EBITDA Adjusted Ratio
2024$83.3 million$6.4 million1.1
2023$76 million$6.2 millionN/A
PAG logo
All News 10:34
PAG

Director/PDMR Shareholding

Paragon Banking Group PLC

<mark style="background-coloryellow">Purchase</mark> of shares pursuant to the Companys Salary in Shares remuneration arrangements.
APN logo
All News 09:36
APN

Holding(s) in Company

Applied Nutrition Plc

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '0.000000', '5.065098']
LABS logo
All News 09:09
LABS

Holding(s) in Company

Life Science REIT PLC

TR1 Buy
['Legal & General Group Plc (Group)', '3.990000', '4.000000']
EARN logo
All News 08:52
EARN

Holding(s) in Company

EARNZ plc

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '6.773980', '0.000000']
ENET logo
All News 08:36
ENET

Results for the Year Ended 31 December 2024

Ethernity Networks Ltd

Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a gross profit decrease of 46%. However, the gross margin percentage increased to 92.1% in 2024 from 61.9% in 2023, reflecting a 30.2% improvement. The operating loss decreased by 4%, and the EBITDA loss decreased by 10%. The company raised net cash funds of $1.86 million during the year and had cash and cash equivalents of $0.05 million at the end of December 2024. Despite challenges, the company successfully exited the Temporary Suspension of Proceedings process and initiated a strategic transition to leverage its Universal Edge Platform development. The companys Chairman and CEO provided statements highlighting the companys achievements and expressing optimism for the future.
YearRevenueGross ProfitOperating LossEBITDA LossNet CashCash Equivalents
2024$1.38 million$1.3m$5.1 million$3.48 million$1.86 million$0.05 million
2023$3.78 million$2.3m$5.3 million$3.86 millionN/A$1.99 million
HCM logo
All News 08:31
HCM

China Approval based on Phase III SACHI Trial

HUTCHMED China Ltd

HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-small cell lung cancer with MET amplification after progression on EGFR inhibitor therapy. The approval is based on the positive results of the SACHI Phase III trial, which showed a significant improvement in progression-free survival for patients treated with the combination compared to chemotherapy. ORPATHYS® is an oral MET inhibitor, and TAGRISSO® is a third-generation EGFR inhibitor. This approval provides a new treatment option for lung cancer patients in China and triggers a US$11 million milestone payment from AstraZeneca, which markets both drugs in the country.
Approvals
OSB logo
All News 08:30
OSB

Holding(s) in Company

OneSavings Bank PLC

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) London, United Kingdom', '', 0]
MLVN logo
All News 07:33
MLVN

Holding(s) in Company

Malvern International

<mark style="background-coloryellow">TR1</mark> Buy
['8 KPG Limited', '2,140,630', 0]
KOD logo
All News 07:31
KOD

Bougouni Lithium Project Off-Take Agreement

Kodal Minerals PLC

Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the projects DMS processing plant for four years, with an annual review of quantities and floor price. The price is referenced to the Shanghai Metals Market and will be subject to adjustments based on grade, quality, and delivery terms. The agreement includes a "take or pay" clause, with LMLB supplying spodumene exclusively to Hainan, who must purchase the agreed-upon quantity. The DMS processing plant has already produced over 40,000 tonnes of spodumene concentrate, and the company is working to secure an export license from the Mali government. The first phase of the project is expected to produce 100,000-120,000 tonnes per year of lithium concentrate with a yield of more than 5.5% Li2O.
Agreement
VOD logo
All News 06:28
VOD

Vodafone Group Plc launches Cash Tender Offers

Vodafone Group PLC

Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates ranging from 2043 to 2059. The company has set a maximum tender amount and acceptance priority levels for each series of notes. The tender offer is subject to certain terms and conditions, including a financing condition related to the issuance of new sterling-denominated notes. The company has retained Merrill Lynch International and Deutsche Bank AG as dealer managers and Kroll Issuer Services Limited as the tender and information agent for the offer. The offer period includes key dates such as the early tender deadline, price determination date, and settlement dates. The offer is subject to applicable laws and regulations in various jurisdictions, including Italy, the United Kingdom, France, and Belgium. The company also provides forward-looking statements and information about its purpose and commitment to environmental sustainability.
Launch
0A3D logo
All News 06:11
0A3D

Net Asset Value

iShares VII Public Limited Company - iShares Core S&P 500 UCITS ETF

TEAM logo
All News 06:07
TEAM

Half-year Report

TEAM plc

Here is a summary of the text provided
TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% increase in revenues to £5.8 million, with total client assets surpassing £1.1 billion. TEAM also successfully raised £2.96 million through equity and convertible loan instruments, and had £2.16 million in cash reserves as of March 31, 2025.
The companys operational highlights include growth in total client assets across its divisions, a successful group-wide cost reduction program, and the upcoming launch of the TEAM UCITS fund. The outlook for the remainder of the financial year remains positive, with a continued focus on migrating client assets to MPS and expanding the international advisory network.
Mark Clubb, Executive Chairman of TEAM, expressed confidence in the companys trajectory and mid-term targets, which include annual revenue of £20 million, an EBITDA margin exceeding 30%, and Assets Under Advice/Management of £4 billion. The company is focused on execution, with the UCITS fund launch being central to driving growth and achieving profitability.
The financial review highlights the companys improved financial position and continued revenue growth, with the goal of achieving month-on-month profitability. The segmental analysis shows the performance of the Groups three principal operating segments: Investment and Fund Management, Advisory and Consultancy, and International.
Overall, the results demonstrate TEAM PLCs strong performance and positive trajectory, with a focus on growth and achieving financial targets.
| | HY 25 | HY 24 | |---|---|---| | Revenues | £5.8m | £4.1m | | Total client assets | £1.112bn | £0.9bn | | Cash in bank | £2.16m | £1.5m | | Total Equity Raised | £1.96m | - | | Convertible Loan Notes | £1m | - | | Gross Total Raised | £2.96m | - | | Underlying loss before tax | £796k | £992k | | Loss before tax | £1.757m | £1.013m | | Loss for the period | £1.757m | £1.010m | | Loss per share | 3.6 pence | 3.5 pence |
CRTA logo
All News 06:02
CRTA

Holding(s) in Company

Cirata plc

<mark style="background-coloryellow">TR1</mark> Buy
['GEORGE WALTER LOEWENBAUM', '5.40', 'n/a']
SSTY logo
All News 06:01
SSTY

Lease agreement to operate hostel in Naples

Safestay PLC

Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnership between the two companies, with plans to expand into other key Italian cities. The Naples hostel, set in a former monastery, is expected to open in August 2025 and will offer guests a range of amenities, including ancillary services. This expansion aligns with Safestays growth strategy and goal to double its portfolio size in the medium term.
Agreement
NAH logo
All News 06:01
NAH

Holding(s) in Company

NAHL Group PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Colebrooke Partners IM Limited', 'Less than 3', '3.27']
MLVN logo
All News 06:01
MLVN

Holding(s) in Company

Malvern International

<mark style="background-coloryellow">TR1</mark> Buy
['Edward Roskill', '2,064,567', 0]
ROQ logo
All News 06:01
ROQ

Director/PDMR Shareholding

Roquefort Investments PLC

<mark style="background-coloryellow">Purchase</mark> of 72,507 ordinary shares
CRTX logo
All News 06:01
CRTX

Placing

CRISM Therapeutics Corporation

APTA logo
All News 06:01
APTA

Liver fibrosis breakthrough with Optimer® platform

Aptamer Group PLC

Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated a novel molecular target for targeted gene therapy delivery to specific liver cells that drive scarring. This advance positions Aptamer for strategic licensing discussions with global pharmaceutical partners in the $20 billion fibrosis market.
The Optimer® technology acts as a magic bullet, precisely targeting a protein in scarred livers and delivering siRNA gene therapy to hepatic stellate cells (HSCs), which cause liver scarring. In laboratory <mark style="background-color:yellow">test</mark>s, the Optimer®-siRNA system significantly reduced processes that mimic scar tissue formation and slowed the harmful activity of HSCs.
Aptamers unique approach to target identification has led to the discovery of a specific protein marker for HSCs, setting their technology apart for precision medicine. The Optimer® platform is compatible with various RNA-based medicines, making it highly versatile.
The company is now planning outsourced in vivo studies to evaluate the platforms performance in animal models and is in discussions with major pharmaceutical companies for parallel studies. These efforts aim to confirm the efficacy and safety of the Optimer® platform, paving the way for human trials and strategic collaborations in the multi-billion-dollar fibrosis market.
Breakthrough
CLCO logo
All News 06:01
CLCO

Interim Results

Cloudcoco Group PLC

Here is a summary of the provided text
CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4 million, with 89% generated from e-commerce sales, stable gross profit of £228k, and improved gross margin to 7%. Trading Group EBITDA was £26k, and administrative expenses were reduced by 13%. The sale of legacy businesses resulted in a cash inflow of £7.9 million, enabling the repayment of MXC loan notes and strengthening the balance sheet. The companys operational highlights include adding 10 new business customers, introducing enhanced automation, onboarding new vendor distribution partners, and forming strategic partnerships. Simon Duckworth, Non-Executive Chairman, expressed confidence in the companys transformation and future growth prospects. The company aims to drive top-line growth, deliver excellent service, maintain cost discipline, and explore new opportunities.
Would you like me to generate a more in-depth summary?
Financial YearRevenue (£)Gross ProfitGross MarginEBITDAPLC Costs (£)Administrative Expenses (£)Cash Balance (£)Debt
H1 20253,383,000228,0007%26,000198,000489,000818,000Minimal debt
H1 20244,335,000228,0005%21,000251,000563,0001,042,0006,200,000 loan notes
SBTX logo
All News 06:01
SBTX

Croda Commercial Launch Progressing as Expected

SkinBioTherapeutics PLC

Here is a summary of the news article
SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ingredient designed to counteract the effects of stress on the skin and improve overall well-being by enhancing melatonin production and improving sleep quality. The company has a long-standing commercial and manufacturing agreement with Croda plc, and due to the competitiveness of the industry, SkinBioTherapeutics is under a strict confidentiality agreement regarding sales and market forecast information. The company also announces an upcoming investor presentation on July 3, 2025, regarding a recently signed commercial agreement with Superdrug. SkinBioTherapeutics is a consolidator in the skin health market, making acquisitions in complementary areas and expanding its distribution, geographical reach, and manufacturing capabilities. The companys proprietary platform, SkinBiotix®, is based on discoveries made by the translational dermatology team at the University of Manchester.
Launch
OBD logo
All News 06:01
OBD

Interim Results

Oxford Biodynamics PLC

Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The operating loss was £5.88m, a slight improvement from £5.99m in H1 2024. Cash and term deposits as of March 31, 2025, were £4.26m, up from £1.2m in the previous year.
The company highlighted several corporate and operational highlights, including the appointment of Iain Ross as Executive Chairman and the growth in sales of the EpiSwitch PSE test. They also announced an agreement with Bupa UK to cover the EpiSwitch PSE test.
The financial highlights included an equity placing, subscription, and retail offer, raising gross proceeds of £7.35m in January 2025.
In his comments, Iain Ross, the Executive Chairman, emphasized the importance of "doing deals" for the commercial success and non-dilutive funding of the business. He also acknowledged that while they are in commercial discussions with third parties, no substantive deals have been finalized yet, and there is no guarantee within the current cash runway.
The text also includes an executive chairmans review, financial review, and detailed financial statements, providing insights into the companys performance and financial position.
YearRevenueOperating LossCash and Term DepositsEquity Placing
2025£587k£5.88m£4.26m£7.35m
2024£327k£5.99m£1.2mN/A
DKL logo
All News 06:01
DKL

2024 Final Results and Financing Update

Dekeloil Public Ltd

Dekel Agri-Vision Plc, a West African agribusiness company, released its financial results for the year ended December 31, 2024, highlighting stable Group EBITDA at €2.6 million. The Palm Oil Operation contributed a positive EBITDA of €3.9 million, while the Cashew Operation reported an improved EBITDA loss of €1.3 million. The company also announced a financial restructuring, including equity fundraising and debt facility revisions, strengthening its balance sheet. The outlook for 2025 is positive, with expectations of enhanced results driven by the ongoing turnaround of the Cashew Operation and rebounding CPO prices.
YearPalm Oil Operation RevenuePalm Oil Operation Gross MarginPalm Oil Operation Gross Margin %Palm Oil Operation EBITDACashew Operation RevenueCashew Operation EBITDAGroup EBITDA
2024€28.2m€5.1m18.1%€3.9m€1.8m€(1.3)m€2.6m
2023€37.2m€6.5m17.5%€4.8m€1.1m€(2.2)m€2.6m
% change-24.2%-21.5%3.4%-18.7%63.6%40.9%No change
ADVT logo
All News 06:01
ADVT

Final Results for Year Ending 28 February 2025

AdvancedAdvT Ltd

Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company reported strong financial performance, including revenue from operations of £43.3 million and recurring revenue of £34.8 million, representing 80.3% of total revenues. The adjusted EBITDA from operations was £11.3 million, ahead of management expectations, and the pre-tax profit from continuing operations was £11.3 million. Cash and cash equivalent assets were reported as £109.5 million. The company also highlighted its proforma financial performance, with organic revenue growth of 17.8% and adjusted EBITDA growth of 90.0% on acquired businesses.
During the period, Advanced AdvT Limited made several acquisitions, including Celaton Limited, HFX Limited, and GOSS Technology Limited, strengthening their position in the market. The companys Chairperson, Vin Murria, emphasized the groups focus on digital transformation and their commitment to supporting customers strategic delivery. The companys CFO, Gavin Hugill, provided additional insights into the financial highlights and operational review.
The Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Consolidated Statement of Changes in Equity, and Consolidated Statement of Cash Flow provided detailed financial information for the year ending February 28, 2025, and the previous eight-month period ending February 29, 2024. The report also included critical accounting judgments, alternative performance measures, and segment information. Overall, Advanced AdvT Limited demonstrated strong financial performance and a commitment to growth through acquisitions and digital transformation.
Financial YearRevenue from Operations (£)Recurring Revenue (£)Adjusted EBITDA from Operations (£)Pre-tax Profit from Continuing Operations (£)Basic EPSCash and Cash Equivalents (£)
Year Ending 28 Feb 202543.3 million34.8 million11.3 million11.3 million8p109.5 million
Period Ending 29 Feb 2024 (8 months)21.1 million16.3 million4.4 million5.1 million5p102.9 million
VRCI logo
All News 06:01
VRCI

Final Results

Verici Dx Plc

Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 million in 2023, primarily due to a commercial contract with Thermo Fisher for the PTRA (Pre Transplant Risk Assessment) test. The adjusted EBITDA loss for the year was US$5.4 million, an improvement from US$7.6 million in 2023. Verici Dx also conducted an equity fundraise in February 2024, raising US$8.2 million in gross proceeds.
Operational highlights include the successful transfer of urine samples to Thermo Fisher, triggering milestone payments, and a collaboration with The Westmead Institute for Medical Research in Australia. The company received CLIA certification and CAP accreditation for its clinical laboratory, enabling testing for patients across 51 US states.
Post-period highlights include securing Medicare coverage for Verici Dxs Tutivia™ assay and a strong acceleration in Tutivia™ testing orders in Q1 2025. The company is proposing an equity fundraising to extend its cash runway and achieve commercial objectives for Tutivia™.
The directors believe that additional funding can be obtained to enable the company to continue operations for at least the next 12 months. However, there is uncertainty regarding the timing and quantum of cash receipts from revenue, and the directors are taking steps to secure funding arrangements.
<>Verici Dx Plc Financials and Debt Year on Year
YearRevenue (in millions)Adjusted EBITDA (in millions)Cash Balance (in millions)Net Proceeds from Equity Fundraising (in millions)
2024$3.3-$5.4$4.1$7.5
2023$1.0-$7.6$2.6N/A
MPL logo
All News 06:01
MPL

Full Year Results

Mercantile Ports & Logistics Ltd

Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite facing challenges such as reduced activity due to government elections and procedural issues, the company generated revenues of £4.35 million. The companys focus for the year was on resolving its outstanding debt obligations, and it remains optimistic about reaching a favorable agreement with lenders. MPL expects to diversify its revenue streams, expand its service offerings, and enhance operational efficiency in 2025. The companys long-term prospects remain positive, and it continues to receive strong support from its major shareholder, Hunch Ventures.
YearRevenueCost of SalesGross MarginAdministrative ExpensesOther IncomeDepreciationImpairment LossOperating LossFinance IncomeFinance CostNet Financing CostLoss Before Tax
20244,3522,3302,0222,8419214,7406,77211,410347,2917,25718,667
20235,4622,4173,0453,2665905,5819,85315,065256,2256,20021,265
CRTA logo
All News 06:01
CRTA

$700K Multiyear Data Integration Contract Renewal

Cirata plc

Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the banks confidence in Ciratas data migration, synchronization, and disaster recovery capabilities. This contract will be facilitated through the Google Marketplace, and the announcement is considered inside information per the UK Market Abuse Regulation. The companys CEO, Stephen Kelly, is responsible for the announcements release. The contact details for Cirata, its financial advisors, and brokers are provided for further inquiries. The London Stock Exchanges news service, RNS, disseminates this information, and users are responsible for adhering to its terms and conditions.
NewContract
OPTI logo
All News 06:01
OPTI

Final Results

OptiBiotix Health Plc

OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners and sales in key markets like the USA and India. The order book for Q1 2025 surpassed sales achieved in H1 2024, and there were multiple product launches and new partnerships across various regions. The companys investments in sales and marketing are delivering returns, and it expects all parts of the business to become profitable as it reduces costs and grows its top line. OptiBiotix ended 2024 with a strong balance sheet and cash position, and it anticipates continuing its upward trajectory. The Chairmans and Chief Executive Officers reports provide further insights into the companys performance and future outlook.
YearRevenueCost of SalesGross ProfitSelling CostsR&D and Patent CostsOther Operating CostsTotal Administrative ExpensesOperating LossFinance IncomeShare of Loss from AssociateGain/Loss on InvestmentsProfit/Loss Before TaxTotal Comprehensive Income
2024870k539k331k651k294k1,605k2,597k2,266k1k350k486k1,866k1,805k
2023644k324k320k125k223k1,662k2,016k1,696k1k323k513k2,043k2,039k
CPX logo
All News 06:01
CPX

Global Distribution Agreement with RS Group plc

CAP-XX Limited

CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reach by making their prismatic, cylindrical, and hybrid supercapacitors more accessible through RS Groups extensive logistics network. With RS Groups presence in over 30 countries and a customer base that includes industrial OEMs and automation engineers, this partnership will enhance CAP-XXs ability to meet the rising global demand for their products. This agreement is part of CAP-XXs strategy to strengthen its global distribution network, which also includes partnerships with Farnell and Digi-Key, positioning the company to support a wide range of applications across various industries. The companys high-performance supercapacitors are known for their high-power density and energy storage capacity, making them valuable in consumer electronics, industrial automation, and renewable energy sectors.
Agreement
SKA logo
All News 06:01
SKA

Annual Results for the year ended 31 December 2024

Shuka Minerals Plc

Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board changes, and the appointment of Richard Lloyd as the new CEO. Shuka Minerals faced production and output challenges at its Rukwa coal mine in Tanzania but expects a restart in mining operations soon. The company entered into a funding commitment with Gathoni Muchai Investments (GMI) for an unsecured, non-convertible, interest-free loan of £500,000, with an additional £1.5 million extension subject to due diligence. Shuka Minerals also agreed to acquire 100% of Leopard Exploration and Mining Limited (LEM), the registered holder of a large-scale mining license for the Kabwe Lead-Zinc-Silver-Vanadium mine in Zambia. The companys financial statements were audited by PKF Littlejohn LLP, who highlighted a material uncertainty related to going concern and emphasized the need to operationalize the 16% Government of Tanzania non-dilutable free carried share interest.
YearRevenueCost of SalesGross LossAdmin ExpensesGroup Operating LossFinance IncomeFinance CostsLoss on Operations
20242,305198,2611,799,5841,997,8452,3519,4332,004,927
2023194,346244,5311,424,1201,668,6513,25616,1331,681,528
RVRG logo
All News 06:01
RVRG

2025 Half-year Report

River Global Plc

River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions for the active asset management industry, with geopolitical turmoil and economic uncertainties impacting investor confidence. Despite these challenges, River Global has made progress in consolidating its asset management business and joint ventures. The A Ordinary Shares business interest reported a loss before taxation of £2.8 million, while the B Shares business interest, representing the companys structured equity interest in Parmenion, reported a profit of £1.2 million. The companys chairman, Martin Gilbert, remains optimistic about the future, focusing on cost-cutting measures and driving efficiencies. The report also includes details on the share reorganization, business review, financial statements, and segmental analysis.
YearLoss on EBITDATotal LossA Ordinary SharesB Shares
2025£0.2m£1.6m-£1.5m£1.3m
2024£1.3m£3.0m-£2.9m£1.2m
WSG logo
All News 06:01
WSG

£680,000 New Contract Awards

Westminster Group Plc

Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, including a sophisticated audio-visual system for broadcasting and recording debates. The second contract is with a worldwide broadcaster for advanced security screening systems in their UK operations. Westminsters CEO, Peter Fowler, highlights the potential for expansion and the importance of these contracts, especially the East African Parliament project. The company specializes in technology-based security solutions and managed services, with a focus on surveillance, detection, and tracking technologies, and has a global presence in over 50 countries. The Westminster Group Foundation, the groups CSR arm, aims to support communities through poverty relief, education, and healthcare initiatives.
NewContract
PRV logo
All News 06:01
PRV

Interim Results

Porvair plc

Porvair PLC, a specialist filtration, laboratory, and environmental technology group, released its interim results for the six months ended May 31, 2025. The Groups revenue increased by 3% to £97.7 million, with a 5% growth on a constant currency basis. Adjusted operating profit was 1% higher at £12.6 million, while operating profit increased by 3% to £11.9 million. The Group also saw improvements in adjusted profit before tax, profit before tax, adjusted basic earnings per share, and basic earnings per share. Porvairs closing cash balance was £17.1 million, and the interim dividend was increased by 0.1 pence per share.
The Groups performance was mixed across its end markets, with strength in certain industrial businesses and laboratory instruments offsetting softness in aerospace and foundry, along with foreign exchange headwinds. The Group continues to monitor the macro-economic uncertainty and tariff environment, noting that its manufacturing footprint primarily serves local customers.
Hooman Caman Javvi, Chief Executive, highlighted the Groups underlying growth trends, including tightening environmental regulation, the growth of analytical science, the need for clean water, and the development of carbon-efficient transportation. The Groups return on capital employed was 14%, and the Board remains confident in the Groups capabilities based on its long-term growth record.
The Groups strategy remains focused on developing specialist filtration, laboratory, and environmental technology businesses, with consistent earnings growth and selected ESG measures as key success indicators. Porvairs businesses are characterized by their specialist design, engineering, and commercial skills, mandated product use, and long-life-cycle systems.
The Board understands the importance of responsible business development and highlights that most of Porvairs products are used for environmental benefits. The Group published a full ESG report in February 2025, outlining its ESG management framework, goals, and metrics.
The Groups divisions, Aerospace & Industrial, Laboratory, and Metal Melt Quality, showed varied performances. Aerospace & Industrial revenue increased by 10%, while Laboratory revenue grew by 1%. Metal Melt Quality revenue decreased by 6%, impacted by lower industrial demand.
The Groups cash flow and cash position improved, with cash generated from operations at £10.2 million and net cash of £17.1 million. The Group continues to invest in capital expenditure and acquisitions, focusing on markets with long-term growth potential and geographic presence aligned with its end markets.
Overall, Porvair PLCs performance for the first six months of 2025 was in line with expectations, and the Group remains well-positioned to benefit from global trends and its long-term growth drivers.
Financial YearRevenueOperating ProfitAdjusted Operating ProfitProfit Before TaxAdjusted Profit Before TaxEarnings Per ShareAdjusted Earnings Per ShareNet Cash
H1 2025£97.7 million£11.9 million£12.6 million£11.3 million£12.0 million19.0 pence20.0 pence£17.1 million
H1 2024£94.6 million£11.6 million£12.5 million£10.6 million£11.5 million18.1 pence19.5 pence£4.1 million
Growth3%3%1%7%4%5%3%N/A
SCP logo
All News 06:01
SCP

Half-year Report

Schroder UK Mid Cap Fund PLC

Here is a summary of the text provided
Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly continuation vote, and a more active buy-back policy. The portfolio NAV saw a negative return of 9.3%, underperforming the Benchmark, but the Company NAV has since outperformed the Benchmark by 2.1 percentage points. The Board announced an interim dividend of 6.3 pence per share, reflecting the ongoing recovery in portfolio income. The discount of the Companys share price to NAV narrowed to 7.9% as of March 31, 2025. The Companys net gearing ratio was 9.5%, and the Board remains confident in the UK mid-cap markets attractiveness and potential for correction in valuation dislocation. The outlook for the Company is positive, with experienced portfolio managers and attractive valuations. The report also includes details on investment and share price performance, dividend, discount management, gearing, and an investment managers review.
YearRevenueCapitalTotalNet AssetsNet Gearing
2025£3,944£(24,100)£(20,156)£215,4239.5%
2024£3,158£18,365£21,523£228,342N/A
2023£8,737£31,395£40,132£242,966N/A
MDZ logo
All News 06:01
MDZ

Half-year Report

MediaZest plc

MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million and a 61% increase in gross profit, resulting in a return to profitability at the EBITDA and pre-tax levels. This positive trend is expected to continue in the second half of the financial year due to recent project wins and new business activity. The basic and diluted profit per share was 0.0031 pence, compared to a loss per share of 0.0092 pence in the previous period. The companys long-term client base remains consistent and continues to generate new opportunities, including digital signage solutions for Pets at Home and new dealership experiences for Hyundai and KIA. MediaZest also completed work for Lululemon Athletica and ArcTeryx, featuring LED technology. A significant new contract was won to deliver audio-visual experiences in airports worldwide. The Groups recurring revenue streams continue to expand, generating over £1 million per annum. The Board believes the outlook for MediaZest is encouraging and well-positioned for continued growth, with a positive start to H2 FY25 and a strong pipeline for FY26 and beyond.
Financial MetricsH1 FY25H1 FY24Change
Revenue£1,906,000£1,173,00063% increase
Gross Profit£1,127,000£701,00061% increase
Gross Margin59%60%1% decrease
EBITDA£197,000£(28,000)Positive change
Profit/(Loss) after tax£53,000£(141,000)Positive change
Profit/(Loss) per share (pence)0.0031(0.0092)Positive change
(Bank overdraft) / Cash in hand(£7,000)£14,000Negative change

The table above compares the financial metrics of MediaZest Plc for the first half of the financial year 2025 (H1 FY25) with the same period in the previous year (H1 FY24). The company has shown significant improvement in revenue, gross profit, EBITDA, and profit after tax. However, there was a slight decrease in gross margin and a negative change in cash position.

Debt MetricsH1 FY25H1 FY24Change
Invoice discounting facility£39,000£227,000Repaid £188,000
Short-term funding agreementUp to £60,000N/ANew agreement
Interest-bearing loans and borrowings (current liabilities)£1,359,000£1,524,000Decrease of £165,000
Interest-bearing loans and borrowings (non-current liabilities)£456,000£7,000Increase of £449,000

Regarding debt, MediaZest Plc has made significant changes. They have repaid a substantial amount of their invoice discounting facility and entered into a short-term funding agreement. There has been a decrease in interest-bearing loans and borrowings under current liabilities, while there is a notable increase in such borrowings under non-current liabilities.

AI 0 news titles 0

No news for this category in the selected date range.

Acquisitions 5 news titles 5
Agreement 3 news titles 3
KOD logo
Agreement 07:31
KOD

Bougouni Lithium Project Off-Take Agreement

Kodal Minerals PLC

Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the projects DMS processing plant for four years, with an annual review of quantities and floor price. The price is referenced to the Shanghai Metals Market and will be subject to adjustments based on grade, quality, and delivery terms. The agreement includes a "take or pay" clause, with LMLB supplying spodumene exclusively to Hainan, who must purchase the agreed-upon quantity. The DMS processing plant has already produced over 40,000 tonnes of spodumene concentrate, and the company is working to secure an export license from the Mali government. The first phase of the project is expected to produce 100,000-120,000 tonnes per year of lithium concentrate with a yield of more than 5.5% Li2O.
Agreement
SSTY logo
Agreement 06:01
SSTY

Lease agreement to operate hostel in Naples

Safestay PLC

Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnership between the two companies, with plans to expand into other key Italian cities. The Naples hostel, set in a former monastery, is expected to open in August 2025 and will offer guests a range of amenities, including ancillary services. This expansion aligns with Safestays growth strategy and goal to double its portfolio size in the medium term.
Agreement
CPX logo
Agreement 06:01
CPX

Global Distribution Agreement with RS Group plc

CAP-XX Limited

CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reach by making their prismatic, cylindrical, and hybrid supercapacitors more accessible through RS Groups extensive logistics network. With RS Groups presence in over 30 countries and a customer base that includes industrial OEMs and automation engineers, this partnership will enhance CAP-XXs ability to meet the rising global demand for their products. This agreement is part of CAP-XXs strategy to strengthen its global distribution network, which also includes partnerships with Farnell and Digi-Key, positioning the company to support a wide range of applications across various industries. The companys high-performance supercapacitors are known for their high-power density and energy storage capacity, making them valuable in consumer electronics, industrial automation, and renewable energy sectors.
Agreement
Approvals 1 news title 1
HCM logo
Approvals 08:31
HCM

China Approval based on Phase III SACHI Trial

HUTCHMED China Ltd

HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-small cell lung cancer with MET amplification after progression on EGFR inhibitor therapy. The approval is based on the positive results of the SACHI Phase III trial, which showed a significant improvement in progression-free survival for patients treated with the combination compared to chemotherapy. ORPATHYS® is an oral MET inhibitor, and TAGRISSO® is a third-generation EGFR inhibitor. This approval provides a new treatment option for lung cancer patients in China and triggers a US$11 million milestone payment from AstraZeneca, which markets both drugs in the country.
Approvals
Authorisation 0 news titles 0

No news for this category in the selected date range.

Awards 0 news titles 0

No news for this category in the selected date range.

BTC 1 news title 1
Blockchain 0 news titles 0

No news for this category in the selected date range.

Breakthrough 1 news title 1
APTA logo
Breakthrough 06:01
APTA

Liver fibrosis breakthrough with Optimer® platform

Aptamer Group PLC

Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated a novel molecular target for targeted gene therapy delivery to specific liver cells that drive scarring. This advance positions Aptamer for strategic licensing discussions with global pharmaceutical partners in the $20 billion fibrosis market.
The Optimer® technology acts as a magic bullet, precisely targeting a protein in scarred livers and delivering siRNA gene therapy to hepatic stellate cells (HSCs), which cause liver scarring. In laboratory <mark style="background-color:yellow">test</mark>s, the Optimer®-siRNA system significantly reduced processes that mimic scar tissue formation and slowed the harmful activity of HSCs.
Aptamers unique approach to target identification has led to the discovery of a specific protein marker for HSCs, setting their technology apart for precision medicine. The Optimer® platform is compatible with various RNA-based medicines, making it highly versatile.
The company is now planning outsourced in vivo studies to evaluate the platforms performance in animal models and is in discussions with major pharmaceutical companies for parallel studies. These efforts aim to confirm the efficacy and safety of the Optimer® platform, paving the way for human trials and strategic collaborations in the multi-billion-dollar fibrosis market.
Breakthrough
BuyBack 0 news titles 0

No news for this category in the selected date range.

Cancellations 1 news title 1
CashOffer 0 news titles 0

No news for this category in the selected date range.

Collaborate 0 news titles 0

No news for this category in the selected date range.

ContractWin 0 news titles 0

No news for this category in the selected date range.

Covid-19 0 news titles 0

No news for this category in the selected date range.

Deals 0 news titles 0

No news for this category in the selected date range.

Diamond 0 news titles 0

No news for this category in the selected date range.

DirectorDealing 37 news titles 37
CLAI logo
DirectorDealing 17:16
CLAI

Director's Dealings

Cel AI PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
NCYF logo
DirectorDealing 15:16
NCYF

Director/PDMR Shareholding

CQS New City High Yield Fund

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
CCH logo
DirectorDealing 14:33
CCH

Director/PDMR Shareholding

Coca Cola HBC AG

<mark style="background-coloryellow">PURCHASE</mark> OF ORDINARY SHARES FOLLOWING THE RE-INVESTMENT OF DIVIDENDS PAID ON THE EMPLOYEES SHARES HELD UNDER THE COMPANYS EQUITIES PLANS
PAG logo
DirectorDealing 10:34
PAG

Director/PDMR Shareholding

Paragon Banking Group PLC

<mark style="background-coloryellow">Purchase</mark> of shares pursuant to the Companys Salary in Shares remuneration arrangements.
ROQ logo
DirectorDealing 06:01
ROQ

Director/PDMR Shareholding

Roquefort Investments PLC

<mark style="background-coloryellow">Purchase</mark> of 72,507 ordinary shares
Discovery 0 news titles 0

No news for this category in the selected date range.

Exceeded 0 news titles 0

No news for this category in the selected date range.

FCA 0 news titles 0

No news for this category in the selected date range.

FDA 0 news titles 0

No news for this category in the selected date range.

Grants 0 news titles 0

No news for this category in the selected date range.

InvestmentPlan 0 news titles 0

No news for this category in the selected date range.

JV 0 news titles 0

No news for this category in the selected date range.

Launch 5 news titles 5
VOD logo
Launch 06:28
VOD

Vodafone Group Plc launches Cash Tender Offers

Vodafone Group PLC

Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates ranging from 2043 to 2059. The company has set a maximum tender amount and acceptance priority levels for each series of notes. The tender offer is subject to certain terms and conditions, including a financing condition related to the issuance of new sterling-denominated notes. The company has retained Merrill Lynch International and Deutsche Bank AG as dealer managers and Kroll Issuer Services Limited as the tender and information agent for the offer. The offer period includes key dates such as the early tender deadline, price determination date, and settlement dates. The offer is subject to applicable laws and regulations in various jurisdictions, including Italy, the United Kingdom, France, and Belgium. The company also provides forward-looking statements and information about its purpose and commitment to environmental sustainability.
Launch
SBTX logo
Launch 06:01
SBTX

Croda Commercial Launch Progressing as Expected

SkinBioTherapeutics PLC

Here is a summary of the news article
SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ingredient designed to counteract the effects of stress on the skin and improve overall well-being by enhancing melatonin production and improving sleep quality. The company has a long-standing commercial and manufacturing agreement with Croda plc, and due to the competitiveness of the industry, SkinBioTherapeutics is under a strict confidentiality agreement regarding sales and market forecast information. The company also announces an upcoming investor presentation on July 3, 2025, regarding a recently signed commercial agreement with Superdrug. SkinBioTherapeutics is a consolidator in the skin health market, making acquisitions in complementary areas and expanding its distribution, geographical reach, and manufacturing capabilities. The companys proprietary platform, SkinBiotix®, is based on discoveries made by the translational dermatology team at the University of Manchester.
Launch
Litigation 0 news titles 0

No news for this category in the selected date range.

NewContract 3 news titles 3
CRTA logo
NewContract 06:01
CRTA

$700K Multiyear Data Integration Contract Renewal

Cirata plc

Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the banks confidence in Ciratas data migration, synchronization, and disaster recovery capabilities. This contract will be facilitated through the Google Marketplace, and the announcement is considered inside information per the UK Market Abuse Regulation. The companys CEO, Stephen Kelly, is responsible for the announcements release. The contact details for Cirata, its financial advisors, and brokers are provided for further inquiries. The London Stock Exchanges news service, RNS, disseminates this information, and users are responsible for adhering to its terms and conditions.
NewContract
WSG logo
NewContract 06:01
WSG

£680,000 New Contract Awards

Westminster Group Plc

Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, including a sophisticated audio-visual system for broadcasting and recording debates. The second contract is with a worldwide broadcaster for advanced security screening systems in their UK operations. Westminsters CEO, Peter Fowler, highlights the potential for expansion and the importance of these contracts, especially the East African Parliament project. The company specializes in technology-based security solutions and managed services, with a focus on surveillance, detection, and tracking technologies, and has a global presence in over 50 countries. The Westminster Group Foundation, the groups CSR arm, aims to support communities through poverty relief, education, and healthcare initiatives.
NewContract
Offers 2 news titles 2
Offtake 0 news titles 0

No news for this category in the selected date range.

Orders 0 news titles 0

No news for this category in the selected date range.

Partner 0 news titles 0

No news for this category in the selected date range.

Patents 0 news titles 0

No news for this category in the selected date range.

Placing 9 news titles 9
Positive 0 news titles 0

No news for this category in the selected date range.

Proposals 0 news titles 0

No news for this category in the selected date range.

Reports 38 news titles 38
PR1 logo
Reports 15:23
PR1

Half-year Report

Pri0r1ty Intelligence Group PLC

Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report reflects only three months of Pri0r1ty trading. During this time, they generated £37,000 in revenue, with 40 customers using their products and 20% paying for services. They also formed strategic partnerships, developed new revenue-generating products, and successfully integrated cryptocurrency payments. The company expects to see increased platform adoption in the second half of 2025 and remains on track to onboard at least 100 paying users by the financial year-end. The financial statements include details on the companys financial position, changes in equity, and cash flows for the period.
Financial YearRevenue (£)Cost of Sales (£)Gross Profit (£)Other Expenses (£)Earnings Before Interest, Tax, Depreciation, and Amortization (£)Interest Expenditure (£)Loss Before Taxation (£)Income Tax (£)Profit/ (Loss) for the Year (£)
31 March 2025 (unaudited)37,000037,000570,436-860,2670-860,2670-860,267
31 March 2024 (unaudited)000151,301-151,3010-151,3010-151,301

| Debt | 31 March 2025 (Unaudited) | 31 March 2024 (Unaudited) | | --- | --- | --- | | Trade and Other Payables (£) | 400,397 | 68,842 |
TEAM logo
Reports 06:07
TEAM

Half-year Report

TEAM plc

Here is a summary of the text provided
TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% increase in revenues to £5.8 million, with total client assets surpassing £1.1 billion. TEAM also successfully raised £2.96 million through equity and convertible loan instruments, and had £2.16 million in cash reserves as of March 31, 2025.
The companys operational highlights include growth in total client assets across its divisions, a successful group-wide cost reduction program, and the upcoming launch of the TEAM UCITS fund. The outlook for the remainder of the financial year remains positive, with a continued focus on migrating client assets to MPS and expanding the international advisory network.
Mark Clubb, Executive Chairman of TEAM, expressed confidence in the companys trajectory and mid-term targets, which include annual revenue of £20 million, an EBITDA margin exceeding 30%, and Assets Under Advice/Management of £4 billion. The company is focused on execution, with the UCITS fund launch being central to driving growth and achieving profitability.
The financial review highlights the companys improved financial position and continued revenue growth, with the goal of achieving month-on-month profitability. The segmental analysis shows the performance of the Groups three principal operating segments: Investment and Fund Management, Advisory and Consultancy, and International.
Overall, the results demonstrate TEAM PLCs strong performance and positive trajectory, with a focus on growth and achieving financial targets.
| | HY 25 | HY 24 | |---|---|---| | Revenues | £5.8m | £4.1m | | Total client assets | £1.112bn | £0.9bn | | Cash in bank | £2.16m | £1.5m | | Total Equity Raised | £1.96m | - | | Convertible Loan Notes | £1m | - | | Gross Total Raised | £2.96m | - | | Underlying loss before tax | £796k | £992k | | Loss before tax | £1.757m | £1.013m | | Loss for the period | £1.757m | £1.010m | | Loss per share | 3.6 pence | 3.5 pence |
RVRG logo
Reports 06:01
RVRG

2025 Half-year Report

River Global Plc

River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions for the active asset management industry, with geopolitical turmoil and economic uncertainties impacting investor confidence. Despite these challenges, River Global has made progress in consolidating its asset management business and joint ventures. The A Ordinary Shares business interest reported a loss before taxation of £2.8 million, while the B Shares business interest, representing the companys structured equity interest in Parmenion, reported a profit of £1.2 million. The companys chairman, Martin Gilbert, remains optimistic about the future, focusing on cost-cutting measures and driving efficiencies. The report also includes details on the share reorganization, business review, financial statements, and segmental analysis.
YearLoss on EBITDATotal LossA Ordinary SharesB Shares
2025£0.2m£1.6m-£1.5m£1.3m
2024£1.3m£3.0m-£2.9m£1.2m
SCP logo
Reports 06:01
SCP

Half-year Report

Schroder UK Mid Cap Fund PLC

Here is a summary of the text provided
Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly continuation vote, and a more active buy-back policy. The portfolio NAV saw a negative return of 9.3%, underperforming the Benchmark, but the Company NAV has since outperformed the Benchmark by 2.1 percentage points. The Board announced an interim dividend of 6.3 pence per share, reflecting the ongoing recovery in portfolio income. The discount of the Companys share price to NAV narrowed to 7.9% as of March 31, 2025. The Companys net gearing ratio was 9.5%, and the Board remains confident in the UK mid-cap markets attractiveness and potential for correction in valuation dislocation. The outlook for the Company is positive, with experienced portfolio managers and attractive valuations. The report also includes details on investment and share price performance, dividend, discount management, gearing, and an investment managers review.
YearRevenueCapitalTotalNet AssetsNet Gearing
2025£3,944£(24,100)£(20,156)£215,4239.5%
2024£3,158£18,365£21,523£228,342N/A
2023£8,737£31,395£40,132£242,966N/A
MDZ logo
Reports 06:01
MDZ

Half-year Report

MediaZest plc

MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million and a 61% increase in gross profit, resulting in a return to profitability at the EBITDA and pre-tax levels. This positive trend is expected to continue in the second half of the financial year due to recent project wins and new business activity. The basic and diluted profit per share was 0.0031 pence, compared to a loss per share of 0.0092 pence in the previous period. The companys long-term client base remains consistent and continues to generate new opportunities, including digital signage solutions for Pets at Home and new dealership experiences for Hyundai and KIA. MediaZest also completed work for Lululemon Athletica and ArcTeryx, featuring LED technology. A significant new contract was won to deliver audio-visual experiences in airports worldwide. The Groups recurring revenue streams continue to expand, generating over £1 million per annum. The Board believes the outlook for MediaZest is encouraging and well-positioned for continued growth, with a positive start to H2 FY25 and a strong pipeline for FY26 and beyond.
Financial MetricsH1 FY25H1 FY24Change
Revenue£1,906,000£1,173,00063% increase
Gross Profit£1,127,000£701,00061% increase
Gross Margin59%60%1% decrease
EBITDA£197,000£(28,000)Positive change
Profit/(Loss) after tax£53,000£(141,000)Positive change
Profit/(Loss) per share (pence)0.0031(0.0092)Positive change
(Bank overdraft) / Cash in hand(£7,000)£14,000Negative change

The table above compares the financial metrics of MediaZest Plc for the first half of the financial year 2025 (H1 FY25) with the same period in the previous year (H1 FY24). The company has shown significant improvement in revenue, gross profit, EBITDA, and profit after tax. However, there was a slight decrease in gross margin and a negative change in cash position.

Debt MetricsH1 FY25H1 FY24Change
Invoice discounting facility£39,000£227,000Repaid £188,000
Short-term funding agreementUp to £60,000N/ANew agreement
Interest-bearing loans and borrowings (current liabilities)£1,359,000£1,524,000Decrease of £165,000
Interest-bearing loans and borrowings (non-current liabilities)£456,000£7,000Increase of £449,000

Regarding debt, MediaZest Plc has made significant changes. They have repaid a substantial amount of their invoice discounting facility and entered into a short-term funding agreement. There has been a decrease in interest-bearing loans and borrowings under current liabilities, while there is a notable increase in such borrowings under non-current liabilities.

Results 59 news titles 59
SBDS logo
Results 16:14
SBDS

Final Results for the year ended 31 December 2024

Silver Bullet Data Services Group PLC

Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million, with a gross profit of £7.13 million, representing a 12% increase. The companys services revenue increased by 8% to £6.0 million, while its 4D revenue grew by 20% to £3.37 million, driven by US demand. US and globally operating clients now account for over 60% of total group revenues. Silver Bullet also reported a positive EBITDA during Q4 of FY24 and a strong start to 2025. The company raised £3.3 million through the issue of new convertible loan notes and restructured its existing CLNs, simplifying its capital structure and aligning financing with its growth plans.
YearRevenueGross ProfitLoss Before TaxLoss Per Share
2024£9.37m£7.13m£3.04m£0.17
2023£8.36m£6.36m£3.45m£0.20
80M logo
Results 15:16
80M

Final Results for the year ended 31 December 2024

80 Mile Plc

80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue remained nil, while its cost of sales decreased to £35,887 from £213,523 in the previous year. 80 Mile Plcs administrative expenses increased to £2,262,385 from £1,629,273 in the previous year. The companys impairment of intangible assets decreased to £4,902,058 from £3,535,254 in the previous year. 80 Mile Plcs share of losses from joint ventures increased to £18,114 from £13,779 in the previous year. The companys other losses increased to £2,259,088 from a gain of £2,962,769 in the previous year. 80 Mile Plcs finance expense decreased to £1,663 from a finance income of £7,039 in the previous year. The companys other income increased to £116,844 from £320,925 in the previous year. As of December 31, 2024, 80 Mile Plcs total assets decreased to £34,153,950 from £40,520,554 in the previous year. The companys total liabilities decreased to £1,187,350 from £1,143,927 in the previous year. 80 Mile Plcs net assets decreased to £32,966,600 from £39,376,627 in the previous year.
YearFinancialsDebt
2024£34,153,950£1,187,350
2023£40,520,554£1,143,927
JARA logo
Results 14:50
JARA

Final results for the year ended 28 February 2025

Jpmorgan Global Core Real Assets Ltd

Here is a summary of the text provided
JPMorgan Global Core Real Assets Limited has released its final results for the year ended February 28, 2025, announcing a managed wind-down of the company and a shift in its investment objective. The companys continuation vote failed to pass at the 2024 AGM, leading to a new strategy that involves liquidating assets and returning capital to shareholders. As of February 28, 2025, the company has realized its holdings in the Listed Real Assets Strategy, with the exception of Home REIT plc, and has made significant progress in redeeming its holdings in other strategies. The Board expects to have realized and returned over 55% of assets to shareholders by the end of 2025 and over 80% by the end of 2026. The companys return on net asset value was 5.2% for the year, while the return to shareholders was 36.8%. The Board has taken steps to reduce costs, including reducing directors fees and disbanding certain committees. The companys sixth AGM will be held on August 28, 2025, and the Board encourages shareholders to vote in advance. The Board acknowledges the challenges faced by the company since its launch in 2019 but remains focused on liquidating assets and returning proceeds to shareholders efficiently.
YearFinancialsDebt
2025£162,311,000£35,260,000
2024£196,411,000£3,682,000
EAAS logo
Results 14:19
EAAS

Final Results

Eenergy Group PLC

eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and transitioned into profit with an Adjusted EBITDA of £0.6 million. The companys net debt was reduced to £2.4 million, and it was awarded a solar installation contract worth £5.2 million with Spire Healthcare. The companys outlook for FY2025 is optimistic, with a strong contracted forward order book and increased sales pipeline. The company expects to be cash positive in H1 2025 and further cash generative in H2 2025.
<>eEnergy Group Financials
YearRevenueAdjusted EBITDANet DebtCash
2024£25.1 million£0.6 million£2.4 million£2.3 million
2023£14.7 million-£6.4 million£8.0 million£0.6 million
VLG logo
Results 14:14
VLG

Final Results for year ended 31 December 2024

Venture Life Group PLC

Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported strong growth in its core business, with a revenue increase of 18.9% to £26.6 million and an underlying growth of 14.9% excluding acquisitions. The gross profit increased by 31.1% to £12.2 million, and the gross margin improved to 45.8%. The adjusted EBITDA rose by 26.1% to £6.2 million, and the adjusted profit before tax increased to £4.3 million. The company also announced the sale of its contract development and manufacturing operations and certain non-core products for €62 million in cash. The Board expects to complete the sale of its oral care brands, which are now considered non-core, by the end of 2025.
YearRevenueGross ProfitMarketing CostsAdjusted EBITDAAdjusted Profit Before TaxAdjusted EPSFree Cash FlowGroup Net LeverageGroup Net Debt
2024£26.6 million£12.2 million6.1%£6.2 million£4.3 million3.37p£4.3 million1.83x£18.7 million
2023£22.4 million£9.3 million3.9%£4.9 million£2.8 million2.60p£2.7 million1.30x£13.7 million
VRS logo
Results 14:04
VRS

Interim Results

Versarien PLC

Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March 31, 2025. Versariens strategy is to monetize its intellectual property and know-how by licensing its technology and brands as commercial traction for graphene develops. The company has a pipeline of commercial opportunities worth £2.1 million and is seeking additional funding to continue as a going concern. Versarien is also simplifying its corporate structure and seeking strategic partners for its 3D Construction Printing business. The Board expects the Groups ongoing costs to reduce with the simplified structure.
Financial MetricsFY 2025FY 2024Change
Group revenues£1.47 million£1.34 million10.45% increase
Graphene revenues£0.21 million£0.28 million25% decrease
Grant income£0.23 million£0.20 million15% increase
Adjusted LBITDA£0.77 million£0.67 million14.93% increase
Loss before tax£1.49 million£1.61 million7.45% decrease
Cash as of 31 March£0.85 million£0.15 million466.67% increase

Debt MetricsFY 2025FY 2024Change
Innovate UK Loan£5 million£4.5 million11.11% increase
Long-term borrowings£285£47539.99% decrease
Total debt£5,285£4,9756.23% increase
EQT logo
Results 13:27
EQT

Final Results

EQTEC plc

EQTEC plc announces its audited results for the year ended 31 December 2024.
YearRevenueOperating LossNet LossNet Assets
2024€2.2 million€3.6 million€19.4 million€13.7 million
2023€2.5 million€3.5 million€23.5 million€21.2 million
WATR logo
Results 11:01
WATR

Audited Results for Year Ended 31 December 2024

Water Intelligence plc

Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 10% to $83.3 million, with statutory profit before tax growing 2% to $6.4 million and statutory EBITDA growing by 11% to $13.1 million. The companys balance sheet remains strong, with cash of $12.1 million and a Total Net Debt to EBITDA Adjusted ratio of 1.1. The companys critical mass of sales and technology-driven foundation establish a scalable Technology Enabled Services (TES) platform. Between Q4 2024 and Q1 2025, Water Intelligence completed three strategic transactions, including reacquiring its Dallas franchise and establishing it as the headquarters for its core American Leak Detection business, forming a partnership with Chubb insurance and its StreamLabs Water business, and reaffirming its capital allocation guidance with acquisitions. The companys TES platform enables it to provide recurring Preventive Maintenance solutions and efficiently offer proprietary, technology-driven solutions to its customers. Based on its competitive strategy and the Dallas Template, the company expects to deliver higher organic revenue and profit trajectory.
YearRevenueProfit Before TaxNet Debt to EBITDA Adjusted Ratio
2024$83.3 million$6.4 million1.1
2023$76 million$6.2 millionN/A
ENET logo
Results 08:36
ENET

Results for the Year Ended 31 December 2024

Ethernity Networks Ltd

Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a gross profit decrease of 46%. However, the gross margin percentage increased to 92.1% in 2024 from 61.9% in 2023, reflecting a 30.2% improvement. The operating loss decreased by 4%, and the EBITDA loss decreased by 10%. The company raised net cash funds of $1.86 million during the year and had cash and cash equivalents of $0.05 million at the end of December 2024. Despite challenges, the company successfully exited the Temporary Suspension of Proceedings process and initiated a strategic transition to leverage its Universal Edge Platform development. The companys Chairman and CEO provided statements highlighting the companys achievements and expressing optimism for the future.
YearRevenueGross ProfitOperating LossEBITDA LossNet CashCash Equivalents
2024$1.38 million$1.3m$5.1 million$3.48 million$1.86 million$0.05 million
2023$3.78 million$2.3m$5.3 million$3.86 millionN/A$1.99 million
CLCO logo
Results 06:01
CLCO

Interim Results

Cloudcoco Group PLC

Here is a summary of the provided text
CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4 million, with 89% generated from e-commerce sales, stable gross profit of £228k, and improved gross margin to 7%. Trading Group EBITDA was £26k, and administrative expenses were reduced by 13%. The sale of legacy businesses resulted in a cash inflow of £7.9 million, enabling the repayment of MXC loan notes and strengthening the balance sheet. The companys operational highlights include adding 10 new business customers, introducing enhanced automation, onboarding new vendor distribution partners, and forming strategic partnerships. Simon Duckworth, Non-Executive Chairman, expressed confidence in the companys transformation and future growth prospects. The company aims to drive top-line growth, deliver excellent service, maintain cost discipline, and explore new opportunities.
Would you like me to generate a more in-depth summary?
Financial YearRevenue (£)Gross ProfitGross MarginEBITDAPLC Costs (£)Administrative Expenses (£)Cash Balance (£)Debt
H1 20253,383,000228,0007%26,000198,000489,000818,000Minimal debt
H1 20244,335,000228,0005%21,000251,000563,0001,042,0006,200,000 loan notes
OBD logo
Results 06:01
OBD

Interim Results

Oxford Biodynamics PLC

Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The operating loss was £5.88m, a slight improvement from £5.99m in H1 2024. Cash and term deposits as of March 31, 2025, were £4.26m, up from £1.2m in the previous year.
The company highlighted several corporate and operational highlights, including the appointment of Iain Ross as Executive Chairman and the growth in sales of the EpiSwitch PSE test. They also announced an agreement with Bupa UK to cover the EpiSwitch PSE test.
The financial highlights included an equity placing, subscription, and retail offer, raising gross proceeds of £7.35m in January 2025.
In his comments, Iain Ross, the Executive Chairman, emphasized the importance of "doing deals" for the commercial success and non-dilutive funding of the business. He also acknowledged that while they are in commercial discussions with third parties, no substantive deals have been finalized yet, and there is no guarantee within the current cash runway.
The text also includes an executive chairmans review, financial review, and detailed financial statements, providing insights into the companys performance and financial position.
YearRevenueOperating LossCash and Term DepositsEquity Placing
2025£587k£5.88m£4.26m£7.35m
2024£327k£5.99m£1.2mN/A
ADVT logo
Results 06:01
ADVT

Final Results for Year Ending 28 February 2025

AdvancedAdvT Ltd

Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company reported strong financial performance, including revenue from operations of £43.3 million and recurring revenue of £34.8 million, representing 80.3% of total revenues. The adjusted EBITDA from operations was £11.3 million, ahead of management expectations, and the pre-tax profit from continuing operations was £11.3 million. Cash and cash equivalent assets were reported as £109.5 million. The company also highlighted its proforma financial performance, with organic revenue growth of 17.8% and adjusted EBITDA growth of 90.0% on acquired businesses.
During the period, Advanced AdvT Limited made several acquisitions, including Celaton Limited, HFX Limited, and GOSS Technology Limited, strengthening their position in the market. The companys Chairperson, Vin Murria, emphasized the groups focus on digital transformation and their commitment to supporting customers strategic delivery. The companys CFO, Gavin Hugill, provided additional insights into the financial highlights and operational review.
The Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Consolidated Statement of Changes in Equity, and Consolidated Statement of Cash Flow provided detailed financial information for the year ending February 28, 2025, and the previous eight-month period ending February 29, 2024. The report also included critical accounting judgments, alternative performance measures, and segment information. Overall, Advanced AdvT Limited demonstrated strong financial performance and a commitment to growth through acquisitions and digital transformation.
Financial YearRevenue from Operations (£)Recurring Revenue (£)Adjusted EBITDA from Operations (£)Pre-tax Profit from Continuing Operations (£)Basic EPSCash and Cash Equivalents (£)
Year Ending 28 Feb 202543.3 million34.8 million11.3 million11.3 million8p109.5 million
Period Ending 29 Feb 2024 (8 months)21.1 million16.3 million4.4 million5.1 million5p102.9 million
VRCI logo
Results 06:01
VRCI

Final Results

Verici Dx Plc

Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 million in 2023, primarily due to a commercial contract with Thermo Fisher for the PTRA (Pre Transplant Risk Assessment) test. The adjusted EBITDA loss for the year was US$5.4 million, an improvement from US$7.6 million in 2023. Verici Dx also conducted an equity fundraise in February 2024, raising US$8.2 million in gross proceeds.
Operational highlights include the successful transfer of urine samples to Thermo Fisher, triggering milestone payments, and a collaboration with The Westmead Institute for Medical Research in Australia. The company received CLIA certification and CAP accreditation for its clinical laboratory, enabling testing for patients across 51 US states.
Post-period highlights include securing Medicare coverage for Verici Dxs Tutivia™ assay and a strong acceleration in Tutivia™ testing orders in Q1 2025. The company is proposing an equity fundraising to extend its cash runway and achieve commercial objectives for Tutivia™.
The directors believe that additional funding can be obtained to enable the company to continue operations for at least the next 12 months. However, there is uncertainty regarding the timing and quantum of cash receipts from revenue, and the directors are taking steps to secure funding arrangements.
<>Verici Dx Plc Financials and Debt Year on Year
YearRevenue (in millions)Adjusted EBITDA (in millions)Cash Balance (in millions)Net Proceeds from Equity Fundraising (in millions)
2024$3.3-$5.4$4.1$7.5
2023$1.0-$7.6$2.6N/A
MPL logo
Results 06:01
MPL

Full Year Results

Mercantile Ports & Logistics Ltd

Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite facing challenges such as reduced activity due to government elections and procedural issues, the company generated revenues of £4.35 million. The companys focus for the year was on resolving its outstanding debt obligations, and it remains optimistic about reaching a favorable agreement with lenders. MPL expects to diversify its revenue streams, expand its service offerings, and enhance operational efficiency in 2025. The companys long-term prospects remain positive, and it continues to receive strong support from its major shareholder, Hunch Ventures.
YearRevenueCost of SalesGross MarginAdministrative ExpensesOther IncomeDepreciationImpairment LossOperating LossFinance IncomeFinance CostNet Financing CostLoss Before Tax
20244,3522,3302,0222,8419214,7406,77211,410347,2917,25718,667
20235,4622,4173,0453,2665905,5819,85315,065256,2256,20021,265
OPTI logo
Results 06:01
OPTI

Final Results

OptiBiotix Health Plc

OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners and sales in key markets like the USA and India. The order book for Q1 2025 surpassed sales achieved in H1 2024, and there were multiple product launches and new partnerships across various regions. The companys investments in sales and marketing are delivering returns, and it expects all parts of the business to become profitable as it reduces costs and grows its top line. OptiBiotix ended 2024 with a strong balance sheet and cash position, and it anticipates continuing its upward trajectory. The Chairmans and Chief Executive Officers reports provide further insights into the companys performance and future outlook.
YearRevenueCost of SalesGross ProfitSelling CostsR&D and Patent CostsOther Operating CostsTotal Administrative ExpensesOperating LossFinance IncomeShare of Loss from AssociateGain/Loss on InvestmentsProfit/Loss Before TaxTotal Comprehensive Income
2024870k539k331k651k294k1,605k2,597k2,266k1k350k486k1,866k1,805k
2023644k324k320k125k223k1,662k2,016k1,696k1k323k513k2,043k2,039k
SKA logo
Results 06:01
SKA

Annual Results for the year ended 31 December 2024

Shuka Minerals Plc

Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board changes, and the appointment of Richard Lloyd as the new CEO. Shuka Minerals faced production and output challenges at its Rukwa coal mine in Tanzania but expects a restart in mining operations soon. The company entered into a funding commitment with Gathoni Muchai Investments (GMI) for an unsecured, non-convertible, interest-free loan of £500,000, with an additional £1.5 million extension subject to due diligence. Shuka Minerals also agreed to acquire 100% of Leopard Exploration and Mining Limited (LEM), the registered holder of a large-scale mining license for the Kabwe Lead-Zinc-Silver-Vanadium mine in Zambia. The companys financial statements were audited by PKF Littlejohn LLP, who highlighted a material uncertainty related to going concern and emphasized the need to operationalize the 16% Government of Tanzania non-dilutable free carried share interest.
YearRevenueCost of SalesGross LossAdmin ExpensesGroup Operating LossFinance IncomeFinance CostsLoss on Operations
20242,305198,2611,799,5841,997,8452,3519,4332,004,927
2023194,346244,5311,424,1201,668,6513,25616,1331,681,528
PRV logo
Results 06:01
PRV

Interim Results

Porvair plc

Porvair PLC, a specialist filtration, laboratory, and environmental technology group, released its interim results for the six months ended May 31, 2025. The Groups revenue increased by 3% to £97.7 million, with a 5% growth on a constant currency basis. Adjusted operating profit was 1% higher at £12.6 million, while operating profit increased by 3% to £11.9 million. The Group also saw improvements in adjusted profit before tax, profit before tax, adjusted basic earnings per share, and basic earnings per share. Porvairs closing cash balance was £17.1 million, and the interim dividend was increased by 0.1 pence per share.
The Groups performance was mixed across its end markets, with strength in certain industrial businesses and laboratory instruments offsetting softness in aerospace and foundry, along with foreign exchange headwinds. The Group continues to monitor the macro-economic uncertainty and tariff environment, noting that its manufacturing footprint primarily serves local customers.
Hooman Caman Javvi, Chief Executive, highlighted the Groups underlying growth trends, including tightening environmental regulation, the growth of analytical science, the need for clean water, and the development of carbon-efficient transportation. The Groups return on capital employed was 14%, and the Board remains confident in the Groups capabilities based on its long-term growth record.
The Groups strategy remains focused on developing specialist filtration, laboratory, and environmental technology businesses, with consistent earnings growth and selected ESG measures as key success indicators. Porvairs businesses are characterized by their specialist design, engineering, and commercial skills, mandated product use, and long-life-cycle systems.
The Board understands the importance of responsible business development and highlights that most of Porvairs products are used for environmental benefits. The Group published a full ESG report in February 2025, outlining its ESG management framework, goals, and metrics.
The Groups divisions, Aerospace & Industrial, Laboratory, and Metal Melt Quality, showed varied performances. Aerospace & Industrial revenue increased by 10%, while Laboratory revenue grew by 1%. Metal Melt Quality revenue decreased by 6%, impacted by lower industrial demand.
The Groups cash flow and cash position improved, with cash generated from operations at £10.2 million and net cash of £17.1 million. The Group continues to invest in capital expenditure and acquisitions, focusing on markets with long-term growth potential and geographic presence aligned with its end markets.
Overall, Porvair PLCs performance for the first six months of 2025 was in line with expectations, and the Group remains well-positioned to benefit from global trends and its long-term growth drivers.
Financial YearRevenueOperating ProfitAdjusted Operating ProfitProfit Before TaxAdjusted Profit Before TaxEarnings Per ShareAdjusted Earnings Per ShareNet Cash
H1 2025£97.7 million£11.9 million£12.6 million£11.3 million£12.0 million19.0 pence20.0 pence£17.1 million
H1 2024£94.6 million£11.6 million£12.5 million£10.6 million£11.5 million18.1 pence19.5 pence£4.1 million
Growth3%3%1%7%4%5%3%N/A
Significant 0 news titles 0

No news for this category in the selected date range.

Speculation 0 news titles 0

No news for this category in the selected date range.

Strategic 0 news titles 0

No news for this category in the selected date range.

Suspension 0 news titles 0

No news for this category in the selected date range.

TR1 35 news titles 35
CYN logo
TR1 17:21
CYN

Holding(s) in Company

CQS Natural Resources Growth and Income plc

TR1 Buy
['Bank of America Corporation', '5.420847', 0]
BBH logo
TR1 15:17
BBH

Holding(s) in Company

Bellevue Healthcare Trust PLC

TR1 Buy
['Saba Capital Management, L.P.', '0.873177', '1.088320']
HAYD logo
TR1 14:15
HAYD

Holding(s) in Company

Haydale Graphene Industries

TR1 Buy
['Octopus Investments Limited', '9.720000', '10.920000']
APN logo
TR1 09:36
APN

Holding(s) in Company

Applied Nutrition Plc

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '0.000000', '5.065098']
EARN logo
TR1 08:52
EARN

Holding(s) in Company

EARNZ plc

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '6.773980', '0.000000']
OSB logo
TR1 08:30
OSB

Holding(s) in Company

OneSavings Bank PLC

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) London, United Kingdom', '', 0]
MLVN logo
TR1 07:33
MLVN

Holding(s) in Company

Malvern International

<mark style="background-coloryellow">TR1</mark> Buy
['8 KPG Limited', '2,140,630', 0]
CRTA logo
TR1 06:02
CRTA

Holding(s) in Company

Cirata plc

<mark style="background-coloryellow">TR1</mark> Buy
['GEORGE WALTER LOEWENBAUM', '5.40', 'n/a']
NAH logo
TR1 06:01
NAH

Holding(s) in Company

NAHL Group PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Colebrooke Partners IM Limited', 'Less than 3', '3.27']
MLVN logo
TR1 06:01
MLVN

Holding(s) in Company

Malvern International

<mark style="background-coloryellow">TR1</mark> Buy
['Edward Roskill', '2,064,567', 0]
Takeover 1 news title 1
BVA logo
Takeover 16:33
BVA

BBVA's decision on the takeover bid for Sabadell

Banco Bilbao Vizcaya Argentaria S.A

Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resulting from the offer, with an additional condition to BBVAs previously submitted commitments. Despite having the right to withdraw the offer due to the additional condition, BBVA has decided not to withdraw and will proceed with the offer as planned. The merger control procedure in Spain is now complete, and the offer remains in effect.
Takeover
Understanding 0 news titles 0

No news for this category in the selected date range.

Updates 18 news titles 18
BRSC logo
Updates 14:58
BRSC

Portfolio Update

Blackrock Smaller Companies Trust PLC

Here is a summary of the provided text
BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basis, while the benchmark index returned 7.3%. The share price performance was positive for the month, but underperformed the broader market. The largest detractors from performance were Bloomsbury Publishing, Ashtead Technology, and Tatton Asset Management due to stock-specific issues. However, holdings in Chemring, Boku, and Alpha Group International contributed positively to the portfolio.
The update also includes a commentary on the markets by Roland Arnold, representing the Investment Manager. Arnold notes that global financial markets experienced a strong rebound in May, with a boost in risk sentiment and easing geopolitical tensions. While the US Federal Reserve maintained its policy rate, the Bank of England cut rates citing domestic disinflation. Despite this, UK inflation surprised to the upside in April.
Arnold also provides an outlook for the UK equity market, highlighting several positive factors including falling mortgage rates, positive real wage growth, and a recovery in the housing market. Additionally, the pace of M&A activity remains robust, and UK SMID stocks are considered undervalued compared to large-cap stocks. The update concludes by expressing optimism about the attractiveness of the UK market for investors, given the uncertainty in the US equity market.
Financial MetricsOne MonthThree MonthsOne YearThree YearsFive Years
Net Asset Value6.5%3.7%-8.6%-7.2%24.5%
Share Price6.1%4.3%-10.6%-3.8%17.3%
Benchmark7.3%6.4%1.1%1.1%38.9%
Net Asset Value (Capital Only, Debt at Par Value)1,409.19p
Net Asset Value (Capital Only, Debt at Fair Value)1,473.13p
Net Asset Value incl. Income (Debt at Par Value)1,424.01p
Net Asset Value incl. Income (Debt at Fair Value)1,487.95p
Share Price1,296.00p
Discount to Cum Income NAV (Debt at Par Value)9.0%
Discount to Cum Income NAV (Debt at Fair Value)12.9%
Net Yield3.4%
Gross Assets£678.5m
Net Gearing including Income (Debt at Par)7.0%
DKL logo
Updates 06:01
DKL

2024 Final Results and Financing Update

Dekeloil Public Ltd

Dekel Agri-Vision Plc, a West African agribusiness company, released its financial results for the year ended December 31, 2024, highlighting stable Group EBITDA at €2.6 million. The Palm Oil Operation contributed a positive EBITDA of €3.9 million, while the Cashew Operation reported an improved EBITDA loss of €1.3 million. The company also announced a financial restructuring, including equity fundraising and debt facility revisions, strengthening its balance sheet. The outlook for 2025 is positive, with expectations of enhanced results driven by the ongoing turnaround of the Cashew Operation and rebounding CPO prices.
YearPalm Oil Operation RevenuePalm Oil Operation Gross MarginPalm Oil Operation Gross Margin %Palm Oil Operation EBITDACashew Operation RevenueCashew Operation EBITDAGroup EBITDA
2024€28.2m€5.1m18.1%€3.9m€1.8m€(1.3)m€2.6m
2023€37.2m€6.5m17.5%€4.8m€1.1m€(2.2)m€2.6m
% change-24.2%-21.5%3.4%-18.7%63.6%40.9%No change
Vaccine 0 news titles 0

No news for this category in the selected date range.

Wins 0 news titles 0

No news for this category in the selected date range.

Worth 0 news titles 0

No news for this category in the selected date range.

Trading Floor
2025-06-30
812
Headlines
49
News Types
MXCT
Top Mover
Price Movers 2025-06-30
MXCT
+2.9%
News Flow 812 items today
AI
0
Acquisitions
5
Agreement
3
Approvals
1
Authorisation
0
Awards
0
BTC
1
Blockchain
0
Breakthrough
1
BuyBack
0
Cancellations
1
CashOffer
0
Collaborate
0
ContractWin
0
Covid-19
0
Deals
0
Diamond
0
DirectorDealing
37
Discovery
0
Exceeded
0
FCA
0
FDA
0
Grants
0
InvestmentPlan
0
JV
0
Launch
5
Litigation
0
NewContract
3
Offers
2
Offtake
0
Orders
0
Partner
0
Patents
0
Placing
9
Positive
0
Proposals
0
Reports
38
Results
59
Significant
0
Speculation
0
Strategic
0
Suspension
0
TR1
35
Takeover
1
Understanding
0
Updates
18
Vaccine
0
Wins
0
Worth
0
Loading LSTM picks & Results Radar…

My Watchlist

RNS Alerts

Tap any ticker row to open its mobile stock terminal. Today’s move updates from the same stock-terminal feed.

No tickers on your watchlist yet.

RNS Alerts

Push Notifications
Alert me when a watchlist ticker gets new RNS
Email Alerts
2025-06-30 43 picks
98 Exceptional
BVA
Banco Bilbao Vizcaya Argentaria S.A
Positive
BBVA's decision on the takeover bid for Sabadell
Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resulting from the offer, with an additional condition to BBVAs previously submitted commitments. Despite having the right to withdraw the offer due to the additional condition, BBVA has decided not to withdraw and will proceed with the offer as planned. The merger control procedure in Spain is now complete, and the offer remains in effect.
Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resulting from the offer, with an additional condition to BBVAs previously submitted commitments. Despite having the right to withdraw the offer due to the additional condition, BBVA has decided not to withdraw and will proceed with the offer as planned. The merger control procedure in Spain is now complete, and the offer remains in effect.
Takeover
16:33
Open Terminal ↗ RNS Source
93 Strong Beat
SBDS
Silver Bullet Data Services Group PLC
Positive
Final Results for the year ended 31 December 2024
Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million, with a gross profit of £7.13 million, representing a 12% increase. The companys services revenue increased by 8% to £6.0 million, while its 4D revenue grew by 20% to £3.37 million, driven by US demand. US and globally operating clients now account for over 60% of total group revenues. Silver Bullet also reported a positive EBITDA during Q4 of FY24 and a strong start to 2025. The company raised £3.3 million through the issue of new convertible loan notes and restructured its existing CLNs, simplifying its capital structure and aligning financing with its growth plans.
Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million, with a gross profit of £7.13 million, representing a 12% increase. The companys services revenue increased by 8% to £6.0 million, while its 4D revenue grew by 20% to £3.37 million, driven by US demand. US and globally operating clients now account for over 60% of total group revenues. Silver Bullet also reported a positive EBITDA during Q4 of FY24 and a strong start to 2025. The company raised £3.3 million through the issue of new convertible loan notes and restructured its existing CLNs, simplifying its capital structure and aligning financing with its growth plans.
YearRevenueGross ProfitLoss Before TaxLoss Per Share
2024£9.37m£7.13m£3.04m£0.17
2023£8.36m£6.36m£3.45m£0.20
16:14
Open Terminal ↗ RNS Source
84 Broker Upgrade
PR1
Pri0r1ty Intelligence Group PLC
Positive
Half-year Report
Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report reflects only three months of Pri0r1ty trading. During this time, they generated £37,000 in revenue, with 40 customers using their products and 20% paying for services. They also formed strategic partnerships, developed new revenue-generating products, and successfully integrated cryptocurrency payments. The company expects to see increased platform adoption in the second half of 2025 and remains on track to onboard at least 100 paying users by the financial year-end. The financial statements include details on the companys financial position, changes in equity, and cash flows for the period.
Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report reflects only three months of Pri0r1ty trading. During this time, they generated £37,000 in revenue, with 40 customers using their products and 20% paying for services. They also formed strategic partnerships, developed new revenue-generating products, and successfully integrated cryptocurrency payments. The company expects to see increased platform adoption in the second half of 2025 and remains on track to onboard at least 100 paying users by the financial year-end. The financial statements include details on the companys financial position, changes in equity, and cash flows for the period.
Financial YearRevenue (£)Cost of Sales (£)Gross Profit (£)Other Expenses (£)Earnings Before Interest, Tax, Depreciation, and Amortization (£)Interest Expenditure (£)Loss Before Taxation (£)Income Tax (£)Profit/ (Loss) for the Year (£)
31 March 2025 (unaudited)37,000037,000570,436-860,2670-860,2670-860,267
31 March 2024 (unaudited)000151,301-151,3010-151,3010-151,301

| Debt | 31 March 2025 (Unaudited) | 31 March 2024 (Unaudited) | | --- | --- | --- | | Trade and Other Payables (£) | 400,397 | 68,842 |
15:23
Open Terminal ↗ RNS Source
93 Strong Beat
80M
80 Mile Plc
Positive
Final Results for the year ended 31 December 2024
80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue remained nil, while its cost of sales decreased to £35,887 from £213,523 in the previous year. 80 Mile Plcs administrative expenses increased to £2,262,385 from £1,629,273 in the previous year. The companys impairment of intangible assets decreased to £4,902,058 from £3,535,254 in the previous year. 80 Mile Plcs share of losses from joint ventures increased to £18,114 from £13,779 in the previous year. The companys other losses increased to £2,259,088 from a gain of £2,962,769 in the previous year. 80 Mile Plcs finance expense decreased to £1,663 from a finance income of £7,039 in the previous year. The companys other income increased to £116,844 from £320,925 in the previous year. As of December 31, 2024, 80 Mile Plcs total assets decreased to £34,153,950 from £40,520,554 in the previous year. The companys total liabilities decreased to £1,187,350 from £1,143,927 in the previous year. 80 Mile Plcs net assets decreased to £32,966,600 from £39,376,627 in the previous year.
80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue remained nil, while its cost of sales decreased to £35,887 from £213,523 in the previous year. 80 Mile Plcs administrative expenses increased to £2,262,385 from £1,629,273 in the previous year. The companys impairment of intangible assets decreased to £4,902,058 from £3,535,254 in the previous year. 80 Mile Plcs share of losses from joint ventures increased to £18,114 from £13,779 in the previous year. The companys other losses increased to £2,259,088 from a gain of £2,962,769 in the previous year. 80 Mile Plcs finance expense decreased to £1,663 from a finance income of £7,039 in the previous year. The companys other income increased to £116,844 from £320,925 in the previous year. As of December 31, 2024, 80 Mile Plcs total assets decreased to £34,153,950 from £40,520,554 in the previous year. The companys total liabilities decreased to £1,187,350 from £1,143,927 in the previous year. 80 Mile Plcs net assets decreased to £32,966,600 from £39,376,627 in the previous year.
YearFinancialsDebt
2024£34,153,950£1,187,350
2023£40,520,554£1,143,927
15:16
Open Terminal ↗ RNS Source
88 Trading Edge
BRSC
Blackrock Smaller Companies Trust PLC
Positive
Portfolio Update
Here is a summary of the provided text: BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basis, while the benchmark index returned 7.3%. The share price performance was positive for the month, but underperformed the broader market. The largest detractors from performance were Bloomsbury Publishing, Ashtead Technology, and Tatton Asset Management due to stock-specific issues. However, holdings in Chemring, Boku, and Alpha Group International contributed positively to the portfolio. The update also includes a commentary on the markets by Roland Arnold, representing the Investment Manager. Arnold notes that global financial markets experienced a strong rebound in May, with a boost in risk sentiment and easing geopolitical tensions. While the US Federal Reserve maintained its policy rate, the Bank of England cut rates citing domestic disinflation. Despite this, UK inflation surprised to the upside in April. Arnold also provides an outlook for the UK equity market, highlighting several positive factors including falling mortgage rates, positive real wage growth, and a recovery in the housing market. Additionally, the pace of M&A activity remains robust, and UK SMID stocks are considered undervalued compared to large-cap stocks. The update concludes by expressing optimism about the attractiveness of the UK market for investors, given the uncertainty in the US equity market.
Here is a summary of the provided text
BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basis, while the benchmark index returned 7.3%. The share price performance was positive for the month, but underperformed the broader market. The largest detractors from performance were Bloomsbury Publishing, Ashtead Technology, and Tatton Asset Management due to stock-specific issues. However, holdings in Chemring, Boku, and Alpha Group International contributed positively to the portfolio.
The update also includes a commentary on the markets by Roland Arnold, representing the Investment Manager. Arnold notes that global financial markets experienced a strong rebound in May, with a boost in risk sentiment and easing geopolitical tensions. While the US Federal Reserve maintained its policy rate, the Bank of England cut rates citing domestic disinflation. Despite this, UK inflation surprised to the upside in April.
Arnold also provides an outlook for the UK equity market, highlighting several positive factors including falling mortgage rates, positive real wage growth, and a recovery in the housing market. Additionally, the pace of M&A activity remains robust, and UK SMID stocks are considered undervalued compared to large-cap stocks. The update concludes by expressing optimism about the attractiveness of the UK market for investors, given the uncertainty in the US equity market.
Financial MetricsOne MonthThree MonthsOne YearThree YearsFive Years
Net Asset Value6.5%3.7%-8.6%-7.2%24.5%
Share Price6.1%4.3%-10.6%-3.8%17.3%
Benchmark7.3%6.4%1.1%1.1%38.9%
Net Asset Value (Capital Only, Debt at Par Value)1,409.19p
Net Asset Value (Capital Only, Debt at Fair Value)1,473.13p
Net Asset Value incl. Income (Debt at Par Value)1,424.01p
Net Asset Value incl. Income (Debt at Fair Value)1,487.95p
Share Price1,296.00p
Discount to Cum Income NAV (Debt at Par Value)9.0%
Discount to Cum Income NAV (Debt at Fair Value)12.9%
Net Yield3.4%
Gross Assets£678.5m
Net Gearing including Income (Debt at Par)7.0%
14:58
Open Terminal ↗ RNS Source
93 Strong Beat
EAAS
Eenergy Group PLC
Positive
Final Results
eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and transitioned into profit with an Adjusted EBITDA of £0.6 million. The companys net debt was reduced to £2.4 million, and it was awarded a solar installation contract worth £5.2 million with Spire Healthcare. The companys outlook for FY2025 is optimistic, with a strong contracted forward order book and increased sales pipeline. The company expects to be cash positive in H1 2025 and further cash generative in H2 2025.
eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and transitioned into profit with an Adjusted EBITDA of £0.6 million. The companys net debt was reduced to £2.4 million, and it was awarded a solar installation contract worth £5.2 million with Spire Healthcare. The companys outlook for FY2025 is optimistic, with a strong contracted forward order book and increased sales pipeline. The company expects to be cash positive in H1 2025 and further cash generative in H2 2025.
<>eEnergy Group Financials
YearRevenueAdjusted EBITDANet DebtCash
2024£25.1 million£0.6 million£2.4 million£2.3 million
2023£14.7 million-£6.4 million£8.0 million£0.6 million
14:19
Open Terminal ↗ RNS Source
93 Strong Beat
VLG
Venture Life Group PLC
Positive
Final Results for year ended 31 December 2024
Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported strong growth in its core business, with a revenue increase of 18.9% to £26.6 million and an underlying growth of 14.9% excluding acquisitions. The gross profit increased by 31.1% to £12.2 million, and the gross margin improved to 45.8%. The adjusted EBITDA rose by 26.1% to £6.2 million, and the adjusted profit before tax increased to £4.3 million. The company also announced the sale of its contract development and manufacturing operations and certain non-core products for €62 million in cash. The Board expects to complete the sale of its oral care brands, which are now considered non-core, by the end of 2025.
Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported strong growth in its core business, with a revenue increase of 18.9% to £26.6 million and an underlying growth of 14.9% excluding acquisitions. The gross profit increased by 31.1% to £12.2 million, and the gross margin improved to 45.8%. The adjusted EBITDA rose by 26.1% to £6.2 million, and the adjusted profit before tax increased to £4.3 million. The company also announced the sale of its contract development and manufacturing operations and certain non-core products for €62 million in cash. The Board expects to complete the sale of its oral care brands, which are now considered non-core, by the end of 2025.
YearRevenueGross ProfitMarketing CostsAdjusted EBITDAAdjusted Profit Before TaxAdjusted EPSFree Cash FlowGroup Net LeverageGroup Net Debt
2024£26.6 million£12.2 million6.1%£6.2 million£4.3 million3.37p£4.3 million1.83x£18.7 million
2023£22.4 million£9.3 million3.9%£4.9 million£2.8 million2.60p£2.7 million1.30x£13.7 million
14:14
Open Terminal ↗ RNS Source
93 Strong Beat
VRS
Versarien PLC
Positive
Interim Results
Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March 31, 2025. Versariens strategy is to monetize its intellectual property and know-how by licensing its technology and brands as commercial traction for graphene develops. The company has a pipeline of commercial opportunities worth £2.1 million and is seeking additional funding to continue as a going concern. Versarien is also simplifying its corporate structure and seeking strategic partners for its 3D Construction Printing business. The Board expects the Groups ongoing costs to reduce with the simplified structure.
Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March 31, 2025. Versariens strategy is to monetize its intellectual property and know-how by licensing its technology and brands as commercial traction for graphene develops. The company has a pipeline of commercial opportunities worth £2.1 million and is seeking additional funding to continue as a going concern. Versarien is also simplifying its corporate structure and seeking strategic partners for its 3D Construction Printing business. The Board expects the Groups ongoing costs to reduce with the simplified structure.
Financial MetricsFY 2025FY 2024Change
Group revenues£1.47 million£1.34 million10.45% increase
Graphene revenues£0.21 million£0.28 million25% decrease
Grant income£0.23 million£0.20 million15% increase
Adjusted LBITDA£0.77 million£0.67 million14.93% increase
Loss before tax£1.49 million£1.61 million7.45% decrease
Cash as of 31 March£0.85 million£0.15 million466.67% increase

Debt MetricsFY 2025FY 2024Change
Innovate UK Loan£5 million£4.5 million11.11% increase
Long-term borrowings£285£47539.99% decrease
Total debt£5,285£4,9756.23% increase
14:04
Open Terminal ↗ RNS Source
93 Strong Beat
EQT
EQTEC plc
Positive
Final Results
EQTEC plc announces its audited results for the year ended 31 December 2024.
EQTEC plc announces its audited results for the year ended 31 December 2024.
YearRevenueOperating LossNet LossNet Assets
2024€2.2 million€3.6 million€19.4 million€13.7 million
2023€2.5 million€3.5 million€23.5 million€21.2 million
13:27
Open Terminal ↗ RNS Source
93 Strong Beat
WATR
Water Intelligence plc
Positive
Audited Results for Year Ended 31 December 2024
Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 10% to $83.3 million, with statutory profit before tax growing 2% to $6.4 million and statutory EBITDA growing by 11% to $13.1 million. The companys balance sheet remains strong, with cash of $12.1 million and a Total Net Debt to EBITDA Adjusted ratio of 1.1. The companys critical mass of sales and technology-driven foundation establish a scalable Technology Enabled Services (TES) platform. Between Q4 2024 and Q1 2025, Water Intelligence completed three strategic transactions, including reacquiring its Dallas franchise and establishing it as the headquarters for its core American Leak Detection business, forming a partnership with Chubb insurance and its StreamLabs Water business, and reaffirming its capital allocation guidance with acquisitions. The companys TES platform enables it to provide recurring Preventive Maintenance solutions and efficiently offer proprietary, technology-driven solutions to its customers. Based on its competitive strategy and the Dallas Template, the company expects to deliver higher organic revenue and profit trajectory.
Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 10% to $83.3 million, with statutory profit before tax growing 2% to $6.4 million and statutory EBITDA growing by 11% to $13.1 million. The companys balance sheet remains strong, with cash of $12.1 million and a Total Net Debt to EBITDA Adjusted ratio of 1.1. The companys critical mass of sales and technology-driven foundation establish a scalable Technology Enabled Services (TES) platform. Between Q4 2024 and Q1 2025, Water Intelligence completed three strategic transactions, including reacquiring its Dallas franchise and establishing it as the headquarters for its core American Leak Detection business, forming a partnership with Chubb insurance and its StreamLabs Water business, and reaffirming its capital allocation guidance with acquisitions. The companys TES platform enables it to provide recurring Preventive Maintenance solutions and efficiently offer proprietary, technology-driven solutions to its customers. Based on its competitive strategy and the Dallas Template, the company expects to deliver higher organic revenue and profit trajectory.
YearRevenueProfit Before TaxNet Debt to EBITDA Adjusted Ratio
2024$83.3 million$6.4 million1.1
2023$76 million$6.2 millionN/A
11:01
Open Terminal ↗ RNS Source
93 Strong Beat
ENET
Ethernity Networks Ltd
Positive
Results for the Year Ended 31 December 2024
Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a gross profit decrease of 46%. However, the gross margin percentage increased to 92.1% in 2024 from 61.9% in 2023, reflecting a 30.2% improvement. The operating loss decreased by 4%, and the EBITDA loss decreased by 10%. The company raised net cash funds of $1.86 million during the year and had cash and cash equivalents of $0.05 million at the end of December 2024. Despite challenges, the company successfully exited the Temporary Suspension of Proceedings process and initiated a strategic transition to leverage its Universal Edge Platform development. The companys Chairman and CEO provided statements highlighting the companys achievements and expressing optimism for the future.
Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a gross profit decrease of 46%. However, the gross margin percentage increased to 92.1% in 2024 from 61.9% in 2023, reflecting a 30.2% improvement. The operating loss decreased by 4%, and the EBITDA loss decreased by 10%. The company raised net cash funds of $1.86 million during the year and had cash and cash equivalents of $0.05 million at the end of December 2024. Despite challenges, the company successfully exited the Temporary Suspension of Proceedings process and initiated a strategic transition to leverage its Universal Edge Platform development. The companys Chairman and CEO provided statements highlighting the companys achievements and expressing optimism for the future.
YearRevenueGross ProfitOperating LossEBITDA LossNet CashCash Equivalents
2024$1.38 million$1.3m$5.1 million$3.48 million$1.86 million$0.05 million
2023$3.78 million$2.3m$5.3 million$3.86 millionN/A$1.99 million
08:36
Open Terminal ↗ RNS Source
80 Positive
HCM
HUTCHMED China Ltd
Positive
China Approval based on Phase III SACHI Trial
HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-small cell lung cancer with MET amplification after progression on EGFR inhibitor therapy. The approval is based on the positive results of the SACHI Phase III trial, which showed a significant improvement in progression-free survival for patients treated with the combination compared to chemotherapy. ORPATHYS® is an oral MET inhibitor, and TAGRISSO® is a third-generation EGFR inhibitor. This approval provides a new treatment option for lung cancer patients in China and triggers a US$11 million milestone payment from AstraZeneca, which markets both drugs in the country.
HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-small cell lung cancer with MET amplification after progression on EGFR inhibitor therapy. The approval is based on the positive results of the SACHI Phase III trial, which showed a significant improvement in progression-free survival for patients treated with the combination compared to chemotherapy. ORPATHYS® is an oral MET inhibitor, and TAGRISSO® is a third-generation EGFR inhibitor. This approval provides a new treatment option for lung cancer patients in China and triggers a US$11 million milestone payment from AstraZeneca, which markets both drugs in the country.
Approvals
08:31
Open Terminal ↗ RNS Source
80 Positive
KOD
Kodal Minerals PLC
Positive
Bougouni Lithium Project Off-Take Agreement
Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the projects DMS processing plant for four years, with an annual review of quantities and floor price. The price is referenced to the Shanghai Metals Market and will be subject to adjustments based on grade, quality, and delivery terms. The agreement includes a "take or pay" clause, with LMLB supplying spodumene exclusively to Hainan, who must purchase the agreed-upon quantity. The DMS processing plant has already produced over 40,000 tonnes of spodumene concentrate, and the company is working to secure an export license from the Mali government. The first phase of the project is expected to produce 100,000-120,000 tonnes per year of lithium concentrate with a yield of more than 5.5% Li2O.
Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the projects DMS processing plant for four years, with an annual review of quantities and floor price. The price is referenced to the Shanghai Metals Market and will be subject to adjustments based on grade, quality, and delivery terms. The agreement includes a "take or pay" clause, with LMLB supplying spodumene exclusively to Hainan, who must purchase the agreed-upon quantity. The DMS processing plant has already produced over 40,000 tonnes of spodumene concentrate, and the company is working to secure an export license from the Mali government. The first phase of the project is expected to produce 100,000-120,000 tonnes per year of lithium concentrate with a yield of more than 5.5% Li2O.
Agreement
07:31
Open Terminal ↗ RNS Source
80 Positive
VOD
Vodafone Group PLC
Positive
Vodafone Group Plc launches Cash Tender Offers
Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates ranging from 2043 to 2059. The company has set a maximum tender amount and acceptance priority levels for each series of notes. The tender offer is subject to certain terms and conditions, including a financing condition related to the issuance of new sterling-denominated notes. The company has retained Merrill Lynch International and Deutsche Bank AG as dealer managers and Kroll Issuer Services Limited as the tender and information agent for the offer. The offer period includes key dates such as the early tender deadline, price determination date, and settlement dates. The offer is subject to applicable laws and regulations in various jurisdictions, including Italy, the United Kingdom, France, and Belgium. The company also provides forward-looking statements and information about its purpose and commitment to environmental sustainability.
Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates ranging from 2043 to 2059. The company has set a maximum tender amount and acceptance priority levels for each series of notes. The tender offer is subject to certain terms and conditions, including a financing condition related to the issuance of new sterling-denominated notes. The company has retained Merrill Lynch International and Deutsche Bank AG as dealer managers and Kroll Issuer Services Limited as the tender and information agent for the offer. The offer period includes key dates such as the early tender deadline, price determination date, and settlement dates. The offer is subject to applicable laws and regulations in various jurisdictions, including Italy, the United Kingdom, France, and Belgium. The company also provides forward-looking statements and information about its purpose and commitment to environmental sustainability.
Launch
06:28
Open Terminal ↗ RNS Source
84 Broker Upgrade
TEAM
TEAM plc
Positive
Half-year Report
Here is a summary of the text provided: TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% increase in revenues to £5.8 million, with total client assets surpassing £1.1 billion. TEAM also successfully raised £2.96 million through equity and convertible loan instruments, and had £2.16 million in cash reserves as of March 31, 2025. The companys operational highlights include growth in total client assets across its divisions, a successful group-wide cost reduction program, and the upcoming launch of the TEAM UCITS fund. The outlook for the remainder of the financial year remains positive, with a continued focus on migrating client assets to MPS and expanding the international advisory network. Mark Clubb, Executive Chairman of TEAM, expressed confidence in the companys trajectory and mid-term targets, which include annual revenue of £20 million, an EBITDA margin exceeding 30%, and Assets Under Advice/Management of £4 billion. The company is focused on execution, with the UCITS fund launch being central to driving growth and achieving profitability. The financial review highlights the companys improved financial position and continued revenue growth, with the goal of achieving month-on-month profitability. The segmental analysis shows the performance of the Groups three principal operating segments: Investment and Fund Management, Advisory and Consultancy, and International. Overall, the results demonstrate TEAM PLCs strong performance and positive trajectory, with a focus on growth and achieving financial targets.
Here is a summary of the text provided
TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% increase in revenues to £5.8 million, with total client assets surpassing £1.1 billion. TEAM also successfully raised £2.96 million through equity and convertible loan instruments, and had £2.16 million in cash reserves as of March 31, 2025.
The companys operational highlights include growth in total client assets across its divisions, a successful group-wide cost reduction program, and the upcoming launch of the TEAM UCITS fund. The outlook for the remainder of the financial year remains positive, with a continued focus on migrating client assets to MPS and expanding the international advisory network.
Mark Clubb, Executive Chairman of TEAM, expressed confidence in the companys trajectory and mid-term targets, which include annual revenue of £20 million, an EBITDA margin exceeding 30%, and Assets Under Advice/Management of £4 billion. The company is focused on execution, with the UCITS fund launch being central to driving growth and achieving profitability.
The financial review highlights the companys improved financial position and continued revenue growth, with the goal of achieving month-on-month profitability. The segmental analysis shows the performance of the Groups three principal operating segments: Investment and Fund Management, Advisory and Consultancy, and International.
Overall, the results demonstrate TEAM PLCs strong performance and positive trajectory, with a focus on growth and achieving financial targets.
| | HY 25 | HY 24 | |---|---|---| | Revenues | £5.8m | £4.1m | | Total client assets | £1.112bn | £0.9bn | | Cash in bank | £2.16m | £1.5m | | Total Equity Raised | £1.96m | - | | Convertible Loan Notes | £1m | - | | Gross Total Raised | £2.96m | - | | Underlying loss before tax | £796k | £992k | | Loss before tax | £1.757m | £1.013m | | Loss for the period | £1.757m | £1.010m | | Loss per share | 3.6 pence | 3.5 pence |
06:07
Open Terminal ↗ RNS Source
80 Positive
SSTY
Safestay PLC
Positive
Lease agreement to operate hostel in Naples
Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnership between the two companies, with plans to expand into other key Italian cities. The Naples hostel, set in a former monastery, is expected to open in August 2025 and will offer guests a range of amenities, including ancillary services. This expansion aligns with Safestays growth strategy and goal to double its portfolio size in the medium term.
Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnership between the two companies, with plans to expand into other key Italian cities. The Naples hostel, set in a former monastery, is expected to open in August 2025 and will offer guests a range of amenities, including ancillary services. This expansion aligns with Safestays growth strategy and goal to double its portfolio size in the medium term.
Agreement
06:01
Open Terminal ↗ RNS Source
98 Exceptional
APTA
Aptamer Group PLC
Positive
Liver fibrosis breakthrough with Optimer® platform
Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated a novel molecular target for targeted gene therapy delivery to specific liver cells that drive scarring. This advance positions Aptamer for strategic licensing discussions with global pharmaceutical partners in the $20 billion fibrosis market. The Optimer® technology acts as a magic bullet, precisely targeting a protein in scarred livers and delivering siRNA gene therapy to hepatic stellate cells (HSCs), which cause liver scarring. In laboratory <mark style="background-color:yellow">test</mark>s, the Optimer®-siRNA system significantly reduced processes that mimic scar tissue formation and slowed the harmful activity of HSCs. Aptamers unique approach to target identification has led to the discovery of a specific protein marker for HSCs, setting their technology apart for precision medicine. The Optimer® platform is compatible with various RNA-based medicines, making it highly versatile. The company is now planning outsourced in vivo studies to evaluate the platforms performance in animal models and is in discussions with major pharmaceutical companies for parallel studies. These efforts aim to confirm the efficacy and safety of the Optimer® platform, paving the way for human trials and strategic collaborations in the multi-billion-dollar fibrosis market.
Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated a novel molecular target for targeted gene therapy delivery to specific liver cells that drive scarring. This advance positions Aptamer for strategic licensing discussions with global pharmaceutical partners in the $20 billion fibrosis market.
The Optimer® technology acts as a magic bullet, precisely targeting a protein in scarred livers and delivering siRNA gene therapy to hepatic stellate cells (HSCs), which cause liver scarring. In laboratory <mark style="background-color:yellow">test</mark>s, the Optimer®-siRNA system significantly reduced processes that mimic scar tissue formation and slowed the harmful activity of HSCs.
Aptamers unique approach to target identification has led to the discovery of a specific protein marker for HSCs, setting their technology apart for precision medicine. The Optimer® platform is compatible with various RNA-based medicines, making it highly versatile.
The company is now planning outsourced in vivo studies to evaluate the platforms performance in animal models and is in discussions with major pharmaceutical companies for parallel studies. These efforts aim to confirm the efficacy and safety of the Optimer® platform, paving the way for human trials and strategic collaborations in the multi-billion-dollar fibrosis market.
Breakthrough
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
CLCO
Cloudcoco Group PLC
Positive
Interim Results
Here is a summary of the provided text: CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4 million, with 89% generated from e-commerce sales, stable gross profit of £228k, and improved gross margin to 7%. Trading Group EBITDA was £26k, and administrative expenses were reduced by 13%. The sale of legacy businesses resulted in a cash inflow of £7.9 million, enabling the repayment of MXC loan notes and strengthening the balance sheet. The companys operational highlights include adding 10 new business customers, introducing enhanced automation, onboarding new vendor distribution partners, and forming strategic partnerships. Simon Duckworth, Non-Executive Chairman, expressed confidence in the companys transformation and future growth prospects. The company aims to drive top-line growth, deliver excellent service, maintain cost discipline, and explore new opportunities. Would you like me to generate a more in-depth summary?
Here is a summary of the provided text
CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4 million, with 89% generated from e-commerce sales, stable gross profit of £228k, and improved gross margin to 7%. Trading Group EBITDA was £26k, and administrative expenses were reduced by 13%. The sale of legacy businesses resulted in a cash inflow of £7.9 million, enabling the repayment of MXC loan notes and strengthening the balance sheet. The companys operational highlights include adding 10 new business customers, introducing enhanced automation, onboarding new vendor distribution partners, and forming strategic partnerships. Simon Duckworth, Non-Executive Chairman, expressed confidence in the companys transformation and future growth prospects. The company aims to drive top-line growth, deliver excellent service, maintain cost discipline, and explore new opportunities.
Would you like me to generate a more in-depth summary?
Financial YearRevenue (£)Gross ProfitGross MarginEBITDAPLC Costs (£)Administrative Expenses (£)Cash Balance (£)Debt
H1 20253,383,000228,0007%26,000198,000489,000818,000Minimal debt
H1 20244,335,000228,0005%21,000251,000563,0001,042,0006,200,000 loan notes
06:01
Open Terminal ↗ RNS Source
80 Positive
SBTX
SkinBioTherapeutics PLC
Positive
Croda Commercial Launch Progressing as Expected
Here is a summary of the news article: SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ingredient designed to counteract the effects of stress on the skin and improve overall well-being by enhancing melatonin production and improving sleep quality. The company has a long-standing commercial and manufacturing agreement with Croda plc, and due to the competitiveness of the industry, SkinBioTherapeutics is under a strict confidentiality agreement regarding sales and market forecast information. The company also announces an upcoming investor presentation on July 3, 2025, regarding a recently signed commercial agreement with Superdrug. SkinBioTherapeutics is a consolidator in the skin health market, making acquisitions in complementary areas and expanding its distribution, geographical reach, and manufacturing capabilities. The companys proprietary platform, SkinBiotix®, is based on discoveries made by the translational dermatology team at the University of Manchester.
Here is a summary of the news article
SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ingredient designed to counteract the effects of stress on the skin and improve overall well-being by enhancing melatonin production and improving sleep quality. The company has a long-standing commercial and manufacturing agreement with Croda plc, and due to the competitiveness of the industry, SkinBioTherapeutics is under a strict confidentiality agreement regarding sales and market forecast information. The company also announces an upcoming investor presentation on July 3, 2025, regarding a recently signed commercial agreement with Superdrug. SkinBioTherapeutics is a consolidator in the skin health market, making acquisitions in complementary areas and expanding its distribution, geographical reach, and manufacturing capabilities. The companys proprietary platform, SkinBiotix®, is based on discoveries made by the translational dermatology team at the University of Manchester.
Launch
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
OBD
Oxford Biodynamics PLC
Positive
Interim Results
Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The operating loss was £5.88m, a slight improvement from £5.99m in H1 2024. Cash and term deposits as of March 31, 2025, were £4.26m, up from £1.2m in the previous year. The company highlighted several corporate and operational highlights, including the appointment of Iain Ross as Executive Chairman and the growth in sales of the EpiSwitch PSE test. They also announced an agreement with Bupa UK to cover the EpiSwitch PSE test. The financial highlights included an equity placing, subscription, and retail offer, raising gross proceeds of £7.35m in January 2025. In his comments, Iain Ross, the Executive Chairman, emphasized the importance of "doing deals" for the commercial success and non-dilutive funding of the business. He also acknowledged that while they are in commercial discussions with third parties, no substantive deals have been finalized yet, and there is no guarantee within the current cash runway. The text also includes an executive chairmans review, financial review, and detailed financial statements, providing insights into the companys performance and financial position.
Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The operating loss was £5.88m, a slight improvement from £5.99m in H1 2024. Cash and term deposits as of March 31, 2025, were £4.26m, up from £1.2m in the previous year.
The company highlighted several corporate and operational highlights, including the appointment of Iain Ross as Executive Chairman and the growth in sales of the EpiSwitch PSE test. They also announced an agreement with Bupa UK to cover the EpiSwitch PSE test.
The financial highlights included an equity placing, subscription, and retail offer, raising gross proceeds of £7.35m in January 2025.
In his comments, Iain Ross, the Executive Chairman, emphasized the importance of "doing deals" for the commercial success and non-dilutive funding of the business. He also acknowledged that while they are in commercial discussions with third parties, no substantive deals have been finalized yet, and there is no guarantee within the current cash runway.
The text also includes an executive chairmans review, financial review, and detailed financial statements, providing insights into the companys performance and financial position.
YearRevenueOperating LossCash and Term DepositsEquity Placing
2025£587k£5.88m£4.26m£7.35m
2024£327k£5.99m£1.2mN/A
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
ADVT
AdvancedAdvT Ltd
Positive
Final Results for Year Ending 28 February 2025
Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company reported strong financial performance, including revenue from operations of £43.3 million and recurring revenue of £34.8 million, representing 80.3% of total revenues. The adjusted EBITDA from operations was £11.3 million, ahead of management expectations, and the pre-tax profit from continuing operations was £11.3 million. Cash and cash equivalent assets were reported as £109.5 million. The company also highlighted its proforma financial performance, with organic revenue growth of 17.8% and adjusted EBITDA growth of 90.0% on acquired businesses. During the period, Advanced AdvT Limited made several acquisitions, including Celaton Limited, HFX Limited, and GOSS Technology Limited, strengthening their position in the market. The companys Chairperson, Vin Murria, emphasized the groups focus on digital transformation and their commitment to supporting customers strategic delivery. The companys CFO, Gavin Hugill, provided additional insights into the financial highlights and operational review. The Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Consolidated Statement of Changes in Equity, and Consolidated Statement of Cash Flow provided detailed financial information for the year ending February 28, 2025, and the previous eight-month period ending February 29, 2024. The report also included critical accounting judgments, alternative performance measures, and segment information. Overall, Advanced AdvT Limited demonstrated strong financial performance and a commitment to growth through acquisitions and digital transformation.
Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company reported strong financial performance, including revenue from operations of £43.3 million and recurring revenue of £34.8 million, representing 80.3% of total revenues. The adjusted EBITDA from operations was £11.3 million, ahead of management expectations, and the pre-tax profit from continuing operations was £11.3 million. Cash and cash equivalent assets were reported as £109.5 million. The company also highlighted its proforma financial performance, with organic revenue growth of 17.8% and adjusted EBITDA growth of 90.0% on acquired businesses.
During the period, Advanced AdvT Limited made several acquisitions, including Celaton Limited, HFX Limited, and GOSS Technology Limited, strengthening their position in the market. The companys Chairperson, Vin Murria, emphasized the groups focus on digital transformation and their commitment to supporting customers strategic delivery. The companys CFO, Gavin Hugill, provided additional insights into the financial highlights and operational review.
The Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Consolidated Statement of Changes in Equity, and Consolidated Statement of Cash Flow provided detailed financial information for the year ending February 28, 2025, and the previous eight-month period ending February 29, 2024. The report also included critical accounting judgments, alternative performance measures, and segment information. Overall, Advanced AdvT Limited demonstrated strong financial performance and a commitment to growth through acquisitions and digital transformation.
Financial YearRevenue from Operations (£)Recurring Revenue (£)Adjusted EBITDA from Operations (£)Pre-tax Profit from Continuing Operations (£)Basic EPSCash and Cash Equivalents (£)
Year Ending 28 Feb 202543.3 million34.8 million11.3 million11.3 million8p109.5 million
Period Ending 29 Feb 2024 (8 months)21.1 million16.3 million4.4 million5.1 million5p102.9 million
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
VRCI
Verici Dx Plc
Positive
Final Results
Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 million in 2023, primarily due to a commercial contract with Thermo Fisher for the PTRA (Pre Transplant Risk Assessment) test. The adjusted EBITDA loss for the year was US$5.4 million, an improvement from US$7.6 million in 2023. Verici Dx also conducted an equity fundraise in February 2024, raising US$8.2 million in gross proceeds. Operational highlights include the successful transfer of urine samples to Thermo Fisher, triggering milestone payments, and a collaboration with The Westmead Institute for Medical Research in Australia. The company received CLIA certification and CAP accreditation for its clinical laboratory, enabling testing for patients across 51 US states. Post-period highlights include securing Medicare coverage for Verici Dxs Tutivia™ assay and a strong acceleration in Tutivia™ testing orders in Q1 2025. The company is proposing an equity fundraising to extend its cash runway and achieve commercial objectives for Tutivia™. The directors believe that additional funding can be obtained to enable the company to continue operations for at least the next 12 months. However, there is uncertainty regarding the timing and quantum of cash receipts from revenue, and the directors are taking steps to secure funding arrangements.
Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 million in 2023, primarily due to a commercial contract with Thermo Fisher for the PTRA (Pre Transplant Risk Assessment) test. The adjusted EBITDA loss for the year was US$5.4 million, an improvement from US$7.6 million in 2023. Verici Dx also conducted an equity fundraise in February 2024, raising US$8.2 million in gross proceeds.
Operational highlights include the successful transfer of urine samples to Thermo Fisher, triggering milestone payments, and a collaboration with The Westmead Institute for Medical Research in Australia. The company received CLIA certification and CAP accreditation for its clinical laboratory, enabling testing for patients across 51 US states.
Post-period highlights include securing Medicare coverage for Verici Dxs Tutivia™ assay and a strong acceleration in Tutivia™ testing orders in Q1 2025. The company is proposing an equity fundraising to extend its cash runway and achieve commercial objectives for Tutivia™.
The directors believe that additional funding can be obtained to enable the company to continue operations for at least the next 12 months. However, there is uncertainty regarding the timing and quantum of cash receipts from revenue, and the directors are taking steps to secure funding arrangements.
<>Verici Dx Plc Financials and Debt Year on Year
YearRevenue (in millions)Adjusted EBITDA (in millions)Cash Balance (in millions)Net Proceeds from Equity Fundraising (in millions)
2024$3.3-$5.4$4.1$7.5
2023$1.0-$7.6$2.6N/A
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
MPL
Mercantile Ports & Logistics Ltd
Positive
Full Year Results
Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite facing challenges such as reduced activity due to government elections and procedural issues, the company generated revenues of £4.35 million. The companys focus for the year was on resolving its outstanding debt obligations, and it remains optimistic about reaching a favorable agreement with lenders. MPL expects to diversify its revenue streams, expand its service offerings, and enhance operational efficiency in 2025. The companys long-term prospects remain positive, and it continues to receive strong support from its major shareholder, Hunch Ventures.
Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite facing challenges such as reduced activity due to government elections and procedural issues, the company generated revenues of £4.35 million. The companys focus for the year was on resolving its outstanding debt obligations, and it remains optimistic about reaching a favorable agreement with lenders. MPL expects to diversify its revenue streams, expand its service offerings, and enhance operational efficiency in 2025. The companys long-term prospects remain positive, and it continues to receive strong support from its major shareholder, Hunch Ventures.
YearRevenueCost of SalesGross MarginAdministrative ExpensesOther IncomeDepreciationImpairment LossOperating LossFinance IncomeFinance CostNet Financing CostLoss Before Tax
20244,3522,3302,0222,8419214,7406,77211,410347,2917,25718,667
20235,4622,4173,0453,2665905,5819,85315,065256,2256,20021,265
06:01
Open Terminal ↗ RNS Source
80 Positive
CRTA
Cirata plc
Positive
$700K Multiyear Data Integration Contract Renewal
Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the banks confidence in Ciratas data migration, synchronization, and disaster recovery capabilities. This contract will be facilitated through the Google Marketplace, and the announcement is considered inside information per the UK Market Abuse Regulation. The companys CEO, Stephen Kelly, is responsible for the announcements release. The contact details for Cirata, its financial advisors, and brokers are provided for further inquiries. The London Stock Exchanges news service, RNS, disseminates this information, and users are responsible for adhering to its terms and conditions.
Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the banks confidence in Ciratas data migration, synchronization, and disaster recovery capabilities. This contract will be facilitated through the Google Marketplace, and the announcement is considered inside information per the UK Market Abuse Regulation. The companys CEO, Stephen Kelly, is responsible for the announcements release. The contact details for Cirata, its financial advisors, and brokers are provided for further inquiries. The London Stock Exchanges news service, RNS, disseminates this information, and users are responsible for adhering to its terms and conditions.
NewContract
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
OPTI
OptiBiotix Health Plc
Positive
Final Results
OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners and sales in key markets like the USA and India. The order book for Q1 2025 surpassed sales achieved in H1 2024, and there were multiple product launches and new partnerships across various regions. The companys investments in sales and marketing are delivering returns, and it expects all parts of the business to become profitable as it reduces costs and grows its top line. OptiBiotix ended 2024 with a strong balance sheet and cash position, and it anticipates continuing its upward trajectory. The Chairmans and Chief Executive Officers reports provide further insights into the companys performance and future outlook.
OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners and sales in key markets like the USA and India. The order book for Q1 2025 surpassed sales achieved in H1 2024, and there were multiple product launches and new partnerships across various regions. The companys investments in sales and marketing are delivering returns, and it expects all parts of the business to become profitable as it reduces costs and grows its top line. OptiBiotix ended 2024 with a strong balance sheet and cash position, and it anticipates continuing its upward trajectory. The Chairmans and Chief Executive Officers reports provide further insights into the companys performance and future outlook.
YearRevenueCost of SalesGross ProfitSelling CostsR&D and Patent CostsOther Operating CostsTotal Administrative ExpensesOperating LossFinance IncomeShare of Loss from AssociateGain/Loss on InvestmentsProfit/Loss Before TaxTotal Comprehensive Income
2024870k539k331k651k294k1,605k2,597k2,266k1k350k486k1,866k1,805k
2023644k324k320k125k223k1,662k2,016k1,696k1k323k513k2,043k2,039k
06:01
Open Terminal ↗ RNS Source
98 Exceptional
CPX
CAP-XX Limited
Positive
Global Distribution Agreement with RS Group plc
CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reach by making their prismatic, cylindrical, and hybrid supercapacitors more accessible through RS Groups extensive logistics network. With RS Groups presence in over 30 countries and a customer base that includes industrial OEMs and automation engineers, this partnership will enhance CAP-XXs ability to meet the rising global demand for their products. This agreement is part of CAP-XXs strategy to strengthen its global distribution network, which also includes partnerships with Farnell and Digi-Key, positioning the company to support a wide range of applications across various industries. The companys high-performance supercapacitors are known for their high-power density and energy storage capacity, making them valuable in consumer electronics, industrial automation, and renewable energy sectors.
CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reach by making their prismatic, cylindrical, and hybrid supercapacitors more accessible through RS Groups extensive logistics network. With RS Groups presence in over 30 countries and a customer base that includes industrial OEMs and automation engineers, this partnership will enhance CAP-XXs ability to meet the rising global demand for their products. This agreement is part of CAP-XXs strategy to strengthen its global distribution network, which also includes partnerships with Farnell and Digi-Key, positioning the company to support a wide range of applications across various industries. The companys high-performance supercapacitors are known for their high-power density and energy storage capacity, making them valuable in consumer electronics, industrial automation, and renewable energy sectors.
Agreement
06:01
Open Terminal ↗ RNS Source
93 Strong Beat
SKA
Shuka Minerals Plc
Positive
Annual Results for the year ended 31 December 2024
Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board changes, and the appointment of Richard Lloyd as the new CEO. Shuka Minerals faced production and output challenges at its Rukwa coal mine in Tanzania but expects a restart in mining operations soon. The company entered into a funding commitment with Gathoni Muchai Investments (GMI) for an unsecured, non-convertible, interest-free loan of £500,000, with an additional £1.5 million extension subject to due diligence. Shuka Minerals also agreed to acquire 100% of Leopard Exploration and Mining Limited (LEM), the registered holder of a large-scale mining license for the Kabwe Lead-Zinc-Silver-Vanadium mine in Zambia. The companys financial statements were audited by PKF Littlejohn LLP, who highlighted a material uncertainty related to going concern and emphasized the need to operationalize the 16% Government of Tanzania non-dilutable free carried share interest.
Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board changes, and the appointment of Richard Lloyd as the new CEO. Shuka Minerals faced production and output challenges at its Rukwa coal mine in Tanzania but expects a restart in mining operations soon. The company entered into a funding commitment with Gathoni Muchai Investments (GMI) for an unsecured, non-convertible, interest-free loan of £500,000, with an additional £1.5 million extension subject to due diligence. Shuka Minerals also agreed to acquire 100% of Leopard Exploration and Mining Limited (LEM), the registered holder of a large-scale mining license for the Kabwe Lead-Zinc-Silver-Vanadium mine in Zambia. The companys financial statements were audited by PKF Littlejohn LLP, who highlighted a material uncertainty related to going concern and emphasized the need to operationalize the 16% Government of Tanzania non-dilutable free carried share interest.
YearRevenueCost of SalesGross LossAdmin ExpensesGroup Operating LossFinance IncomeFinance CostsLoss on Operations
20242,305198,2611,799,5841,997,8452,3519,4332,004,927
2023194,346244,5311,424,1201,668,6513,25616,1331,681,528
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
RVRG
River Global Plc
Positive
2025 Half-year Report
River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions for the active asset management industry, with geopolitical turmoil and economic uncertainties impacting investor confidence. Despite these challenges, River Global has made progress in consolidating its asset management business and joint ventures. The A Ordinary Shares business interest reported a loss before taxation of £2.8 million, while the B Shares business interest, representing the companys structured equity interest in Parmenion, reported a profit of £1.2 million. The companys chairman, Martin Gilbert, remains optimistic about the future, focusing on cost-cutting measures and driving efficiencies. The report also includes details on the share reorganization, business review, financial statements, and segmental analysis.
River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions for the active asset management industry, with geopolitical turmoil and economic uncertainties impacting investor confidence. Despite these challenges, River Global has made progress in consolidating its asset management business and joint ventures. The A Ordinary Shares business interest reported a loss before taxation of £2.8 million, while the B Shares business interest, representing the companys structured equity interest in Parmenion, reported a profit of £1.2 million. The companys chairman, Martin Gilbert, remains optimistic about the future, focusing on cost-cutting measures and driving efficiencies. The report also includes details on the share reorganization, business review, financial statements, and segmental analysis.
YearLoss on EBITDATotal LossA Ordinary SharesB Shares
2025£0.2m£1.6m-£1.5m£1.3m
2024£1.3m£3.0m-£2.9m£1.2m
06:01
Open Terminal ↗ RNS Source
80 Positive
WSG
Westminster Group Plc
Positive
£680,000 New Contract Awards
Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, including a sophisticated audio-visual system for broadcasting and recording debates. The second contract is with a worldwide broadcaster for advanced security screening systems in their UK operations. Westminsters CEO, Peter Fowler, highlights the potential for expansion and the importance of these contracts, especially the East African Parliament project. The company specializes in technology-based security solutions and managed services, with a focus on surveillance, detection, and tracking technologies, and has a global presence in over 50 countries. The Westminster Group Foundation, the groups CSR arm, aims to support communities through poverty relief, education, and healthcare initiatives.
Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, including a sophisticated audio-visual system for broadcasting and recording debates. The second contract is with a worldwide broadcaster for advanced security screening systems in their UK operations. Westminsters CEO, Peter Fowler, highlights the potential for expansion and the importance of these contracts, especially the East African Parliament project. The company specializes in technology-based security solutions and managed services, with a focus on surveillance, detection, and tracking technologies, and has a global presence in over 50 countries. The Westminster Group Foundation, the groups CSR arm, aims to support communities through poverty relief, education, and healthcare initiatives.
NewContract
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
SCP
Schroder UK Mid Cap Fund PLC
Positive
Half-year Report
Here is a summary of the text provided: Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly continuation vote, and a more active buy-back policy. The portfolio NAV saw a negative return of 9.3%, underperforming the Benchmark, but the Company NAV has since outperformed the Benchmark by 2.1 percentage points. The Board announced an interim dividend of 6.3 pence per share, reflecting the ongoing recovery in portfolio income. The discount of the Companys share price to NAV narrowed to 7.9% as of March 31, 2025. The Companys net gearing ratio was 9.5%, and the Board remains confident in the UK mid-cap markets attractiveness and potential for correction in valuation dislocation. The outlook for the Company is positive, with experienced portfolio managers and attractive valuations. The report also includes details on investment and share price performance, dividend, discount management, gearing, and an investment managers review.
Here is a summary of the text provided
Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly continuation vote, and a more active buy-back policy. The portfolio NAV saw a negative return of 9.3%, underperforming the Benchmark, but the Company NAV has since outperformed the Benchmark by 2.1 percentage points. The Board announced an interim dividend of 6.3 pence per share, reflecting the ongoing recovery in portfolio income. The discount of the Companys share price to NAV narrowed to 7.9% as of March 31, 2025. The Companys net gearing ratio was 9.5%, and the Board remains confident in the UK mid-cap markets attractiveness and potential for correction in valuation dislocation. The outlook for the Company is positive, with experienced portfolio managers and attractive valuations. The report also includes details on investment and share price performance, dividend, discount management, gearing, and an investment managers review.
YearRevenueCapitalTotalNet AssetsNet Gearing
2025£3,944£(24,100)£(20,156)£215,4239.5%
2024£3,158£18,365£21,523£228,342N/A
2023£8,737£31,395£40,132£242,966N/A
06:01
Open Terminal ↗ RNS Source
84 Broker Upgrade
MDZ
MediaZest plc
Positive
Half-year Report
MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million and a 61% increase in gross profit, resulting in a return to profitability at the EBITDA and pre-tax levels. This positive trend is expected to continue in the second half of the financial year due to recent project wins and new business activity. The basic and diluted profit per share was 0.0031 pence, compared to a loss per share of 0.0092 pence in the previous period. The companys long-term client base remains consistent and continues to generate new opportunities, including digital signage solutions for Pets at Home and new dealership experiences for Hyundai and KIA. MediaZest also completed work for Lululemon Athletica and ArcTeryx, featuring LED technology. A significant new contract was won to deliver audio-visual experiences in airports worldwide. The Groups recurring revenue streams continue to expand, generating over £1 million per annum. The Board believes the outlook for MediaZest is encouraging and well-positioned for continued growth, with a positive start to H2 FY25 and a strong pipeline for FY26 and beyond.
MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million and a 61% increase in gross profit, resulting in a return to profitability at the EBITDA and pre-tax levels. This positive trend is expected to continue in the second half of the financial year due to recent project wins and new business activity. The basic and diluted profit per share was 0.0031 pence, compared to a loss per share of 0.0092 pence in the previous period. The companys long-term client base remains consistent and continues to generate new opportunities, including digital signage solutions for Pets at Home and new dealership experiences for Hyundai and KIA. MediaZest also completed work for Lululemon Athletica and ArcTeryx, featuring LED technology. A significant new contract was won to deliver audio-visual experiences in airports worldwide. The Groups recurring revenue streams continue to expand, generating over £1 million per annum. The Board believes the outlook for MediaZest is encouraging and well-positioned for continued growth, with a positive start to H2 FY25 and a strong pipeline for FY26 and beyond.
Financial MetricsH1 FY25H1 FY24Change
Revenue£1,906,000£1,173,00063% increase
Gross Profit£1,127,000£701,00061% increase
Gross Margin59%60%1% decrease
EBITDA£197,000£(28,000)Positive change
Profit/(Loss) after tax£53,000£(141,000)Positive change
Profit/(Loss) per share (pence)0.0031(0.0092)Positive change
(Bank overdraft) / Cash in hand(£7,000)£14,000Negative change

The table above compares the financial metrics of MediaZest Plc for the first half of the financial year 2025 (H1 FY25) with the same period in the previous year (H1 FY24). The company has shown significant improvement in revenue, gross profit, EBITDA, and profit after tax. However, there was a slight decrease in gross margin and a negative change in cash position.

Debt MetricsH1 FY25H1 FY24Change
Invoice discounting facility£39,000£227,000Repaid £188,000
Short-term funding agreementUp to £60,000N/ANew agreement
Interest-bearing loans and borrowings (current liabilities)£1,359,000£1,524,000Decrease of £165,000
Interest-bearing loans and borrowings (non-current liabilities)£456,000£7,000Increase of £449,000

Regarding debt, MediaZest Plc has made significant changes. They have repaid a substantial amount of their invoice discounting facility and entered into a short-term funding agreement. There has been a decrease in interest-bearing loans and borrowings under current liabilities, while there is a notable increase in such borrowings under non-current liabilities.

06:01
Open Terminal ↗ RNS Source
Market Pulse --
Up
0
Down
0
Good0
Bad0
AI Net0
Most Active Tickers 0
No active AI ticker data for this session.
Strongest Bullish 0
No bullish tickers scored yet.
Strongest Bearish 0
No bearish tickers scored yet.
CUSN
CUSN
Price --
Move --
News 0
Mode AI
Site ↗
🤖 AI Chartist
Full AI chart intelligence
LSTM forecast path, EMA stack, RSI, MACD, support & resistance — all live in the Chart tab.
CUSN logo
Ticker Overview

CUSN

Pulse--
AI Net0
Market News812
Up
0
Down
0
🏢
Company Overview
Profile · broker target · market cap · sector · catalyst count
Select a ticker above
AI VIP Intelligence

Signal Storm

⚡ Live 2025-06-30 812 alerts
CUSN
CUSN Cornish Metals Inc.
17:26
Market

CORNISH METALS ANNOUNCES RESULTS OF ITS 2025 AGM

Open Terminal Source RNS
CYN
CYN CQS Natural Resources Growt…
17:21
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Bank of America Corporation', '5.420847', 0]
Open Terminal Source RNS
ADT1
ADT1 Adriatic Metals
17:20
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
['Helikon Investments Limited', '2.567000', '1.990700']
Open Terminal Source RNS
CLAI
CLAI Cel AI PLC
17:16
Market

Director's Dealings

<mark style="background-color:yellow">Purchase</mark> of Ordinary Shares

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Open Terminal Source RNS
ARB
ARB Argo Blockchain PLC
17:11
Market

Adjournment of AGM

Open Terminal Source RNS
ELM
ELM Elementis PLC
17:03
Market

Transaction in Own Shares

Open Terminal Source RNS
HUD
HUD Huddled Group Plc
17:01
Market

Result of AGM

Open Terminal Source RNS
LGEN
LGEN Legal & General Group PLC
17:01
Market

Transaction in Own Shares

Open Terminal Source RNS
LWI
LWI Lowland Investment Co
17:00
Market

Transaction in Own Shares

Open Terminal Source RNS
UKOG
UKOG UK Oil & Gas PLC
17:00
Market

Delay to the Publication of the Interim Results

Open Terminal Source RNS
SSON
SSON Smithson Investment Trust P…
16:59
Market

Transaction in Own Shares

Open Terminal Source RNS
JADE
JADE Jade Road Investments Ltd
16:58
Market

Annual Results for 2024

Open Terminal Source RNS
BEZ
BEZ Beazley plc
16:57
Market

Transaction in Own Shares

Open Terminal Source RNS
PCTN
PCTN Picton Property Income Ltd
16:56
Market

Total Voting Rights

Open Terminal Source RNS
AGL
AGL ANGLE plc
16:51
Market

Result of 2025 Annual General Meeting

Open Terminal Source RNS
ESCT
ESCT The European Smaller Compan…
16:48
Market

Transaction in Own Shares

Open Terminal Source RNS
SMIN
SMIN Smiths Group PLC
16:48
Market

Transaction in Own Shares

Open Terminal Source RNS
SGE
SGE Sage Group PLC
16:47
Market

Transaction in Own Shares

Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
16:45
Market

Transaction in Own Shares

Open Terminal Source RNS
BTC
BTC Vinanz Limited
16:45
Market

PDMR and Correction

Open Terminal Source RNS
HUW
HUW Helios Underwriting PLC
16:41
Market

Appointment of Executive Director

Open Terminal Source RNS
BKG
BKG The Berkeley Group Holdings…
16:41
Market

Transaction in Own Shares

Open Terminal Source RNS
GMS
GMS Gulf Marine Services PLC
16:39
Market

Total Voting Rights

Open Terminal Source RNS
BIRD
BIRD Blackbird PLC
16:38
Market

Block admission six monthly return

Open Terminal Source RNS
AGT
AGT AVI Global Trust PLC
16:37
Market

Transaction in Own Shares

Open Terminal Source RNS
ICG
ICG Intermediate Capital Group …
16:35
Market

Block Listing Six Monthly Return

Open Terminal Source RNS
THRG
THRG Throgmorton Trust Plc
16:35
Market

Transaction in Own Shares

Open Terminal Source RNS
BVA
BVA Banco Bilbao Vizcaya Argent…
16:33
Market

BBVA's decision on the takeover bid for Sabadell

Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resul…

Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resulting from the offer, with an additional condition to BBVAs previously submitted commitments. Despite having the right to withdraw the offer due to the additional condition, BBVA has decided not to withdraw and will proceed with the offer as planned. The merger control procedure in Spain is now complete, and the offer remains in effect.
Takeover
Open Terminal Source RNS
GCP
GCP GCP Infrastructure Investme…
16:33
Market

Total Voting Rights

Open Terminal Source RNS
TRST
TRST Trustpilot Group PLC
16:32
Market

Total Voting Rights

Open Terminal Source RNS
IMB
IMB Imperial Brands PLC
16:32
Market

Transaction in Own Shares

Open Terminal Source RNS
SHEL
SHEL Shell plc
16:32
Market

Voting Rights and Capital

Open Terminal Source RNS
HSL
HSL Henderson Smaller Cos Inv T…
16:32
Market

Transaction in Own Shares

Open Terminal Source RNS
BERI
BERI Blackrock Energy and Resour…
16:32
Market

Transaction in Own Shares

Open Terminal Source RNS
BNKR
BNKR Bankers Investment Trust
16:31
Market

Transaction in Own Shares

Open Terminal Source RNS
AUTO
AUTO Auto Trader Group plc
16:31
Market

Transaction in Own Shares

Open Terminal Source RNS
PNPL
PNPL Pineapple Power Corporation…
16:31
Market

Annual Financial Report

Open Terminal Source RNS
VTY
VTY Vistry Group PLC
16:31
Market

Total Voting Rights

Open Terminal Source RNS
IPO
IPO IP Group
16:30
Market

Total Voting Rights

Open Terminal Source RNS
SDP
SDP Schroder Asia Pacific Fund
16:30
Market

Total Voting Rights

Open Terminal Source RNS
IBT
IBT International Biotechnology…
16:29
Market

Total Voting Rights

Open Terminal Source RNS
SCP
SCP Schroder UK Mid Cap Fund PLC
16:28
Market

Total Voting Rights

Open Terminal Source RNS
IPO
IPO IP Group
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
SOI
SOI Schroder Oriental Income Fu…
16:28
Market

Total Voting Rights

Open Terminal Source RNS
MNL
MNL Manchester and London Inves…
16:28
Market

Transaction in Own Shares

Open Terminal Source RNS
MONY
MONY MONY Group plc
16:25
Market

Transaction in Own Shares

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
FGT
FGT Finsbury Growth & Income Tr…
16:24
Market

Transaction in Own Shares

Open Terminal Source RNS
SBSI
SBSI Schroder BSC Social Impact …
16:23
Market

Total Voting Rights

Open Terminal Source RNS
GCL
GCL Geiger Counter Limited
16:23
Market

Release of Interim Report and Financial Statements

Open Terminal Source RNS
CGT
CGT Capital Gearing Trust
16:22
Market

Transaction in Own Shares

Open Terminal Source RNS
SVS
SVS Savills
16:21
Market

Director/PDMR Shareholding

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
16:21
Market

Director/PDMR Shareholding

Open Terminal Source RNS
JUP
JUP Jupiter Fund Management Plc
16:21
Market

Total Voting Rights

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
16:20
Market

Director/PDMR Shareholding

Open Terminal Source RNS
PSON
PSON Pearson PLC
16:20
Market

Transaction in Own Shares

Open Terminal Source RNS
GCP
GCP GCP Infrastructure Investme…
16:20
Market

Transaction in Own Shares

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
16:19
Market

Director/PDMR Shareholding

Open Terminal Source RNS
ZPHR
ZPHR Zephyr Energy PLC
16:19
Market

Total Voting Rights

Open Terminal Source RNS
SMWH
SMWH WH Smith PLC
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
HWDN
HWDN Howden Joinery Group Plc
16:17
Market

Transaction in Own Shares

Open Terminal Source RNS
IEM
IEM Impax Environmental Markets…
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
CGEO
CGEO Georgia Capital PLC
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
ASL
ASL Aberforth Smaller Companies…
16:16
Market

Total Voting Rights

Open Terminal Source RNS
AHT
AHT Ashtead Group PLC
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
JUP
JUP Jupiter Fund Management Plc
16:16
Market

Transaction in Own Shares

Open Terminal Source RNS
BHMG
BHMG BH Macro Limited
16:15
Market

Transaction in Own Shares

Open Terminal Source RNS
FEML
FEML Fidelity Emerging Markets O…
16:15
Market

Transaction in Own Shares

Open Terminal Source RNS
RCP
RCP RIT Capital Partners
16:14
Market

Share Buyback Management

Open Terminal Source RNS
SBDS
SBDS Silver Bullet Data Services…
16:14
Market

Final Results for the year ended 31 December 2024

Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million…

Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million, with a gross profit of £7.13 million, representing a 12% increase. The companys services revenue increased by 8% to £6.0 million, while its 4D revenue grew by 20% to £3.37 million, driven by US demand. US and globally operating clients now account for over 60% of total group revenues. Silver Bullet also reported a positive EBITDA during Q4 of FY24 and a strong start to 2025. The company raised £3.3 million through the issue of new convertible loan notes and restructured its existing CLNs, simplifying its capital structure and aligning financing with its growth plans.
YearRevenueGross ProfitLoss Before TaxLoss Per Share
2024£9.37m£7.13m£3.04m£0.17
2023£8.36m£6.36m£3.45m£0.20
Open Terminal Source RNS
MRC
MRC The Mercantile Investment T…
16:13
Market

Transaction in Own Shares

Open Terminal Source RNS
PAG
PAG Paragon Banking Group PLC
16:13
Market

Total Voting Rights

Open Terminal Source RNS
MTE
MTE Montanaro European Smaller …
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
AQX
AQX Aquis Exchange PLC
16:11
Market

Form 8 (DD) - Aquis Exchange Plc

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
ASL
ASL Aberforth Smaller Companies…
16:11
Market

Transaction in Own Shares

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
16:10
Market

Transaction in Own Shares

Open Terminal Source RNS
FRGT
FRGT Franklin Global Trust Ord
16:10
Market

Transaction in Own Shares

Open Terminal Source RNS
PCT
PCT Polar Capital Technology Tr…
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
FSFL
FSFL Foresight Solar Fund Ltd
16:09
Market

Total Voting Rights

Open Terminal Source RNS
EPWN
EPWN Epwin Group PLC
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
BGCG
BGCG Baillie Gifford China Growt…
16:09
Market

Transaction in Own Shares

Open Terminal Source RNS
LLOY
LLOY Lloyds Banking Group PLC
16:09
Market

Total Voting Rights

Open Terminal Source RNS
SCF
SCF Schroder Income Growth Fund
16:09
Market

Total Voting Rights

Open Terminal Source RNS
AUSC
AUSC Abrdn UK Smaller Companies …
16:08
Market

Transaction in Own Shares

Open Terminal Source RNS
JMG
JMG JPMorgan Emerging Markets O…
16:08
Market

Transaction in Own Shares

Open Terminal Source RNS
AQX
AQX Aquis Exchange PLC
16:08
Market

Form 8 (DD) - Aquis Exchange Plc

Open Terminal Source RNS
DIVI
DIVI Diverse Income Trust Ord
16:08
Market

Compliance with Market Abuse Regulation

Open Terminal Source RNS
PAG
PAG Paragon Banking Group PLC
16:07
Market

Transaction in Own Shares

Open Terminal Source RNS
TEM
TEM Templeton Emerging Markets …
16:07
Market

Transaction in Own Shares

Open Terminal Source RNS
DIG
DIG Dunedin Income Growth Inves…
16:06
Market

Transaction in Own Shares

Open Terminal Source RNS
FSFL
FSFL Foresight Solar Fund Ltd
16:05
Market

Transaction in Own Shares

Open Terminal Source RNS
CARD
CARD Card Factory PLC
16:05
Market

Total Voting Rights

Open Terminal Source RNS
PHI
PHI Pacific Horizon Investment …
16:05
Market

Transaction in Own Shares

Open Terminal Source RNS
71LF
71LF 71LF
16:04
Market

ISM- MSBV - PARTIAL_RETIREMENT - 30th June 25

Open Terminal Source RNS
PU55
PU55 PU55
16:04
Market

Publication of Final Terms

Open Terminal Source RNS
DCTA
DCTA Directa Plus PLC
16:04
Market

Result of AGM

Open Terminal Source RNS
IAD
IAD Invesco Asia Dragon Trust p…
16:04
Market

Transaction in Own Shares

Open Terminal Source RNS
17TZ
17TZ 17TZ
16:03
Market

Publication of a Prospectus

Open Terminal Source RNS
SMT
SMT Scottish Mortgage Investmen…
16:03
Market

Transaction in Own Shares

Open Terminal Source RNS
GSCT
GSCT The Global Smaller Companie…
16:03
Market

Transaction in Own Shares

Open Terminal Source RNS
JUGI
JUGI JPMorgan UK Small Cap Growt…
16:03
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BGFD
BGFD Baillie Gifford Japan Trust
16:02
Market

Transaction in Own Shares

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
16:02
Market

Transaction in Own Shares

Open Terminal Source RNS
71LF
71LF 71LF
16:02
Market

ISM -MSBV - EARLY REDEMPTION -30th June 2025

Open Terminal Source RNS
JAGI
JAGI JPMorgan Asia Growth & Inco…
16:02
Market

Transaction in Own Shares

Open Terminal Source RNS
FAS
FAS Fidelity Asian Values
16:02
Market

Transaction in Own Shares

Open Terminal Source RNS
PNL
PNL Personal Assets Trust plc
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FCIT
FCIT F&C Investment Trust PLC
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
71LF
71LF 71LF
16:01
Market

ISM - MSBV- RETIREMENT -30th June 25

Open Terminal Source RNS
KDR
KDR Karelian Diamond Resources …
16:01
Market

Total Voting Rights

Open Terminal Source RNS
TTE
TTE TotalEnergies SE
16:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SGE
SGE Sage Group PLC
16:01
Market

Total Voting Rights

Open Terminal Source RNS
CRS
CRS Crystal Amber Fund Limited
16:01
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
FMET
FMET Fulcrum Metals PLC
16:01
Market

Total Voting Rights

Open Terminal Source RNS
MIRI
MIRI Mirriad Advertising PLC
16:01
Market

Total Voting Rights

Open Terminal Source RNS
ZNWD
ZNWD Zinnwald Lithium PLC
16:01
Market

Total Voting Rights

Open Terminal Source RNS
ELEG
ELEG Electric Guitar PLC
16:01
Market

Total Voting Rights

Open Terminal Source RNS
NBDD
NBDD NB Distressed Debt Investme…
16:01
Market

Total Voting Rights

Open Terminal Source RNS
III
III 3I Group PLC
16:00
Market

Total Voting Rights

Open Terminal Source RNS
III
III 3I Group PLC
16:00
Market

Director/PDMR Shareholding

Open Terminal Source RNS
71LF
71LF 71LF
16:00
Market

ISM - MSBV- PARTIAL RETIRE -AMEND - 30th June 25

Open Terminal Source RNS
FCH
FCH Funding Circle Holdings PLC
15:59
Market

Funding Circle Holdings plc: TVR-Total Voting Rights

Open Terminal Source RNS
EXPN
EXPN Experian PLC
15:58
Market

Total Voting Rights

Open Terminal Source RNS
IRON
IRON Ironveld Plc
15:58
Market

Change of Registered Office Address

Open Terminal Source RNS
SHEL
SHEL Shell plc
15:58
Market

Transaction in Own Shares

Open Terminal Source RNS
PNS
PNS Panther Securities P L C
15:57
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
33JE
33JE 33JE
15:57
Market

Launch of accelerated placing of shares in InPost

Open Terminal Source RNS
JUGI
JUGI JPMorgan UK Small Cap Growt…
15:56
Market

Director/PDMR Shareholding

Open Terminal Source RNS
FCH
FCH Funding Circle Holdings PLC
15:55
Market

Funding Circle Holdings plc: POS-Transaction in Own Shares

Open Terminal Source RNS
BGUK
BGUK Baillie Gifford UK Growth F…
15:54
Market

Transaction in Own Shares

Open Terminal Source RNS
MET
MET Metir PLC
15:54
Market

Publication of Annual Report & Accounts

Open Terminal Source RNS
UEM
UEM Utilico Emerging Markets Ltd
15:54
Market

Transaction in Own Shares & Total Voting Rights

Open Terminal Source RNS
BGEU
BGEU Baillie Gifford European Gr…
15:53
Market

Transaction in Own Shares

Open Terminal Source RNS
SAIN
SAIN Scottish American Investmen…
15:53
Market

Transaction in Own Shares

Open Terminal Source RNS
AQX
AQX Aquis Exchange PLC
15:52
Market

Rule 2.9 Announcement

Open Terminal Source RNS
MWY
MWY Mid Wynd International Inve…
15:51
Market

Transaction in Own Shares

Open Terminal Source RNS
ALFA
ALFA Alfa Financial Software Hol…
15:49
Market

Total Voting Rights

Open Terminal Source RNS
DELT
DELT Deltic Energy PLC
15:46
Market

Final Results

Open Terminal Source RNS
BP.
BP. BP.
15:46
Market

Transaction in Own Shares

Open Terminal Source RNS
WG.
WG. WG.
15:46
Market

Blocklisting - Interim Review

Open Terminal Source RNS
AGVI
AGVI Aberforth Geared Value &
15:46
Market

Total Voting Rights

Open Terminal Source RNS
DLN
DLN Derwent London PLC
15:46
Market

Total Voting Rights

Open Terminal Source RNS
ADT1
ADT1 Adriatic Metals
15:45
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
Open Terminal Source RNS
FDP
FDP FD Technologies Plc
15:42
Market

Results of Court Meeting and General Meeting

Open Terminal Source RNS
BIPS
BIPS Invesco Bond Income Plus Li…
15:42
Market

Issue of Equity

Open Terminal Source RNS
UTG
UTG Unite Group PLC
15:41
Market

Total Voting Rights

Open Terminal Source RNS
SHEL
SHEL Shell plc
15:39
Market

Director/PDMR Shareholding

Open Terminal Source RNS
XTR
XTR Xtract Resources PLC
15:36
Market

Notice of AGM

Open Terminal Source RNS
MBO
MBO Mobilityone Ltd
15:35
Market

Delay in publication of Annual Report and Accounts

Open Terminal Source RNS
CRWN
CRWN Crown Place VCT PLC
15:31
Market

Total voting rights and Capital

Open Terminal Source RNS
AATG
AATG Albion Technology & General…
15:31
Market

Total voting rights and Capital

Open Terminal Source RNS
AAEV
AAEV Albion Enterprise VCT PLC
15:31
Market

Total voting rights and Capital

Open Terminal Source RNS
0A28
0A28 Prosus N.V.
15:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
MPE
MPE M.P.Evans Group
15:31
Market

Total Voting Rights

Open Terminal Source RNS
MOS
MOS Mobile Streams Plc
15:31
Market

Exercise of Warrants & Total Voting Rights (“TVR”)

Open Terminal Source RNS
VANQ
VANQ Vanquis Banking Group PLC
15:31
Market

Total Voting Rights

Open Terminal Source RNS
PODP
PODP Pod Point Group Holdings PLC
15:30
Market

Result of 2025 AGM

Open Terminal Source RNS
NTVO
NTVO Nativo Resources plc
15:25
Market

Result of AGM

Open Terminal Source RNS
0QYU
0QYU Morgan Stanley
15:25
Market

Form 8.3 - Replacement of Dundee Precious Metals

Open Terminal Source RNS
GWMO
GWMO Great Western Mining Corp P…
15:23
Market

Total Voting Rights

Open Terminal Source RNS
PR1
PR1 Pri0r1ty Intelligence Group…
15:23
Market

Half-year Report

Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report r…

Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report reflects only three months of Pri0r1ty trading. During this time, they generated £37,000 in revenue, with 40 customers using their products and 20% paying for services. They also formed strategic partnerships, developed new revenue-generating products, and successfully integrated cryptocurrency payments. The company expects to see increased platform adoption in the second half of 2025 and remains on track to onboard at least 100 paying users by the financial year-end. The financial statements include details on the companys financial position, changes in equity, and cash flows for the period.
Financial YearRevenue (£)Cost of Sales (£)Gross Profit (£)Other Expenses (£)Earnings Before Interest, Tax, Depreciation, and Amortization (£)Interest Expenditure (£)Loss Before Taxation (£)Income Tax (£)Profit/ (Loss) for the Year (£)
31 March 2025 (unaudited)37,000037,000570,436-860,2670-860,2670-860,267
31 March 2024 (unaudited)000151,301-151,3010-151,3010-151,301

| Debt | 31 March 2025 (Unaudited) | 31 March 2024 (Unaudited) | | --- | --- | --- | | Trade and Other Payables (£) | 400,397 | 68,842 |
Open Terminal Source RNS
CVCE
CVCE CVC Income & Growth Limited
15:22
Market

Issue of Equity

Open Terminal Source RNS
TEP
TEP Telecom Plus PLC
15:21
Market

Total Voting Rights

Open Terminal Source RNS
PBEE
PBEE Pensionbee Group PLC
15:20
Market

Total Voting Rights

Open Terminal Source RNS
SMWH
SMWH WH Smith PLC
15:19
Market

Total Voting Rights

Open Terminal Source RNS
EWI
EWI Edinburgh Worldwide Investm…
15:19
Market

Edinburgh Wrldwde Inv Trust Interim Report Updated

<mark style="background-color:yellow"></mark>

<mark style="background-coloryellow"></mark>
Open Terminal Source RNS
FSG
FSG Foresight Group Holdings Li…
15:19
Market

Notice of AGM

Open Terminal Source RNS
ABF
ABF Associated British Foods PLC
15:19
Market

Total Voting Rights

Open Terminal Source RNS
BBH
BBH Bellevue Healthcare Trust P…
15:17
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Saba Capital Management, L.P.', '0.873177', '1.088320']
Open Terminal Source RNS
80M
80M 80 Mile Plc
15:16
Market

Final Results for the year ended 31 December 2024

80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue …

80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue remained nil, while its cost of sales decreased to £35,887 from £213,523 in the previous year. 80 Mile Plcs administrative expenses increased to £2,262,385 from £1,629,273 in the previous year. The companys impairment of intangible assets decreased to £4,902,058 from £3,535,254 in the previous year. 80 Mile Plcs share of losses from joint ventures increased to £18,114 from £13,779 in the previous year. The companys other losses increased to £2,259,088 from a gain of £2,962,769 in the previous year. 80 Mile Plcs finance expense decreased to £1,663 from a finance income of £7,039 in the previous year. The companys other income increased to £116,844 from £320,925 in the previous year. As of December 31, 2024, 80 Mile Plcs total assets decreased to £34,153,950 from £40,520,554 in the previous year. The companys total liabilities decreased to £1,187,350 from £1,143,927 in the previous year. 80 Mile Plcs net assets decreased to £32,966,600 from £39,376,627 in the previous year.
YearFinancialsDebt
2024£34,153,950£1,187,350
2023£40,520,554£1,143,927
Open Terminal Source RNS
NCYF
NCYF CQS New City High Yield Fund
15:16
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Ordinary Shares

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Open Terminal Source RNS
PEG
PEG Petards Group plc
15:16
Market

Posting of Annual Report and Notice of AGM

Open Terminal Source RNS
SRE
SRE Sirius Real Estate Limited
15:16
Market

Total Voting Rights

Open Terminal Source RNS
RMR
RMR Rome Resources Plc
15:15
Market

2024 Annual Report Webinar

Open Terminal Source RNS
PR1
PR1 Pri0r1ty Intelligence Group…
15:14
Market

Results of General Meeting

Open Terminal Source RNS
HWG
HWG Harworth Group PLC
15:13
Market

Director/PDMR Shareholding

Open Terminal Source RNS
FTV
FTV Foresight VCT PLC
15:12
Market

Issue of Equity

Open Terminal Source RNS
PINE
PINE Pinewood Technologies Group…
15:11
Market

Results of AGM & General Meeting

Open Terminal Source RNS
MGCI
MGCI M&G Credit Income Investmen…
15:07
Market

Issue of Equity

Open Terminal Source RNS
HFD
HFD Halfords Group PLC
15:01
Market

Halfords Group PLC: Total Voting Rights

Open Terminal Source RNS
PREM
PREM Premier African Minerals Ltd
15:01
Market

Final Results

Open Terminal Source RNS
QQ.
QQ. QQ.
15:01
Market

Total Voting Rights

Open Terminal Source RNS
IQE
IQE IQE PLC
15:01
Market

IQE plc: Total Voting Rights and Block Admission

Open Terminal Source RNS
GFRD
GFRD Galliford Try PLC
15:01
Market

Total Voting Rights

Open Terminal Source RNS
SXS
SXS Spectris PLC
15:00
Market

Director/PDMR Shareholding

Open Terminal Source RNS
NWG
NWG NatWest Group PLC
15:00
Market

Total Voting Rights

Open Terminal Source RNS
BRSC
BRSC Blackrock Smaller Companies…
14:58
Market

Portfolio Update

Here is a summary of the provided text: BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basi…

Here is a summary of the provided text
BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basis, while the benchmark index returned 7.3%. The share price performance was positive for the month, but underperformed the broader market. The largest detractors from performance were Bloomsbury Publishing, Ashtead Technology, and Tatton Asset Management due to stock-specific issues. However, holdings in Chemring, Boku, and Alpha Group International contributed positively to the portfolio.
The update also includes a commentary on the markets by Roland Arnold, representing the Investment Manager. Arnold notes that global financial markets experienced a strong rebound in May, with a boost in risk sentiment and easing geopolitical tensions. While the US Federal Reserve maintained its policy rate, the Bank of England cut rates citing domestic disinflation. Despite this, UK inflation surprised to the upside in April.
Arnold also provides an outlook for the UK equity market, highlighting several positive factors including falling mortgage rates, positive real wage growth, and a recovery in the housing market. Additionally, the pace of M&A activity remains robust, and UK SMID stocks are considered undervalued compared to large-cap stocks. The update concludes by expressing optimism about the attractiveness of the UK market for investors, given the uncertainty in the US equity market.
Financial MetricsOne MonthThree MonthsOne YearThree YearsFive Years
Net Asset Value6.5%3.7%-8.6%-7.2%24.5%
Share Price6.1%4.3%-10.6%-3.8%17.3%
Benchmark7.3%6.4%1.1%1.1%38.9%
Net Asset Value (Capital Only, Debt at Par Value)1,409.19p
Net Asset Value (Capital Only, Debt at Fair Value)1,473.13p
Net Asset Value incl. Income (Debt at Par Value)1,424.01p
Net Asset Value incl. Income (Debt at Fair Value)1,487.95p
Share Price1,296.00p
Discount to Cum Income NAV (Debt at Par Value)9.0%
Discount to Cum Income NAV (Debt at Fair Value)12.9%
Net Yield3.4%
Gross Assets£678.5m
Net Gearing including Income (Debt at Par)7.0%
Open Terminal Source RNS
WIZZ
WIZZ Wizz Air Holdings PLC
14:57
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['The Capital Group Companies, Inc.', '8.058573', '9.951957']
Open Terminal Source RNS
OXA2
OXA2 OXA2
14:54
Market

Buy-Back of Securities

Open Terminal Source RNS
JARA
JARA Jpmorgan Global Core Real A…
14:50
Market

Final results for the year ended 28 February 2025

Here is a summary of the text provided: JPMorgan Global Core Real Assets Limited has released its final results for the year ended February 28, 2025, announcing a managed wind-down of the company and a shift in its investment objective. …

Here is a summary of the text provided
JPMorgan Global Core Real Assets Limited has released its final results for the year ended February 28, 2025, announcing a managed wind-down of the company and a shift in its investment objective. The companys continuation vote failed to pass at the 2024 AGM, leading to a new strategy that involves liquidating assets and returning capital to shareholders. As of February 28, 2025, the company has realized its holdings in the Listed Real Assets Strategy, with the exception of Home REIT plc, and has made significant progress in redeeming its holdings in other strategies. The Board expects to have realized and returned over 55% of assets to shareholders by the end of 2025 and over 80% by the end of 2026. The companys return on net asset value was 5.2% for the year, while the return to shareholders was 36.8%. The Board has taken steps to reduce costs, including reducing directors fees and disbanding certain committees. The companys sixth AGM will be held on August 28, 2025, and the Board encourages shareholders to vote in advance. The Board acknowledges the challenges faced by the company since its launch in 2019 but remains focused on liquidating assets and returning proceeds to shareholders efficiently.
YearFinancialsDebt
2025£162,311,000£35,260,000
2024£196,411,000£3,682,000
Open Terminal Source RNS
VAL
VAL ValiRx plc
14:49
Market

Result of AGM

Open Terminal Source RNS
BGO
BGO Bango plc
14:45
Market

Result of AGM

Open Terminal Source RNS
38LO
38LO 38LO
14:44
Market

Publication of Final Terms

Open Terminal Source RNS
ELSA
ELSA Electrica SA
14:43
Market

Supplemented 2025 CAPEX Plan

Open Terminal Source RNS
CAN
CAN Groupe Canal Plus
14:43
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Morgan Stanley', '5.017919', '4.999584']
Open Terminal Source RNS
GNC
GNC Greencore Group
14:40
Market

Total Voting Rights

Open Terminal Source RNS
FC98
FC98 FC98
14:39
Market

Annual Financial Report

Open Terminal Source RNS
EML
EML Emmerson PLC
14:37
Market

2024 Financial Results

Open Terminal Source RNS
NEO
NEO Neo Energy Metals Plc
14:36
Market

NEO to Complete Fast-Track Listing on the JSE

Open Terminal Source RNS
AJB
AJB AJ Bell plc
14:36
Market

Total Voting Rights

Open Terminal Source RNS
HHV
HHV Hargreave Hale Aim Vct PLC
14:35
Market

Total voting rights

Open Terminal Source RNS
CCH
CCH Coca Cola HBC AG
14:33
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">PURCHASE</mark> OF ORDINARY SHARES FOLLOWING THE RE-INVESTMENT OF DIVIDENDS PAID ON THE EMPLOYEES SHARES HELD UNDER THE COMPANYS EQUITIES PLANS

<mark style="background-coloryellow">PURCHASE</mark> OF ORDINARY SHARES FOLLOWING THE RE-INVESTMENT OF DIVIDENDS PAID ON THE EMPLOYEES SHARES HELD UNDER THE COMPANYS EQUITIES PLANS
Open Terminal Source RNS
OXA1
OXA1 Db Etc Plc
14:33
Market

Issuance of Securities

Open Terminal Source RNS
GVCT
GVCT Guinness VCT PLC
14:31
Market

Issue of Equity & Close of Offer

Open Terminal Source RNS
FA26
FA26 FA26
14:31
Market

Annual Financial Report

Open Terminal Source RNS
HMSO
HMSO Hammerson PLC
14:31
Market

Total Voting Rights

Open Terminal Source RNS
CNA
CNA Centrica PLC
14:31
Market

Report on Payments to Govts

Open Terminal Source RNS
CRH
CRH CRH PLC
14:31
Market

Total Voting Rights

Open Terminal Source RNS
17TZ
17TZ 17TZ
14:28
Market

Form 8.5 (EPT/NON-RI), Dundee Precious Metals Inc

Open Terminal Source RNS
ICON
ICON Iconic Labs Plc
14:28
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
14:26
Market

Form 8.3 - Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:26
Market

Form 8.3 - Alphawave IP Group plc

Open Terminal Source RNS
AV.
AV. AV.
14:26
Market

Form 8.3 - Aviva plc

Open Terminal Source RNS
DLG
DLG Direct Line Insurance Group…
14:26
Market

Form 8.3 - Direct Line Insurance Group plc

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
14:26
Market

Form 8.3 - Dowlais Group plc

Open Terminal Source RNS
HAT
HAT H&T Group plc
14:26
Market

Form 8.3 - H&T Group plc

Open Terminal Source RNS
AGR
AGR Assura PLC
14:26
Market

Form 8.3 - Assura plc

Open Terminal Source RNS
PHP
PHP Primary Health Properties
14:26
Market

Form 8.3 - Primary Health Properties plc

Open Terminal Source RNS
SPT
SPT Spirent Communications plc
14:26
Market

Form 8.3 - Spirent Communications plc

Open Terminal Source RNS
ICON
ICON Iconic Labs Plc
14:26
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Maximum Media Network Limited', '15.12', '0']
Open Terminal Source RNS
EAAS
EAAS Eenergy Group PLC
14:19
Market

Final Results

eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and …

eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and transitioned into profit with an Adjusted EBITDA of £0.6 million. The companys net debt was reduced to £2.4 million, and it was awarded a solar installation contract worth £5.2 million with Spire Healthcare. The companys outlook for FY2025 is optimistic, with a strong contracted forward order book and increased sales pipeline. The company expects to be cash positive in H1 2025 and further cash generative in H2 2025.
<>eEnergy Group Financials
YearRevenueAdjusted EBITDANet DebtCash
2024£25.1 million£0.6 million£2.4 million£2.3 million
2023£14.7 million-£6.4 million£8.0 million£0.6 million
Open Terminal Source RNS
MUT
MUT Murray Income Trust
14:17
Market

Gearing disclosure

Open Terminal Source RNS
AAIF
AAIF abrdn Asian Income Fund Lim…
14:17
Market

Gearing disclosure

Open Terminal Source RNS
AEI
AEI abrdn Equity Income Trust p…
14:17
Market

Gearing disclosure

Open Terminal Source RNS
AAS
AAS Abrdn Asia Focus PLC
14:17
Market

Gearing disclosure

Open Terminal Source RNS
ANII
ANII Aberdeen New India Investme…
14:17
Market

Gearing disclosure

Open Terminal Source RNS
AUSC
AUSC Abrdn UK Smaller Companies …
14:17
Market

Gearing disclosure

Open Terminal Source RNS
SHRS
SHRS Shires Income
14:17
Market

Gearing disclosure

Open Terminal Source RNS
MYI
MYI Murray International Trust
14:17
Market

Gearing disclosure

Open Terminal Source RNS
DIG
DIG Dunedin Income Growth Inves…
14:17
Market

Gearing disclosure

Open Terminal Source RNS
ASHM
ASHM Ashmore Group Plc
14:17
Market

Directorate Change

Open Terminal Source RNS
VLG
VLG Venture Life Group PLC
14:16
Market

Result of AGM

Open Terminal Source RNS
BA.
BA. BA.
14:16
Market

Total Voting Rights

Open Terminal Source RNS
HAYD
HAYD Haydale Graphene Industries
14:15
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Octopus Investments Limited', '9.720000', '10.920000']
Open Terminal Source RNS
VLG
VLG Venture Life Group PLC
14:14
Market

Final Results for year ended 31 December 2024

Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported …

Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported strong growth in its core business, with a revenue increase of 18.9% to £26.6 million and an underlying growth of 14.9% excluding acquisitions. The gross profit increased by 31.1% to £12.2 million, and the gross margin improved to 45.8%. The adjusted EBITDA rose by 26.1% to £6.2 million, and the adjusted profit before tax increased to £4.3 million. The company also announced the sale of its contract development and manufacturing operations and certain non-core products for €62 million in cash. The Board expects to complete the sale of its oral care brands, which are now considered non-core, by the end of 2025.
YearRevenueGross ProfitMarketing CostsAdjusted EBITDAAdjusted Profit Before TaxAdjusted EPSFree Cash FlowGroup Net LeverageGroup Net Debt
2024£26.6 million£12.2 million6.1%£6.2 million£4.3 million3.37p£4.3 million1.83x£18.7 million
2023£22.4 million£9.3 million3.9%£4.9 million£2.8 million2.60p£2.7 million1.30x£13.7 million
Open Terminal Source RNS
CPAI
CPAI Dukemount Capital Plc
14:12
Market

Total Voting Rights

Open Terminal Source RNS
ROO
ROO Deliveroo Holdings PLC
14:09
Market

Rule 2.9 Announcement

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
14:08
Market

Form 8.3 - Warehouse REIT Plc

Open Terminal Source RNS
FUTR
FUTR Future PLC
14:08
Market

Purchase of Company’s shares by EBT

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
14:06
Market

Form 8.3 - Unite Group Plc

Open Terminal Source RNS
VRS
VRS Versarien PLC
14:04
Market

Interim Results

Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March …

Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March 31, 2025. Versariens strategy is to monetize its intellectual property and know-how by licensing its technology and brands as commercial traction for graphene develops. The company has a pipeline of commercial opportunities worth £2.1 million and is seeking additional funding to continue as a going concern. Versarien is also simplifying its corporate structure and seeking strategic partners for its 3D Construction Printing business. The Board expects the Groups ongoing costs to reduce with the simplified structure.
Financial MetricsFY 2025FY 2024Change
Group revenues£1.47 million£1.34 million10.45% increase
Graphene revenues£0.21 million£0.28 million25% decrease
Grant income£0.23 million£0.20 million15% increase
Adjusted LBITDA£0.77 million£0.67 million14.93% increase
Loss before tax£1.49 million£1.61 million7.45% decrease
Cash as of 31 March£0.85 million£0.15 million466.67% increase

Debt MetricsFY 2025FY 2024Change
Innovate UK Loan£5 million£4.5 million11.11% increase
Long-term borrowings£285£47539.99% decrease
Total debt£5,285£4,9756.23% increase
Open Terminal Source RNS
BBOX
BBOX Tritax Big Box REIT plc
14:04
Market

Form 8.3 - Tritax Big Box REIT plc

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
14:03
Market

Form 8.3 - Tritax Big Box Reit Plc

Open Terminal Source RNS
PHP
PHP Primary Health Properties
14:03
Market

Form 8.3 - Primary Health Properties plc

Open Terminal Source RNS
HSBA
HSBA HSBC Holdings PLC
14:02
Market

Total Voting Rights

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
14:01
Market

Form 8.3 - Primary Health Properties Plc

Open Terminal Source RNS
BLND
BLND British Land Company PLC
14:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
HSBA
HSBA HSBC Holdings PLC
14:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
14:01
Market

Annual General Meeting Results

Open Terminal Source RNS
AVCT
AVCT Avacta Group PLC
14:01
Market

Appointment of Zeus Capital as Joint Broker

Open Terminal Source RNS
MAB
MAB Mitchells & Butlers PLC
14:01
Market

Total Voting Rights

Open Terminal Source RNS
QLT
QLT Quilter PLC
14:01
Market

Form 8.3 - Assura PLC

Open Terminal Source RNS
MOON
MOON Moonpig Group PLC
14:01
Market

Employee Benefit Trust Share Purchase

Open Terminal Source RNS
HAT
HAT H&T Group plc
14:01
Market

Form 8.3 - H&T Group plc

Open Terminal Source RNS
SPT
SPT Spirent Communications plc
14:01
Market

Form 8.3 - Spirent Communications PLC

Open Terminal Source RNS
AWE
AWE Alphawave IP Group PLC
14:01
Market

Form 8.3 - Alphawave IP Group plc

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
13:59
Market

Form 8.3 - Empiric Student Property Plc

Open Terminal Source RNS
PHP
PHP Primary Health Properties
13:59
Market

Form 8.3 - Primary Health Properties PLC

Open Terminal Source RNS
MET1
MET1 Metals One PLC
13:56
Market

Notice of AGM & Issue of Equity

Open Terminal Source RNS
MTO
MTO Mitie Group PLC
13:56
Market

Form 8.3 - Mitie Group PLC

Open Terminal Source RNS
SNT
SNT Sabien Technology Group Plc
13:54
Market

Issue of shares to directors

Open Terminal Source RNS
RAT
RAT Rathbone Brothers PLC
13:54
Market

Form 8.3 - Assura Plc

Open Terminal Source RNS
MRL
MRL Marlowe plc
13:54
Market

Form 8.3 - Marlowe PLC

Open Terminal Source RNS
OIT
OIT Odyssean Investment Trust P…
13:51
Market

Director/PDMR Shareholding

Open Terminal Source RNS
GNC
GNC Greencore Group
13:51
Market

Form 8.3 - Greencore Group PLC

Open Terminal Source RNS
WSBN
WSBN Wishbone Gold Plc
13:50
Market

Final Results for the year ended 31 December 2024

Open Terminal Source RNS
GLB
GLB Glanbia plc
13:50
Market

Total Voting Rights

Open Terminal Source RNS
DWL
DWL Dowlais Group Plc
13:49
Market

Form 8.3 - Dowlais Group PLC

Open Terminal Source RNS
ROO
ROO Deliveroo Holdings PLC
13:45
Market

Form 8.3 - Deliveroo PLC

Open Terminal Source RNS
AV.
AV. AV.
13:43
Market

Form 8.3 - Tritax Big Box REIT plc

Open Terminal Source RNS
BAKK
BAKK Bakkavor Group PLC
13:43
Market

Form 8.3 - Bakkavor Group PLC

Open Terminal Source RNS
TBCG
TBCG TBC Bank Group PLC
13:41
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Allan Gray Proprietary Limited', '2.993000', '3.886100']
Open Terminal Source RNS
AGR
AGR Assura PLC
13:41
Market

Form 8.3 - Assura PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
13:38
Market

Form 8.3 - Wood Group (John) plc Replacement

Open Terminal Source RNS
ESCT
ESCT The European Smaller Compan…
13:32
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
COBR
COBR Cobra Resources PLC
13:31
Market

Result of AGM

Open Terminal Source RNS
OOA
OOA Octopus Aim Vct Plc
13:31
Market

Annual Report for the year ended 28 February 2025 and Notice of Meeting

Open Terminal Source RNS
SPT
SPT Spirent Communications plc
13:31
Market

Form 8.3 - Spirent Communications plc

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
13:31
Market

Form 8.3 - Qualcomm Incorporated

Open Terminal Source RNS
AGR
AGR Assura PLC
13:31
Market

Form 8.3 - Assura plc

Open Terminal Source RNS
PHP
PHP Primary Health Properties
13:31
Market

Form 8.3 - Primary Health Properties plc

Open Terminal Source RNS
EXPN
EXPN Experian PLC
13:31
Market

Share repurchase programme

Open Terminal Source RNS
EQT
EQT EQTEC plc
13:27
Market

Final Results

EQTEC plc announces its audited results for the year ended 31 December 2024.

EQTEC plc announces its audited results for the year ended 31 December 2024.
YearRevenueOperating LossNet LossNet Assets
2024€2.2 million€3.6 million€19.4 million€13.7 million
2023€2.5 million€3.5 million€23.5 million€21.2 million
Open Terminal Source RNS
SDR
SDR Schroders PLC
13:24
Market

Form 8.3 - Aviva PLC

Open Terminal Source RNS
EGT
EGT European Green Transition P…
13:24
Market

Results of AGM

Open Terminal Source RNS
ADT1
ADT1 Adriatic Metals
13:23
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
['Citigroup Inc.', '5.080442', '0.000000']
Open Terminal Source RNS
77LC
77LC 77LC
13:22
Market

Annual Financial Report

Open Terminal Source RNS
CPAI
CPAI Dukemount Capital Plc
13:19
Market

Half-year Report

Open Terminal Source RNS
55WI
55WI 55WI
13:16
Market

Designation of New Chair of the Board

Open Terminal Source RNS
N4P
N4P N4 Pharma PLC
13:16
Market

Result of AGM

Open Terminal Source RNS
HMI
HMI Harvest Minerals Ltd
13:11
Market

Issue of Settlement Shares and TVR

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
13:06
Market

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated

Open Terminal Source RNS
DLAR
DLAR De La Rue PLC
13:06
Market

Court sanction of Scheme

Open Terminal Source RNS
SPT
SPT Spirent Communications plc
13:06
Market

Form 8.3 - Spirent Communications plc

Open Terminal Source RNS
IRSH
IRSH IRSH
13:05
Market

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc

Open Terminal Source RNS
BT.A
BT.A BT.A
13:04
Market

Total Voting Rights

Open Terminal Source RNS
AV.
AV. AV.
13:04
Market

Form 8.3 - The Vanguard Group, Inc.: Aviva plc

Open Terminal Source RNS
UTG
UTG Unite Group PLC
13:03
Market

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The

Open Terminal Source RNS
PAIM
PAIM PAIM
13:03
Market

Issue of Supplementary Prospectus

Open Terminal Source RNS
SXS
SXS Spectris PLC
13:03
Market

Form 8.3 - The Vanguard Group, Inc.: Spectris plc

Open Terminal Source RNS
PGV
PGV Praetura Growth Vct Plc
13:02
Market

Issue of Equity

Open Terminal Source RNS
XAR
XAR Xaar plc
13:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
TRP
TRP Tower Resources plc
13:01
Market

Result of Annual General Meeting

Open Terminal Source RNS
SGRO
SGRO Segro Plc
13:01
Market

Total Voting Rights

Open Terminal Source RNS
INVP
INVP Investec PLC
13:01
Market

Investec Ltd - BBBEE Annual Compliance Report

Open Terminal Source RNS
ACRM
ACRM Acuity RM Group Plc
12:55
Market

Issue of Equity

Open Terminal Source RNS
ALPH
ALPH Alpha Group International p…
12:54
Market

Form 8.3 - Alpha Group International plc

Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
12:52
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AV.
AV. AV.
12:52
Market

Form 8.3 - Aviva PLC

Open Terminal Source RNS
ROO
ROO Deliveroo Holdings PLC
12:50
Market

Form 8.3 - Deliveroo plc

Open Terminal Source RNS
NOG
NOG Nostrum Oil & Gas PLC
12:49
Market

Stakeholder discussions and Board changes

Open Terminal Source RNS
OPT
OPT Optima Health plc
12:48
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Octopus Investments Limited', '10.620000', '9.210000']
Open Terminal Source RNS
BBB
BBB Bigblu Broadband PLC
12:48
Market

Result of AGM

Open Terminal Source RNS
STAF
STAF Staffline Group Plc
12:47
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CIZ
CIZ Cizzle Biotechnology Holdin…
12:46
Market

Result of AGM

Open Terminal Source RNS
87FZ
87FZ AECI Ltd
12:46
Market

Director/PDMR Shareholding

Open Terminal Source RNS
YZ61
YZ61 YZ61
12:45
Market

Form 8.5 (EPT/RI)- Replacement of Spectris plc

Open Terminal Source RNS
CCH
CCH Coca Cola HBC AG
12:45
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
YZ61
YZ61 YZ61
12:44
Market

Form 8.5 (EPT/RI)- Replacement of Aviva plc

Open Terminal Source RNS
IAG
IAG International Consolidated …
12:43
Market

Total Voting Rights

Open Terminal Source RNS
OCI
OCI Oakley Capital Investments …
12:43
Market

Oakley Capital agrees sale of vLex to Clio

Open Terminal Source RNS
YZ61
YZ61 YZ61
12:43
Market

Form 8.5 (EPT/RI)- Replacement of Direct Line

Open Terminal Source RNS
EST
EST East Star Resources PLC
12:43
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['First Equity Limited', '3.031089', 0]
Open Terminal Source RNS
WOSG
WOSG Watches Of Switzerland Grou…
12:42
Market

Total Voting Rights

Open Terminal Source RNS
VCT
VCT Victrex plc
12:39
Market

Total Voting Rights

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:38
Market

Form 8.3 - ME Group International plc

Open Terminal Source RNS
GNC
GNC Greencore Group
12:34
Market

Form 8.3 - GREENCORE GROUP PLC

Open Terminal Source RNS
PAIM
PAIM PAIM
12:32
Market

Offer for Subscription - Update

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:32
Market

Form 8.3 - Assura PLC

Open Terminal Source RNS
AMS
AMS Advanced Medical Solutions …
12:30
Market

Results of Annual General Meeting

Open Terminal Source RNS
ABDN
ABDN Abrdn PLC
12:28
Market

Form 8.3 - Alpha Group International plc

Open Terminal Source RNS
73VA
73VA 73VA
12:25
Market

Annual Financial Report

Open Terminal Source RNS
MKS
MKS Marks and Spencer Group PLC
12:24
Market

Director/PDMR Shareholding

Open Terminal Source RNS
MNG
MNG M&G Plc
12:21
Market

Form 8.3 - Aviva Plc

Open Terminal Source RNS
AAZ
AAZ Anglo Asian Mining Plc
12:19
Market

Change of registered office

Open Terminal Source RNS
IM88
IM88 IM88
12:16
Market

Annual Financial Report

Open Terminal Source RNS
AQX
AQX Aquis Exchange PLC
12:12
Market

Court Sanction of Scheme of Arrangement

Open Terminal Source RNS
AGR
AGR Assura PLC
12:11
Market

Form 8.3 - Assura PLC

Open Terminal Source RNS
SEEN
SEEN SEEEN PLC
12:06
Market

Delay in publication of Annual Accounts

Open Terminal Source RNS
PH80
PH80 PH80
12:01
Market

Announcement of 2024 Full Year Annual Report

Open Terminal Source RNS
IQE
IQE IQE PLC
12:01
Market

IQE plc: Result of AGM

Open Terminal Source RNS
KIST
KIST Kistos PLC
12:01
Market

Results of AGM

Open Terminal Source RNS
BLND
BLND British Land Company PLC
12:01
Market

Total Voting Rights

Open Terminal Source RNS
ITRK
ITRK Intertek Group PLC
12:01
Market

Total Voting Rights

Open Terminal Source RNS
AW03
AW03 AW03
11:58
Market

Annual Financial Report

Open Terminal Source RNS
ALPH
ALPH Alpha Group International p…
11:57
Market

Form 8.3 - Alpha Group International plc

Open Terminal Source RNS
OVCT
OVCT New Century AIM VCT 2 PLC
11:55
Market

Result of AGM

Open Terminal Source RNS
VID
VID Videndum Plc
11:53
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Harwood Capital LLP', '5.308000', '3.715740']
Open Terminal Source RNS
BOKU
BOKU Boku Inc
11:52
Market

Total Voting Rights and Share Capital

Open Terminal Source RNS
SPT
SPT Spirent Communications plc
11:52
Market

Directorate Change

Open Terminal Source RNS
SY73
SY73 SY73
11:52
Market

Annual Financial Report

Open Terminal Source RNS
0RPR
0RPR Ringkjoebing Landbobank A/S
11:48
Market

Ringkjøbing Landbobank issues Tier 2 capital

Open Terminal Source RNS
SPT
SPT Spirent Communications plc
11:47
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BLU
BLU Blue Star Capital plc
11:46
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Christophe SEBAKHI', '3.830000', '4.700000']
Open Terminal Source RNS
OCN
OCN Ocean Wilsons Holdings Ltd
11:39
Market

Interim Dividend 2025

Open Terminal Source RNS
ARR
ARR Aurora Investment Trust plc
11:34
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
AXS
AXS Accsys Technologies PLC
11:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:29
Market

Form 8.3 MITIE GROUP PLC - Replacement

Open Terminal Source RNS
BARC
BARC Barclays PLC
11:29
Market

Form 8.3 WAREHOUSE REIT PLC - Replacement

Open Terminal Source RNS
HUW
HUW Helios Underwriting PLC
11:29
Market

Result of AGM

Open Terminal Source RNS
BE36
BE36 BE36
11:27
Market

Annual Financial Report

Open Terminal Source RNS
YU66
YU66 YU66
11:25
Market

Publication of a Prospectus

Open Terminal Source RNS
EMVC
EMVC EMV Capital plc
11:23
Market

Result of AGM

Open Terminal Source RNS
BK85
BK85 BK85
11:21
Market

Annual Financial Report

Open Terminal Source RNS
JAR
JAR Jardine Matheson Holdings L…
11:20
Market

Extractive Sector: Payments to Govts Report 2024

Open Terminal Source RNS
NOG
NOG Nostrum Oil & Gas PLC
11:19
Market

Result of AGM

Open Terminal Source RNS
VOF
VOF VinaCapital Vietnam Opportu…
11:15
Market

Investment Manager Share Purchase

Open Terminal Source RNS
HHPD
HHPD Hon Hai Precision Industry …
11:14
Market

Subsidiary acquires real estate use rights assets

Open Terminal Source RNS
SXS
SXS Spectris PLC
11:12
Market

Form 8 (DD) Spectris plc

Open Terminal Source RNS
BRK
BRK Brooks Macdonald Group
11:11
Market

Form 8.3 - Tritax Big Box REIT plc

Open Terminal Source RNS
GBG
GBG GB Group plc
11:09
Market

Total Voting Rights

Open Terminal Source RNS
SMIF
SMIF TwentyFour Select Monthly I…
11:09
Market

Block Listing

Open Terminal Source RNS
TERN
TERN Tern Plc
11:08
Market

Result of AGM

Open Terminal Source RNS
SXS
SXS Spectris PLC
11:06
Market

Form 8 (DD) - Spectris plc

Open Terminal Source RNS
COBR
COBR Cobra Resources PLC
11:01
Market

Conditional Sale of Wudinna Gold Assets-Correction

Open Terminal Source RNS
WATR
WATR Water Intelligence plc
11:01
Market

Audited Results for Year Ended 31 December 2024

Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 1…

Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 10% to $83.3 million, with statutory profit before tax growing 2% to $6.4 million and statutory EBITDA growing by 11% to $13.1 million. The companys balance sheet remains strong, with cash of $12.1 million and a Total Net Debt to EBITDA Adjusted ratio of 1.1. The companys critical mass of sales and technology-driven foundation establish a scalable Technology Enabled Services (TES) platform. Between Q4 2024 and Q1 2025, Water Intelligence completed three strategic transactions, including reacquiring its Dallas franchise and establishing it as the headquarters for its core American Leak Detection business, forming a partnership with Chubb insurance and its StreamLabs Water business, and reaffirming its capital allocation guidance with acquisitions. The companys TES platform enables it to provide recurring Preventive Maintenance solutions and efficiently offer proprietary, technology-driven solutions to its customers. Based on its competitive strategy and the Dallas Template, the company expects to deliver higher organic revenue and profit trajectory.
YearRevenueProfit Before TaxNet Debt to EBITDA Adjusted Ratio
2024$83.3 million$6.4 million1.1
2023$76 million$6.2 millionN/A
Open Terminal Source RNS
COIN
COIN Coinsillium
11:01
Market

Coinsilium Group Limited: Forza! Bitcoin Treasury Update

Open Terminal Source RNS
FARN
FARN Faron Pharmaceuticals Oy
11:01
Market

Faron Pharmaceuticals Ltd: Director/PCA Dealing

b. Nature of the transaction <mark style="background-color:yellow">Purchase</mark> of ordinary shares

b. Nature of the transaction <mark style="background-color:yellow">Purchase</mark> of ordinary shares
Open Terminal Source RNS
0UKI
0UKI Bank of Nova Scotia
11:00
Market

Form 8.3 - Spectris Plc

Open Terminal Source RNS
BNC
BNC Banco Santander S.A.
10:56
Market

Total Voting Rights

Open Terminal Source RNS
11FN
11FN 11FN
10:56
Market

Annual Financial Report

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:55
Market

Form 8.5 EPT/Non RI QUALCOMM INC

Open Terminal Source RNS
CLI
CLI CLS Holdings plc
10:49
Market

Board Change

Open Terminal Source RNS
SAVE
SAVE Savannah Energy PLC
10:45
Market

Result of AGM

Open Terminal Source RNS
0QYU
0QYU Morgan Stanley
10:45
Market

Form 8.3 - Dundee Precious Metals Inc.

Open Terminal Source RNS
GENI
GENI Genincode PLC
10:43
Market

Result of AGM

Open Terminal Source RNS
SXS
SXS Spectris PLC
10:42
Market

Form 8 (OPD) - Spectris plc

Open Terminal Source RNS
0QYU
0QYU Morgan Stanley
10:41
Market

Form 8.3 - Adriatic Metals plc

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:36
Market

Form 8.3 WAREHOUSE REIT PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:36
Market

Form 8.3 UNITE GROUP PLC/THE

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:36
Market

Form 8.3 TRITAX BIG BOX REIT PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:36
Market

Form 8.3 SPIRENT COMMUNICATIONS PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:35
Market

Form 8.3 MITIE GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:35
Market

Form 8.3 MARLOWE PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:35
Market

Form 8.3 H&T GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:35
Market

Form 8.3 GREENCORE GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:35
Market

Form 8.3 FD TECHNOLOGIES PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:35
Market

Form 8.3 EMPIRIC STUDENT PROPERTY PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:34
Market

Form 8.3 DIRECT LINE INSURANCE GROUP PLC

Open Terminal Source RNS
PAG
PAG Paragon Banking Group PLC
10:34
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares pursuant to the Companys Salary in Shares remuneration arrangements.

<mark style="background-coloryellow">Purchase</mark> of shares pursuant to the Companys Salary in Shares remuneration arrangements.
Open Terminal Source RNS
BARC
BARC Barclays PLC
10:34
Market

Form 8.3 BAKKAVOR GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:34
Market

Form 8.3 AVIVA PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
10:34
Market

Form 8.3 ALPHA GROUP INTERNATIONAL PLC

Open Terminal Source RNS
AEX
AEX Aminex PLC
10:32
Market

Notice of AGM

Open Terminal Source RNS
HLMA
HLMA Halma PLC
10:31
Market

Director/PDMR Shareholding

Open Terminal Source RNS
DNM
DNM Dianomi PLC
10:31
Market

Change in Registered Office

Open Terminal Source RNS
91VR
91VR 91VR
10:27
Market

Publication of Final Terms

Open Terminal Source RNS
PRU
PRU Prudential plc
10:26
Market

Total Voting Rights

Open Terminal Source RNS
JEDT
JEDT JPMorgan Euro Small Compani…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JII
JII JPMorgan Indian Inv Trust
10:25
Market

Gearing announcement

Open Terminal Source RNS
JAGI
JAGI JPMorgan Asia Growth & Inco…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JCGI
JCGI JPMorgan China Growth & Inc…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JMG
JMG JPMorgan Emerging Markets O…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JFJ
JFJ JPMorgan Japanese Investmen…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JEMI
JEMI JPMorgan Global Emerging Ma…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JUGI
JUGI JPMorgan UK Small Cap Growt…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JEGI
JEGI JPMorgan European Growth & …
10:25
Market

Gearing announcement

Open Terminal Source RNS
MRC
MRC The Mercantile Investment T…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JGGI
JGGI JP Morgan Global Growth & I…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JUSC
JUSC JPmorgan US Smaller Compani…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JAM
JAM JPMorgan American Investmen…
10:25
Market

Gearing announcement

Open Terminal Source RNS
JCH
JCH JPMorgan Claverhouse Invest…
10:25
Market

Gearing announcement

Open Terminal Source RNS
NTVO
NTVO Nativo Resources plc
10:22
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Peel Hunt LLP', '23.281097', '22.923145']
Open Terminal Source RNS
EARN
EARN EARNZ plc
10:20
Market

Result of GM, Issue of Equity & Directorate Change

Open Terminal Source RNS
CHIN
CHIN KraneShares ICBCCS S&P Chin…
10:20
Market

Shareholder Notice- Fund Name Change- IE0001QF56M0

Open Terminal Source RNS
GLV
GLV Glenveagh Properties PLC
10:18
Market

Director/PDMR Shareholding

Open Terminal Source RNS
AATG
AATG Albion Technology & General…
10:18
Market

Issue of Equity and Total Voting Rights

Open Terminal Source RNS
KSTR
KSTR KraneShares ICBCCS SSE Star…
10:17
Market

Shareholder Notice- Fund Name Change- IE00BKPJY434

Open Terminal Source RNS
DFCH
DFCH Distribution Finance Capita…
10:17
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
Open Terminal Source RNS
ROO
ROO Deliveroo Holdings PLC
10:16
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Societe Generale', '5.343200', 0]
Open Terminal Source RNS
BK64
BK64 BK64
10:15
Market

Third Consent Requests Super Senior Issuer Funding

Open Terminal Source RNS
57FF
57FF 57FF
10:12
Market

Annual Financial Report

Open Terminal Source RNS
IRSH
IRSH IRSH
10:09
Market

Form 8.3 - Alphawave IP Group plc

Open Terminal Source RNS
WEIR
WEIR Weir Group PLC
10:07
Market

Directorate Change

Open Terminal Source RNS
AW14
AW14 AW14
10:04
Market

Third Consent Requests Super Senior Issuer Funding

Open Terminal Source RNS
BBH
BBH Bellevue Healthcare Trust P…
10:02
Market

Compliance with Market Abuse Regulation

Open Terminal Source RNS
PAF
PAF Pan African Resources PLC
10:01
Market

Share Buyback Programme

Open Terminal Source RNS
NTN
NTN Northern 3 Vct Plc
10:01
Market

Total voting rights

Open Terminal Source RNS
NVT
NVT Northern Venture Trust
10:01
Market

Total voting rights

Open Terminal Source RNS
NTV
NTV Northern 2 Vct Plc
10:01
Market

Total voting rights

Open Terminal Source RNS
FLTR
FLTR Flutter Entertainment PLC
10:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ROO
ROO Deliveroo Holdings PLC
10:01
Market

Total Voting Rights

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:51
Market

Form 8.5 EPT/Non RI DELIVEROO PLC - Replacement

Open Terminal Source RNS
HKLD
HKLD HONGKONG LAND HLDGS
09:51
Market

Total Voting Rights

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:51
Market

Form 8.5 EPT/Non RI SPECTRIS PLC

Open Terminal Source RNS
HKLD
HKLD HONGKONG LAND HLDGS
09:50
Market

Transaction in Own Shares

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:49
Market

Form 8.5 EPT/Non RI DELIVEROO PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:49
Market

Form 8.5 EPT/Non RI PRIMARY HEALTH PROPERTIES PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:49
Market

Form 8.5 EPT/Non RI DOWLAIS GROUP PLC

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:48
Market

Form 8.5 EPT/Non RI ALPHAWAVE IP GROUP PLC

Open Terminal Source RNS
HKLD
HKLD HONGKONG LAND HLDGS
09:48
Market

Transaction in Own Shares

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:48
Market

Form8.5EPT/NonRIAMERICANAXLE&MANUFACTURINGHOLDINGS

Open Terminal Source RNS
BARC
BARC Barclays PLC
09:48
Market

Form 8.5 EPT/Non RI ASSURA PLC

Open Terminal Source RNS
MNKS
MNKS Monks Investment Trust PLC
09:47
Market

Director/PDMR Shareholding

Open Terminal Source RNS
YZ61
YZ61 YZ61
09:38
Market

Form 8.5 (EPT/RI)-Aviva plc

Open Terminal Source RNS
APN
APN Applied Nutrition Plc
09:36
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '0.000000', '5.065098']
Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
09:30
Market

Publication of Final Terms

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
09:30
Market

Publication of Final Terms

Open Terminal Source RNS
CHSS
CHSS World Chess PLC
09:28
Market

Total Voting Rights

Open Terminal Source RNS
JAR
JAR Jardine Matheson Holdings L…
09:28
Market

Director/PDMR Shareholding

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
09:27
Market

Publication of Final Terms

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
09:25
Market

Publication of Final Terms

Open Terminal Source RNS
XGDU
XGDU Xtrackers IE Physical Gold …
09:25
Market

Publication of Final Terms

Open Terminal Source RNS
RMR
RMR Rome Resources Plc
09:22
Market

Final results for the year ended 31 December 2024

Open Terminal Source RNS
TYM
TYM Tertiary Minerals Plc
09:14
Market

Total Voting Rights

Open Terminal Source RNS
54TF
54TF 54TF
09:11
Market

Annual Financial Report

Open Terminal Source RNS
LABS
LABS Life Science REIT PLC
09:09
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Legal & General Group Plc (Group)', '3.990000', '4.000000']
Open Terminal Source RNS
KIST
KIST Kistos PLC
09:09
Market

Block Admission Application

Open Terminal Source RNS
BIRG
BIRG Bank of Ireland Group PLC
09:06
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['Pzena Investment Management, LLC', '3.01', 0]
Open Terminal Source RNS
DPP
DPP DP Poland Plc
09:05
Market

2024 Annual Report and Notice of AGM

Open Terminal Source RNS
DO72
DO72 DO72
09:04
Market

Form 8.5 (EPT/NON-RI)- Spectris plc

Open Terminal Source RNS
YZ61
YZ61 YZ61
09:03
Market

Form 8.5 (EPT/RI)- Spectris plc

Open Terminal Source RNS
CVSG
CVSG CVS Group Plc
09:02
Market

Standard form for notification of major holdings

TR1 Buy

TR1 Buy
['Grandeur Peak Global Advisors, LLC', '3.87', '4.93']
Open Terminal Source RNS
INCH
INCH Inchcape PLC
09:01
Market

Total Voting Rights

Open Terminal Source RNS
CWK
CWK Cranswick PLC
09:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
HMSO
HMSO Hammerson PLC
09:01
Market

Notice of Results

Open Terminal Source RNS
CWR
CWR Ceres Power Holdings PLC
09:01
Market

Total Voting Rights

Open Terminal Source RNS
WPS
WPS WAG Payment Solutions PLC
09:01
Market

Total Voting Rights

Open Terminal Source RNS
CRH
CRH CRH PLC
09:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CWK
CWK Cranswick PLC
08:58
Market

Director/PDMR Shareholding

Open Terminal Source RNS
IRSH
IRSH IRSH
08:56
Market

Form 8.3 - Direct Line Insurance Group plc

Open Terminal Source RNS
IRSH
IRSH IRSH
08:53
Market

Form 8.3 - Mitie Group plc

Open Terminal Source RNS
EARN
EARN EARNZ plc
08:52
Market

Holding(s) in Company

TR1 Buy

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '6.773980', '0.000000']
Open Terminal Source RNS
HHI
HHI Henderson High Income Trust
08:52
Market

Director Declaration

Open Terminal Source RNS
BGCG
BGCG Baillie Gifford China Growt…
08:51
Market

UK Listing Rule 6.4.9R

Open Terminal Source RNS
PALM
PALM Panther Metals PLC
08:50
Market

Result of AGM

Open Terminal Source RNS
IRSH
IRSH IRSH
08:50
Market

Form 8.3 - Aviva plc

Open Terminal Source RNS
38UA
38UA 38UA
08:49
Market

Annual Financial Report

Open Terminal Source RNS
IRSH
IRSH IRSH
08:48
Market

Form 8.3 - Spirent Communications plc

Open Terminal Source RNS
IRSH
IRSH IRSH
08:42
Market

Form 8.3 - Dowlais Group plc

Open Terminal Source RNS
IRSH
IRSH IRSH
08:40
Market

Form 8.3 - Deliveroo Plc

Open Terminal Source RNS
IRSH
IRSH IRSH
08:38
Market

Form 8.3 - Qualcomm Incorporated

Open Terminal Source RNS
AV.
AV. AV.
08:37
Market

Form 8.3 - Aviva plc

Open Terminal Source RNS
ENET
ENET Ethernity Networks Ltd
08:36
Market

Results for the Year Ended 31 December 2024

Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a g…

Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a gross profit decrease of 46%. However, the gross margin percentage increased to 92.1% in 2024 from 61.9% in 2023, reflecting a 30.2% improvement. The operating loss decreased by 4%, and the EBITDA loss decreased by 10%. The company raised net cash funds of $1.86 million during the year and had cash and cash equivalents of $0.05 million at the end of December 2024. Despite challenges, the company successfully exited the Temporary Suspension of Proceedings process and initiated a strategic transition to leverage its Universal Edge Platform development. The companys Chairman and CEO provided statements highlighting the companys achievements and expressing optimism for the future.
YearRevenueGross ProfitOperating LossEBITDA LossNet CashCash Equivalents
2024$1.38 million$1.3m$5.1 million$3.48 million$1.86 million$0.05 million
2023$3.78 million$2.3m$5.3 million$3.86 millionN/A$1.99 million
Open Terminal Source RNS
IRSH
IRSH IRSH
08:36
Market

Form 8.3 - American Axle & Manufacturing Holdings

Open Terminal Source RNS
IRSH
IRSH IRSH
08:34
Market

Form 8.3 - Greencore Group plc

Open Terminal Source RNS
IRSH
IRSH IRSH
08:33
Market

Form 8.3 - Spectris plc

Open Terminal Source RNS
0RYA
0RYA Ryanair Holdings plc
08:31
Market

Transaction in Own Shares

Open Terminal Source RNS
HCM
HCM HUTCHMED China Ltd
08:31
Market

Blocklisting Six Monthly Return

Open Terminal Source RNS
HCM
HCM HUTCHMED China Ltd
08:31
Market

China Approval based on Phase III SACHI Trial

HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-s…

HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-small cell lung cancer with MET amplification after progression on EGFR inhibitor therapy. The approval is based on the positive results of the SACHI Phase III trial, which showed a significant improvement in progression-free survival for patients treated with the combination compared to chemotherapy. ORPATHYS® is an oral MET inhibitor, and TAGRISSO® is a third-generation EGFR inhibitor. This approval provides a new treatment option for lung cancer patients in China and triggers a US$11 million milestone payment from AstraZeneca, which markets both drugs in the country.
Approvals
Open Terminal Source RNS
HCM
HCM HUTCHMED China Ltd
08:31
Market

Total Voting Rights

Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
08:30
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) London, United Kingdom', '', 0]
Open Terminal Source RNS
IRSH
IRSH IRSH
08:30
Market

Form 8.3 - Bakkavor Group plc

Open Terminal Source RNS
BBOX
BBOX Tritax Big Box REIT plc
08:29
Market

Form 8.3 - Tritax Big Box REIT

Open Terminal Source RNS
0MGE
0MGE Sydbank
08:26
Market

Sydbank A/S share buyback programme: transactions in week 26

Open Terminal Source RNS
0MGE
0MGE Sydbank
08:26
Market

Aktietilbagekøb i Sydbank A/S – transaktioner i uge 26

Open Terminal Source RNS
90IY
90IY 90IY
08:26
Market

Chief Executive Departure

Open Terminal Source RNS
GV2O
GV2O Gresham House Renewable Ene…
08:21
Market

Update on Sale of Remaining Assets

Open Terminal Source RNS
GV1O
GV1O Gresham House Renewable Ene…
08:20
Market

Update on Sale of Remaining Assets

Open Terminal Source RNS
INVP
INVP Investec PLC
08:20
Market

Form 8.5 (EPT/RI) - Dowlais Group plc

Open Terminal Source RNS
BUC
BUC Built Cybernetics plc
08:19
Market

Issue of Equity

Open Terminal Source RNS
VCT
VCT Victrex plc
08:14
Market

Director Declaration

Open Terminal Source RNS
INVP
INVP Investec PLC
08:09
Market

Form 8.5 (EPT/RI) - De La Rue plc

Open Terminal Source RNS
AWEM
AWEM Ashoka WhiteOak Emerging Mr…
08:06
Market

Total Voting Rights

Open Terminal Source RNS
GCL
GCL Geiger Counter Limited
08:03
Market

Transaction in Own Shares

Open Terminal Source RNS
ENT
ENT Entain PLC
08:01
Market

New Zealand Government Establishes Legislative Net

Open Terminal Source RNS
INVP
INVP Investec PLC
08:01
Market

Notice of AGM, Annual Report, Board Change

Open Terminal Source RNS
DRX
DRX Drax Group PLC
08:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
CHAR
CHAR Chariot Oil & Gas Limited
08:01
Market

Posting of Annual Report and Notice of AGM

Open Terminal Source RNS
14MD
14MD 14MD
08:01
Market

Acquisition

Open Terminal Source RNS
GMET
GMET Guardian Metal Resources PLC
08:01
Market

Total Voting Rights

Open Terminal Source RNS
ADT1
ADT1 Adriatic Metals
07:59
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
['T. Rowe Price Associates, Inc.', '4.829612', '9.338210']
Open Terminal Source RNS
IRSH
IRSH IRSH
07:59
Market

Form 8.3 - Dalata Hotel Group PLC

Open Terminal Source RNS
YZ61
YZ61 YZ61
07:48
Market

Form 8.5 (EPT/RI)- Direct Line Insurance Group plc

Open Terminal Source RNS
OTES
OTES HELLENIC TELECOMMUNICATIONS…
07:47
Market

Purchase of Own Shares

Open Terminal Source RNS
DO72
DO72 DO72
07:43
Market

Form 8.5 (EPT/NON-RI) - Aviva plc

Open Terminal Source RNS
JTC
JTC JTC PLC
07:41
Market

Total Voting Rights

Open Terminal Source RNS
DO72
DO72 DO72
07:37
Market

Form 8.5 (EPT/NON-RI)- Direct Line Insurance Group

Open Terminal Source RNS
CCL
CCL Carnival PLC
07:35
Market

Carnival Corporation & plc Announces the Launch of New Senior Unsecured Notes Offering

Open Terminal Source RNS
RNWH
RNWH Renew Holdings plc
07:35
Market

Change of Nominated Adviser

Open Terminal Source RNS
MLVN
MLVN Malvern International
07:33
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['8 KPG Limited', '2,140,630', 0]
Open Terminal Source RNS
KOD
KOD Kodal Minerals PLC
07:31
Market

Bougouni Lithium Project Off-Take Agreement

Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the pr…

Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the projects DMS processing plant for four years, with an annual review of quantities and floor price. The price is referenced to the Shanghai Metals Market and will be subject to adjustments based on grade, quality, and delivery terms. The agreement includes a "take or pay" clause, with LMLB supplying spodumene exclusively to Hainan, who must purchase the agreed-upon quantity. The DMS processing plant has already produced over 40,000 tonnes of spodumene concentrate, and the company is working to secure an export license from the Mali government. The first phase of the project is expected to produce 100,000-120,000 tonnes per year of lithium concentrate with a yield of more than 5.5% Li2O.
Agreement
Open Terminal Source RNS
RHIM
RHIM RHI Magnesita NV
07:30
Market

Director Declaration

Open Terminal Source RNS
IRSH
IRSH IRSH
07:29
Market

Form 8.5 (EPT/NON-RI) - Greencore Group plc

Open Terminal Source RNS
0H7D
0H7D Deutsche Bank AG NA O.N.
07:01
Market

Form 8.5 (EPT/RI) - Primary Health Properties plc

Open Terminal Source RNS
DKL
DKL Dekeloil Public Ltd
07:01
Market

Directors’ Subscription and Conversion

Open Terminal Source RNS
BUR
BUR Burford Capital Limited
07:01
Market

Further Statement Re US Budget Reconciliation Bill

Open Terminal Source RNS
COBR
COBR Cobra Resources PLC
06:51
Market

Conditional Sale of Wudinna Gold Assets

Open Terminal Source RNS
0RPR
0RPR Ringkjoebing Landbobank A/S
06:49
Market

Share buyback programme – week 26

Open Terminal Source RNS
ARB
ARB Argo Blockchain PLC
06:46
Market

Restructuring and Directorate Change

Open Terminal Source RNS
0MGD
0MGD Jyske Bank A/S
06:36
Market

Aktietilbagekøb: Transaktioner i uge 26 2025

Open Terminal Source RNS
0MGD
0MGD Jyske Bank A/S
06:36
Market

Share repurchase programme: Transactions of week 26 2025

Open Terminal Source RNS
ONDO
ONDO Ondo InsurTech PLC
06:31
Market

Total Voting Rights

Open Terminal Source RNS
BARC
BARC Barclays PLC
06:31
Market

Transaction in Own Shares

Open Terminal Source RNS
PHAR
PHAR Pharos Energy plc
06:31
Market

Share Purchases by Directors

Open Terminal Source RNS
VOD
VOD Vodafone Group PLC
06:28
Market

Vodafone Group Plc launches Cash Tender Offers

Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates r…

Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates ranging from 2043 to 2059. The company has set a maximum tender amount and acceptance priority levels for each series of notes. The tender offer is subject to certain terms and conditions, including a financing condition related to the issuance of new sterling-denominated notes. The company has retained Merrill Lynch International and Deutsche Bank AG as dealer managers and Kroll Issuer Services Limited as the tender and information agent for the offer. The offer period includes key dates such as the early tender deadline, price determination date, and settlement dates. The offer is subject to applicable laws and regulations in various jurisdictions, including Italy, the United Kingdom, France, and Belgium. The company also provides forward-looking statements and information about its purpose and commitment to environmental sustainability.
Launch
Open Terminal Source RNS
87FZ
87FZ AECI Ltd
06:23
Market

Voluntary Trading Update for the five month period ended 31 May 2025

Open Terminal Source RNS
ZPHR
ZPHR Zephyr Energy PLC
06:18
Market

Director Subscription to raise £0.7 million

Open Terminal Source RNS
EOT
EOT European Opportunities Trus…
06:16
Market

Investment Manager update

Open Terminal Source RNS
POLR
POLR Polar Capital Holdings plc
06:16
Market

Change of Nominated Adviser

Open Terminal Source RNS
FMET
FMET Fulcrum Metals PLC
06:11
Market

Posting of Annual Report and Notice of AGM

Open Terminal Source RNS
0A3G
0A3G 0A3G
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3D
0A3D iShares VII Public Limited …
06:11
Market

Net Asset Value

Open Terminal Source RNS
CMB1
CMB1 iShares FTSE MIB UCITS
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3E
0A3E 0A3E
06:11
Market

Net Asset Value

Open Terminal Source RNS
0A3F
0A3F 0A3F
06:11
Market

Net Asset Value(s)

Open Terminal Source RNS
BBY
BBY Balfour Beatty plc
06:11
Market

Transaction in Own Shares

Open Terminal Source RNS
TEAM
TEAM TEAM plc
06:07
Market

Half-year Report

Here is a summary of the text provided: TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% incr…

Here is a summary of the text provided
TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% increase in revenues to £5.8 million, with total client assets surpassing £1.1 billion. TEAM also successfully raised £2.96 million through equity and convertible loan instruments, and had £2.16 million in cash reserves as of March 31, 2025.
The companys operational highlights include growth in total client assets across its divisions, a successful group-wide cost reduction program, and the upcoming launch of the TEAM UCITS fund. The outlook for the remainder of the financial year remains positive, with a continued focus on migrating client assets to MPS and expanding the international advisory network.
Mark Clubb, Executive Chairman of TEAM, expressed confidence in the companys trajectory and mid-term targets, which include annual revenue of £20 million, an EBITDA margin exceeding 30%, and Assets Under Advice/Management of £4 billion. The company is focused on execution, with the UCITS fund launch being central to driving growth and achieving profitability.
The financial review highlights the companys improved financial position and continued revenue growth, with the goal of achieving month-on-month profitability. The segmental analysis shows the performance of the Groups three principal operating segments: Investment and Fund Management, Advisory and Consultancy, and International.
Overall, the results demonstrate TEAM PLCs strong performance and positive trajectory, with a focus on growth and achieving financial targets.
| | HY 25 | HY 24 | |---|---|---| | Revenues | £5.8m | £4.1m | | Total client assets | £1.112bn | £0.9bn | | Cash in bank | £2.16m | £1.5m | | Total Equity Raised | £1.96m | - | | Convertible Loan Notes | £1m | - | | Gross Total Raised | £2.96m | - | | Underlying loss before tax | £796k | £992k | | Loss before tax | £1.757m | £1.013m | | Loss for the period | £1.757m | £1.010m | | Loss per share | 3.6 pence | 3.5 pence |
Open Terminal Source RNS
ONDO
ONDO Ondo InsurTech PLC
06:06
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of Ordinary Shares

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Open Terminal Source RNS
TRST
TRST Trustpilot Group PLC
06:06
Market

Transaction in Own Shares

Open Terminal Source RNS
CTL
CTL CleanTech Lithium plc
06:06
Market

Update to CEOL Appeal

Open Terminal Source RNS
ACG
ACG ACG Acquisition Co. Ltd.
06:04
Market

Appointment of Chief Operating Officer

Open Terminal Source RNS
CRTA
CRTA Cirata plc
06:02
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['GEORGE WALTER LOEWENBAUM', '5.40', 'n/a']
Open Terminal Source RNS
POLR
POLR Polar Capital Holdings plc
06:02
Market

Group Audited Results for year ended 31 March 2025

Open Terminal Source RNS
SCP
SCP Schroder UK Mid Cap Fund PLC
06:02
Market

Dividend Declaration

Open Terminal Source RNS
CRTX
CRTX CRISM Therapeutics Corporat…
06:02
Market

Retail Offer

Open Terminal Source RNS
RVRG
RVRG River Global Plc
06:02
Market

Acquisition of Devon Equity Management

Open Terminal Source RNS
IWG
IWG IWG PLC
06:02
Market

Second Tranche of Share Buyback

Open Terminal Source RNS
BREE
BREE Breedon Group PLC
06:01
Market

Total Voting Rights

Open Terminal Source RNS
IQE
IQE IQE PLC
06:01
Market

IQE plc: AGM Notice

Open Terminal Source RNS
SBAR
SBAR Sundae Bar Plc
06:01
Market

Update on TAO Strategies Partnership

Open Terminal Source RNS
OBI
OBI Ondine Biomedical Inc
06:01
Market

Leading Canadian Surgery Centre Adopts Steriwave

Open Terminal Source RNS
SSTY
SSTY Safestay PLC
06:01
Market

Lease agreement to operate hostel in Naples

Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnershi…

Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnership between the two companies, with plans to expand into other key Italian cities. The Naples hostel, set in a former monastery, is expected to open in August 2025 and will offer guests a range of amenities, including ancillary services. This expansion aligns with Safestays growth strategy and goal to double its portfolio size in the medium term.
Agreement
Open Terminal Source RNS
HVO
HVO hVIVO plc
06:01
Market

Positive results from client Phase 2b field study

Open Terminal Source RNS
EAAS
EAAS Eenergy Group PLC
06:01
Market

Notice of Results

Open Terminal Source RNS
AMS
AMS Advanced Medical Solutions …
06:01
Market

Annual General Meeting

Open Terminal Source RNS
BOOM
BOOM Audioboom Group plc
06:01
Market

Annual Report, Notice of AGM and Presentation

Open Terminal Source RNS
CLBS
CLBS Celebrus Technologies plc
06:01
Market

Notice of Results and Investor Presentation

Open Terminal Source RNS
GHH
GHH Gooch & Housego Plc
06:01
Market

Notification of Major Holdings

TR1 Buy

TR1 Buy
['Gan Atid USA LLC', '4.41', 0]
Open Terminal Source RNS
GGP
GGP Greatland Resources Limited
06:01
Market

Grant of Replacement Awards

Open Terminal Source RNS
TKO
TKO Taseko Mines Limited
06:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
ATG
ATG Auction Technology Group PLC
06:01
Market

Director/PDMR Shareholding

Open Terminal Source RNS
NAH
NAH NAHL Group PLC
06:01
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['Colebrooke Partners IM Limited', 'Less than 3', '3.27']
Open Terminal Source RNS
ALTR
ALTR ALTR
06:01
Market

Board Change

Open Terminal Source RNS
SYNT
SYNT Synthomer plc
06:01
Market

Directorate Changes

Open Terminal Source RNS
GEM
GEM Gemfields Plc
06:01
Market

Replacement - New Director - Louis du Preez

Open Terminal Source RNS
0QZ3
0QZ3 Qualcomm Inc.
06:01
Market

Rule 2.9 Announcement

Open Terminal Source RNS
MFAI
MFAI Mindflair Plc
06:01
Market

Directorate Change

Open Terminal Source RNS
MLVN
MLVN Malvern International
06:01
Market

Holding(s) in Company

<mark style="background-color:yellow">TR1</mark> Buy

<mark style="background-coloryellow">TR1</mark> Buy
['Edward Roskill', '2,064,567', 0]
Open Terminal Source RNS
91VR
91VR 91VR
06:01
Market

Publication of Final Terms

Open Terminal Source RNS
ROQ
ROQ Roquefort Investments PLC
06:01
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of 72,507 ordinary shares

<mark style="background-coloryellow">Purchase</mark> of 72,507 ordinary shares
Open Terminal Source RNS
FAIR
FAIR Fair Oaks Income Limited
06:01
Market

Issue of Treasury Shares

Open Terminal Source RNS
BREE
BREE Breedon Group PLC
06:01
Market

Block Listing Six Monthly Return

Open Terminal Source RNS
VP.
VP. VP.
06:01
Market

Directorate Change

Open Terminal Source RNS
POLR
POLR Polar Capital Holdings plc
06:01
Market

CEO Succession

Open Terminal Source RNS
B90
B90 B90 Holdings PLC
06:01
Market

Grant of Options

Open Terminal Source RNS
COR
COR Coretx Holdings Plc
06:01
Market

Director/PDMR Shareholding

<mark style="background-color:yellow">Purchase</mark> of shares

<mark style="background-coloryellow">Purchase</mark> of shares
Open Terminal Source RNS
SXS
SXS Spectris PLC
06:01
Market

Rule 2.9 Announcement

Open Terminal Source RNS
GEX
GEX Georgina Energy PLC
06:01
Market

2025 Audited Final Results

Open Terminal Source RNS
KRS
KRS Keras Resources PLC
06:01
Market

Final Results

Open Terminal Source RNS
TXP
TXP Touchstone Exploration Inc
06:01
Market

Private Placement Update

Open Terminal Source RNS
EPP
EPP EnergyPathways plc
06:01
Market

Annual Results and Notice of AGM

Open Terminal Source RNS
AMGO
AMGO Amigo Holdings PLC
06:01
Market

Reduction of Unavoidable Corporate Expenses

Open Terminal Source RNS
CAML
CAML Central Asia Metals Plc
06:01
Market

Executed Third Deed of Variation

Open Terminal Source RNS
STAN
STAN Standard Chartered PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BELL
BELL Belluscura Plc
06:01
Market

Strategic Review Update and Proposed Fundraising

Open Terminal Source RNS
TIR
TIR Tiger Royalties and investm…
06:01
Market

Tiger Alpha Subnet Update

Open Terminal Source RNS
FMET
FMET Fulcrum Metals PLC
06:01
Market

Final Results for the year ended 31 December 2024

Open Terminal Source RNS
PALM
PALM Panther Metals PLC
06:01
Market

Chairman and CEO Subscription and TVR

Open Terminal Source RNS
GFTU
GFTU Grafton Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MET1
MET1 Metals One PLC
06:01
Market

Final Results

Open Terminal Source RNS
CEL
CEL Celadon Pharmaceuticals PLC
06:01
Market

Funding and Operational Update, Delay in Results

Open Terminal Source RNS
BBOX
BBOX Tritax Big Box REIT plc
06:01
Market

Exceptional medium-term value & earnings growth

Open Terminal Source RNS
CTAI
CTAI Catenai PLC
06:01
Market

Final Results & Klarian Update

Open Terminal Source RNS
ROAD
ROAD Roadside Real Estate plc
06:01
Market

Interim Results for the six months ended 31.03.25

Open Terminal Source RNS
FRG
FRG Firering Strategic Minerals…
06:01
Market

Final Results

Open Terminal Source RNS
ZPHR
ZPHR Zephyr Energy PLC
06:01
Market

Final Results

Open Terminal Source RNS
CAN
CAN Groupe Canal Plus
06:01
Market

Launch of Share Buyback Programme

Open Terminal Source RNS
PXEN
PXEN Prospex Energy PLC
06:01
Market

Result of Retail Offer and Additional Subscription

Open Terminal Source RNS
HWDN
HWDN Howden Joinery Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BTC
BTC Vinanz Limited
06:01
Market

Repayment of Debt Facility

Open Terminal Source RNS
SAVE
SAVE Savannah Energy PLC
06:01
Market

Update on FY 2024 Audited Annual Report

Open Terminal Source RNS
VCP
VCP Victoria PLC
06:01
Market

New £130m Super Senior Facility

Open Terminal Source RNS
CRTX
CRTX CRISM Therapeutics Corporat…
06:01
Market

Placing

Open Terminal Source RNS
APTA
APTA Aptamer Group PLC
06:01
Market

Liver fibrosis breakthrough with Optimer® platform

Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated …

Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated a novel molecular target for targeted gene therapy delivery to specific liver cells that drive scarring. This advance positions Aptamer for strategic licensing discussions with global pharmaceutical partners in the $20 billion fibrosis market.
The Optimer® technology acts as a magic bullet, precisely targeting a protein in scarred livers and delivering siRNA gene therapy to hepatic stellate cells (HSCs), which cause liver scarring. In laboratory <mark style="background-color:yellow">test</mark>s, the Optimer®-siRNA system significantly reduced processes that mimic scar tissue formation and slowed the harmful activity of HSCs.
Aptamers unique approach to target identification has led to the discovery of a specific protein marker for HSCs, setting their technology apart for precision medicine. The Optimer® platform is compatible with various RNA-based medicines, making it highly versatile.
The company is now planning outsourced in vivo studies to evaluate the platforms performance in animal models and is in discussions with major pharmaceutical companies for parallel studies. These efforts aim to confirm the efficacy and safety of the Optimer® platform, paving the way for human trials and strategic collaborations in the multi-billion-dollar fibrosis market.
Breakthrough
Open Terminal Source RNS
CORO
CORO Coro Energy PLC
06:01
Market

Final Results

Open Terminal Source RNS
CORO
CORO Coro Energy PLC
06:01
Market

Corporate Update

Open Terminal Source RNS
UOG
UOG United Oil & Gas Plc
06:01
Market

NEPA Permit Publication and Warrant Extension

Open Terminal Source RNS
SQZ
SQZ Serica Energy PLC
06:01
Market

Resumption of production operations at Triton FPSO

Open Terminal Source RNS
CLCO
CLCO Cloudcoco Group PLC
06:01
Market

Interim Results

Here is a summary of the provided text: CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4…

Here is a summary of the provided text
CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4 million, with 89% generated from e-commerce sales, stable gross profit of £228k, and improved gross margin to 7%. Trading Group EBITDA was £26k, and administrative expenses were reduced by 13%. The sale of legacy businesses resulted in a cash inflow of £7.9 million, enabling the repayment of MXC loan notes and strengthening the balance sheet. The companys operational highlights include adding 10 new business customers, introducing enhanced automation, onboarding new vendor distribution partners, and forming strategic partnerships. Simon Duckworth, Non-Executive Chairman, expressed confidence in the companys transformation and future growth prospects. The company aims to drive top-line growth, deliver excellent service, maintain cost discipline, and explore new opportunities.
Would you like me to generate a more in-depth summary?
Financial YearRevenue (£)Gross ProfitGross MarginEBITDAPLC Costs (£)Administrative Expenses (£)Cash Balance (£)Debt
H1 20253,383,000228,0007%26,000198,000489,000818,000Minimal debt
H1 20244,335,000228,0005%21,000251,000563,0001,042,0006,200,000 loan notes
Open Terminal Source RNS
NAH
NAH NAHL Group PLC
06:01
Market

Exercise of Share Options and Total Voting Rights

Open Terminal Source RNS
GMET
GMET Guardian Metal Resources PLC
06:01
Market

Tempiute Mine Project – Significant Assay Results

<mark style="background-color:yellow"></mark>

<mark style="background-coloryellow"></mark>
Open Terminal Source RNS
AJB
AJB AJ Bell plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SBTX
SBTX SkinBioTherapeutics PLC
06:01
Market

Croda Commercial Launch Progressing as Expected

Here is a summary of the news article: SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ing…

Here is a summary of the news article
SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ingredient designed to counteract the effects of stress on the skin and improve overall well-being by enhancing melatonin production and improving sleep quality. The company has a long-standing commercial and manufacturing agreement with Croda plc, and due to the competitiveness of the industry, SkinBioTherapeutics is under a strict confidentiality agreement regarding sales and market forecast information. The company also announces an upcoming investor presentation on July 3, 2025, regarding a recently signed commercial agreement with Superdrug. SkinBioTherapeutics is a consolidator in the skin health market, making acquisitions in complementary areas and expanding its distribution, geographical reach, and manufacturing capabilities. The companys proprietary platform, SkinBiotix®, is based on discoveries made by the translational dermatology team at the University of Manchester.
Launch
Open Terminal Source RNS
ATG
ATG Auction Technology Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
OBD
OBD Oxford Biodynamics PLC
06:01
Market

Interim Results

Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The…

Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The operating loss was £5.88m, a slight improvement from £5.99m in H1 2024. Cash and term deposits as of March 31, 2025, were £4.26m, up from £1.2m in the previous year.
The company highlighted several corporate and operational highlights, including the appointment of Iain Ross as Executive Chairman and the growth in sales of the EpiSwitch PSE test. They also announced an agreement with Bupa UK to cover the EpiSwitch PSE test.
The financial highlights included an equity placing, subscription, and retail offer, raising gross proceeds of £7.35m in January 2025.
In his comments, Iain Ross, the Executive Chairman, emphasized the importance of "doing deals" for the commercial success and non-dilutive funding of the business. He also acknowledged that while they are in commercial discussions with third parties, no substantive deals have been finalized yet, and there is no guarantee within the current cash runway.
The text also includes an executive chairmans review, financial review, and detailed financial statements, providing insights into the companys performance and financial position.
YearRevenueOperating LossCash and Term DepositsEquity Placing
2025£587k£5.88m£4.26m£7.35m
2024£327k£5.99m£1.2mN/A
Open Terminal Source RNS
CHAR
CHAR Chariot Oil & Gas Limited
06:01
Market

2024 Final Results

<mark style="background-color:yellow"></mark>

<mark style="background-coloryellow"></mark>
Open Terminal Source RNS
CLAI
CLAI Cel AI PLC
06:01
Market

Result of £10m Conditional Fundraising

Open Terminal Source RNS
TIR
TIR Tiger Royalties and investm…
06:01
Market

Final Results

Open Terminal Source RNS
BZT
BZT Bezant Resources Plc
06:01
Market

Final Results

Open Terminal Source RNS
BPM
BPM B P Marsh and Partners PLC
06:01
Market

Purchase of Own Shares

Open Terminal Source RNS
DKL
DKL Dekeloil Public Ltd
06:01
Market

2024 Final Results and Financing Update

Dekel Agri-Vision Plc, a West African agribusiness company, released its financial results for the year ended December 31, 2024, highlighting stable Group EBITDA at €2.6 million. The Palm Oil Operation contributed a positive EBITDA of €3.9…

Dekel Agri-Vision Plc, a West African agribusiness company, released its financial results for the year ended December 31, 2024, highlighting stable Group EBITDA at €2.6 million. The Palm Oil Operation contributed a positive EBITDA of €3.9 million, while the Cashew Operation reported an improved EBITDA loss of €1.3 million. The company also announced a financial restructuring, including equity fundraising and debt facility revisions, strengthening its balance sheet. The outlook for 2025 is positive, with expectations of enhanced results driven by the ongoing turnaround of the Cashew Operation and rebounding CPO prices.
YearPalm Oil Operation RevenuePalm Oil Operation Gross MarginPalm Oil Operation Gross Margin %Palm Oil Operation EBITDACashew Operation RevenueCashew Operation EBITDAGroup EBITDA
2024€28.2m€5.1m18.1%€3.9m€1.8m€(1.3)m€2.6m
2023€37.2m€6.5m17.5%€4.8m€1.1m€(2.2)m€2.6m
% change-24.2%-21.5%3.4%-18.7%63.6%40.9%No change
Open Terminal Source RNS
BPM
BPM B P Marsh and Partners PLC
06:01
Market

Follow-on equity purchase in and loan to Pantheon

Open Terminal Source RNS
SML
SML Strategic Minerals Plc
06:01
Market

Identification of Silver Mineralisation at Redmoor

Open Terminal Source RNS
AEG
AEG Active Energy Group PLC
06:01
Market

Final Results for the year ended 31 December 2024

Open Terminal Source RNS
GROW
GROW Draper Esprit PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ADVT
ADVT AdvancedAdvT Ltd
06:01
Market

Final Results for Year Ending 28 February 2025

Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company re…

Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company reported strong financial performance, including revenue from operations of £43.3 million and recurring revenue of £34.8 million, representing 80.3% of total revenues. The adjusted EBITDA from operations was £11.3 million, ahead of management expectations, and the pre-tax profit from continuing operations was £11.3 million. Cash and cash equivalent assets were reported as £109.5 million. The company also highlighted its proforma financial performance, with organic revenue growth of 17.8% and adjusted EBITDA growth of 90.0% on acquired businesses.
During the period, Advanced AdvT Limited made several acquisitions, including Celaton Limited, HFX Limited, and GOSS Technology Limited, strengthening their position in the market. The companys Chairperson, Vin Murria, emphasized the groups focus on digital transformation and their commitment to supporting customers strategic delivery. The companys CFO, Gavin Hugill, provided additional insights into the financial highlights and operational review.
The Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Consolidated Statement of Changes in Equity, and Consolidated Statement of Cash Flow provided detailed financial information for the year ending February 28, 2025, and the previous eight-month period ending February 29, 2024. The report also included critical accounting judgments, alternative performance measures, and segment information. Overall, Advanced AdvT Limited demonstrated strong financial performance and a commitment to growth through acquisitions and digital transformation.
Financial YearRevenue from Operations (£)Recurring Revenue (£)Adjusted EBITDA from Operations (£)Pre-tax Profit from Continuing Operations (£)Basic EPSCash and Cash Equivalents (£)
Year Ending 28 Feb 202543.3 million34.8 million11.3 million11.3 million8p109.5 million
Period Ending 29 Feb 2024 (8 months)21.1 million16.3 million4.4 million5.1 million5p102.9 million
Open Terminal Source RNS
VRCI
VRCI Verici Dx Plc
06:01
Market

Final Results

Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 mill…

Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 million in 2023, primarily due to a commercial contract with Thermo Fisher for the PTRA (Pre Transplant Risk Assessment) test. The adjusted EBITDA loss for the year was US$5.4 million, an improvement from US$7.6 million in 2023. Verici Dx also conducted an equity fundraise in February 2024, raising US$8.2 million in gross proceeds.
Operational highlights include the successful transfer of urine samples to Thermo Fisher, triggering milestone payments, and a collaboration with The Westmead Institute for Medical Research in Australia. The company received CLIA certification and CAP accreditation for its clinical laboratory, enabling testing for patients across 51 US states.
Post-period highlights include securing Medicare coverage for Verici Dxs Tutivia™ assay and a strong acceleration in Tutivia™ testing orders in Q1 2025. The company is proposing an equity fundraising to extend its cash runway and achieve commercial objectives for Tutivia™.
The directors believe that additional funding can be obtained to enable the company to continue operations for at least the next 12 months. However, there is uncertainty regarding the timing and quantum of cash receipts from revenue, and the directors are taking steps to secure funding arrangements.
<>Verici Dx Plc Financials and Debt Year on Year
YearRevenue (in millions)Adjusted EBITDA (in millions)Cash Balance (in millions)Net Proceeds from Equity Fundraising (in millions)
2024$3.3-$5.4$4.1$7.5
2023$1.0-$7.6$2.6N/A
Open Terminal Source RNS
AOM
AOM ActiveOps PLC
06:01
Market

ActiveOps acquires Enlighten Group Pty Ltd

Open Terminal Source RNS
FEN
FEN Frenkel Topping Group
06:01
Market

Extension of PUSU Deadline

Open Terminal Source RNS
IOM
IOM iomart Group plc
06:01
Market

Successful Refinancing and Notice of Results

Open Terminal Source RNS
MPL
MPL Mercantile Ports & Logistic…
06:01
Market

Full Year Results

Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite…

Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite facing challenges such as reduced activity due to government elections and procedural issues, the company generated revenues of £4.35 million. The companys focus for the year was on resolving its outstanding debt obligations, and it remains optimistic about reaching a favorable agreement with lenders. MPL expects to diversify its revenue streams, expand its service offerings, and enhance operational efficiency in 2025. The companys long-term prospects remain positive, and it continues to receive strong support from its major shareholder, Hunch Ventures.
YearRevenueCost of SalesGross MarginAdministrative ExpensesOther IncomeDepreciationImpairment LossOperating LossFinance IncomeFinance CostNet Financing CostLoss Before Tax
20244,3522,3302,0222,8419214,7406,77211,410347,2917,25718,667
20235,4622,4173,0453,2665905,5819,85315,065256,2256,20021,265
Open Terminal Source RNS
CRTA
CRTA Cirata plc
06:01
Market

$700K Multiyear Data Integration Contract Renewal

Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the ba…

Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the banks confidence in Ciratas data migration, synchronization, and disaster recovery capabilities. This contract will be facilitated through the Google Marketplace, and the announcement is considered inside information per the UK Market Abuse Regulation. The companys CEO, Stephen Kelly, is responsible for the announcements release. The contact details for Cirata, its financial advisors, and brokers are provided for further inquiries. The London Stock Exchanges news service, RNS, disseminates this information, and users are responsible for adhering to its terms and conditions.
NewContract
Open Terminal Source RNS
TRLS
TRLS Trellus Health plc
06:01
Market

AGM Statement

Open Terminal Source RNS
N4P
N4P N4 Pharma PLC
06:01
Market

AGM Statement

Open Terminal Source RNS
MHC
MHC MyHealthChecked Plc
06:01
Market

Final Results

Open Terminal Source RNS
MSI
MSI MS INTERNATIONAL plc
06:01
Market

Final Results

Open Terminal Source RNS
GPM
GPM Golden Prospect Precious Me…
06:01
Market

Awarded Best Investment Trust in Growth Category

Open Terminal Source RNS
IWG
IWG IWG PLC
06:01
Market

US GAAP Transition

Open Terminal Source RNS
SMWH
SMWH WH Smith PLC
06:01
Market

Completion of Sale

Open Terminal Source RNS
OPTI
OPTI OptiBiotix Health Plc
06:01
Market

Final Results

OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners a…

OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners and sales in key markets like the USA and India. The order book for Q1 2025 surpassed sales achieved in H1 2024, and there were multiple product launches and new partnerships across various regions. The companys investments in sales and marketing are delivering returns, and it expects all parts of the business to become profitable as it reduces costs and grows its top line. OptiBiotix ended 2024 with a strong balance sheet and cash position, and it anticipates continuing its upward trajectory. The Chairmans and Chief Executive Officers reports provide further insights into the companys performance and future outlook.
YearRevenueCost of SalesGross ProfitSelling CostsR&D and Patent CostsOther Operating CostsTotal Administrative ExpensesOperating LossFinance IncomeShare of Loss from AssociateGain/Loss on InvestmentsProfit/Loss Before TaxTotal Comprehensive Income
2024870k539k331k651k294k1,605k2,597k2,266k1k350k486k1,866k1,805k
2023644k324k320k125k223k1,662k2,016k1,696k1k323k513k2,043k2,039k
Open Terminal Source RNS
OPTI
OPTI OptiBiotix Health Plc
06:01
Market

Change of Broker

Open Terminal Source RNS
TTG
TTG TT Electronics Plc
06:01
Market

AGM Trading Update

Open Terminal Source RNS
SAE
SAE Atlantis Resources Ltd
06:01
Market

Annual Financial Report

Open Terminal Source RNS
PLUS
PLUS Plus500 Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CPX
CPX CAP-XX Limited
06:01
Market

Global Distribution Agreement with RS Group plc

CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reac…

CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reach by making their prismatic, cylindrical, and hybrid supercapacitors more accessible through RS Groups extensive logistics network. With RS Groups presence in over 30 countries and a customer base that includes industrial OEMs and automation engineers, this partnership will enhance CAP-XXs ability to meet the rising global demand for their products. This agreement is part of CAP-XXs strategy to strengthen its global distribution network, which also includes partnerships with Farnell and Digi-Key, positioning the company to support a wide range of applications across various industries. The companys high-performance supercapacitors are known for their high-power density and energy storage capacity, making them valuable in consumer electronics, industrial automation, and renewable energy sectors.
Agreement
Open Terminal Source RNS
SKA
SKA Shuka Minerals Plc
06:01
Market

Annual Results for the year ended 31 December 2024

Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board ch…

Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board changes, and the appointment of Richard Lloyd as the new CEO. Shuka Minerals faced production and output challenges at its Rukwa coal mine in Tanzania but expects a restart in mining operations soon. The company entered into a funding commitment with Gathoni Muchai Investments (GMI) for an unsecured, non-convertible, interest-free loan of £500,000, with an additional £1.5 million extension subject to due diligence. Shuka Minerals also agreed to acquire 100% of Leopard Exploration and Mining Limited (LEM), the registered holder of a large-scale mining license for the Kabwe Lead-Zinc-Silver-Vanadium mine in Zambia. The companys financial statements were audited by PKF Littlejohn LLP, who highlighted a material uncertainty related to going concern and emphasized the need to operationalize the 16% Government of Tanzania non-dilutable free carried share interest.
YearRevenueCost of SalesGross LossAdmin ExpensesGroup Operating LossFinance IncomeFinance CostsLoss on Operations
20242,305198,2611,799,5841,997,8452,3519,4332,004,927
2023194,346244,5311,424,1201,668,6513,25616,1331,681,528
Open Terminal Source RNS
SPDI
SPDI Secure Property Development…
06:01
Market

2024 Annual Results

Open Terminal Source RNS
GWMO
GWMO Great Western Mining Corp P…
06:01
Market

Final Results

Open Terminal Source RNS
ANGS
ANGS Angus Energy PLC
06:01
Market

Interim Results for Six Months ended 31 March 2025

Open Terminal Source RNS
POW
POW Power Metal Resources plc
06:01
Market

Results for the Period Ended 31 December 2024

Open Terminal Source RNS
PRSR
PRSR PRS Reit PLC
06:01
Market

Update re Strategic Review and Formal Sale Process

Open Terminal Source RNS
CTL
CTL CleanTech Lithium plc
06:01
Market

Extension to Loan Notes Maturity Date

Open Terminal Source RNS
RVRG
RVRG River Global Plc
06:01
Market

2025 Half-year Report

River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions…

River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions for the active asset management industry, with geopolitical turmoil and economic uncertainties impacting investor confidence. Despite these challenges, River Global has made progress in consolidating its asset management business and joint ventures. The A Ordinary Shares business interest reported a loss before taxation of £2.8 million, while the B Shares business interest, representing the companys structured equity interest in Parmenion, reported a profit of £1.2 million. The companys chairman, Martin Gilbert, remains optimistic about the future, focusing on cost-cutting measures and driving efficiencies. The report also includes details on the share reorganization, business review, financial statements, and segmental analysis.
YearLoss on EBITDATotal LossA Ordinary SharesB Shares
2025£0.2m£1.6m-£1.5m£1.3m
2024£1.3m£3.0m-£2.9m£1.2m
Open Terminal Source RNS
SEE
SEE Seeing Machines Limited
06:01
Market

Mitsubishi Electric Europe Guardian collaboration

Open Terminal Source RNS
BUR
BUR Burford Capital Limited
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
JET2
JET2 Jet2 PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KYGA
KYGA Kerry Group
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GLB
GLB Glanbia plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PETS
PETS Pets at Home Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EYE
EYE Eagle Eye Solutions Group p…
06:01
Market

Acquisition of Promotional Payments Solutions

Open Terminal Source RNS
WSG
WSG Westminster Group Plc
06:01
Market

£680,000 New Contract Awards

Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, inclu…

Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, including a sophisticated audio-visual system for broadcasting and recording debates. The second contract is with a worldwide broadcaster for advanced security screening systems in their UK operations. Westminsters CEO, Peter Fowler, highlights the potential for expansion and the importance of these contracts, especially the East African Parliament project. The company specializes in technology-based security solutions and managed services, with a focus on surveillance, detection, and tracking technologies, and has a global presence in over 50 countries. The Westminster Group Foundation, the groups CSR arm, aims to support communities through poverty relief, education, and healthcare initiatives.
NewContract
Open Terminal Source RNS
AMCO
AMCO Amcomri Group plc
06:01
Market

£12.9m Contract Win

Open Terminal Source RNS
CHG
CHG Chemring Group PLC
06:01
Market

Acquisition of Landguard Systems

Open Terminal Source RNS
DXRX
DXRX Diaceutics PLC
06:01
Market

PDMR Shareholding/SIP and Total Voting Rights

TR1 Buy

TR1 Buy
Open Terminal Source RNS
BMS
BMS Braemar Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
DAL
DAL Dalata Hotel Group plc
06:01
Market

Dalata Announces Second Hotel in Germany and Fourth in Continental Europe

Open Terminal Source RNS
COIN
COIN Coinsillium
06:01
Market

Coinsilium Group Limited: Exercise of Warrants

Open Terminal Source RNS
EXR
EXR Engage XR Holdings PLC
06:01
Market

Result of AGM - Replacement

Open Terminal Source RNS
RCOI
RCOI Riverstone Credit Opportuni…
06:01
Market

Update Return of Capital via Compulsory Redemption

Open Terminal Source RNS
VOD
VOD Vodafone Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IAG
IAG International Consolidated …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRU
TRU Trufin PLC
06:01
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
TRN
TRN Trainline Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AAF
AAF Airtel Africa Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TSCO
TSCO Tesco PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GLV
GLV Glenveagh Properties PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
INF
INF Informa PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PRV
PRV Porvair plc
06:01
Market

Interim Results

Porvair PLC, a specialist filtration, laboratory, and environmental technology group, released its interim results for the six months ended May 31, 2025. The Groups revenue increased by 3% to £97.7 million, with a 5% growth on a constant c…

Porvair PLC, a specialist filtration, laboratory, and environmental technology group, released its interim results for the six months ended May 31, 2025. The Groups revenue increased by 3% to £97.7 million, with a 5% growth on a constant currency basis. Adjusted operating profit was 1% higher at £12.6 million, while operating profit increased by 3% to £11.9 million. The Group also saw improvements in adjusted profit before tax, profit before tax, adjusted basic earnings per share, and basic earnings per share. Porvairs closing cash balance was £17.1 million, and the interim dividend was increased by 0.1 pence per share.
The Groups performance was mixed across its end markets, with strength in certain industrial businesses and laboratory instruments offsetting softness in aerospace and foundry, along with foreign exchange headwinds. The Group continues to monitor the macro-economic uncertainty and tariff environment, noting that its manufacturing footprint primarily serves local customers.
Hooman Caman Javvi, Chief Executive, highlighted the Groups underlying growth trends, including tightening environmental regulation, the growth of analytical science, the need for clean water, and the development of carbon-efficient transportation. The Groups return on capital employed was 14%, and the Board remains confident in the Groups capabilities based on its long-term growth record.
The Groups strategy remains focused on developing specialist filtration, laboratory, and environmental technology businesses, with consistent earnings growth and selected ESG measures as key success indicators. Porvairs businesses are characterized by their specialist design, engineering, and commercial skills, mandated product use, and long-life-cycle systems.
The Board understands the importance of responsible business development and highlights that most of Porvairs products are used for environmental benefits. The Group published a full ESG report in February 2025, outlining its ESG management framework, goals, and metrics.
The Groups divisions, Aerospace & Industrial, Laboratory, and Metal Melt Quality, showed varied performances. Aerospace & Industrial revenue increased by 10%, while Laboratory revenue grew by 1%. Metal Melt Quality revenue decreased by 6%, impacted by lower industrial demand.
The Groups cash flow and cash position improved, with cash generated from operations at £10.2 million and net cash of £17.1 million. The Group continues to invest in capital expenditure and acquisitions, focusing on markets with long-term growth potential and geographic presence aligned with its end markets.
Overall, Porvair PLCs performance for the first six months of 2025 was in line with expectations, and the Group remains well-positioned to benefit from global trends and its long-term growth drivers.
Financial YearRevenueOperating ProfitAdjusted Operating ProfitProfit Before TaxAdjusted Profit Before TaxEarnings Per ShareAdjusted Earnings Per ShareNet Cash
H1 2025£97.7 million£11.9 million£12.6 million£11.3 million£12.0 million19.0 pence20.0 pence£17.1 million
H1 2024£94.6 million£11.6 million£12.5 million£10.6 million£11.5 million18.1 pence19.5 pence£4.1 million
Growth3%3%1%7%4%5%3%N/A
Open Terminal Source RNS
GSK
GSK GSK plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BATS
BATS British American Tobacco PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EMG
EMG Man Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRCS
TRCS Tracsis Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
QUBE
QUBE Quantum Base Holdings PLC
06:01
Market

Appointment of Chief Commercial Officer

Open Terminal Source RNS
BRK
BRK Brooks Macdonald Group
06:01
Market

Purchase of Own Shares

Open Terminal Source RNS
APTD
APTD Aptitude Software Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HUW
HUW Helios Underwriting PLC
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
RKT
RKT Reckitt Benckiser Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
WTB
WTB Whitbread PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CNA
CNA Centrica PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HMSO
HMSO Hammerson PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ETP
ETP Eneraqua Technologies PLC
06:01
Market

Change of registered office

Open Terminal Source RNS
VTU
VTU Vertu Motors Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CCR
CCR C&C Group plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MRL
MRL Marlowe plc
06:01
Market

Form 8 (DD) - Mitie Group plc

Open Terminal Source RNS
DCC
DCC DCC plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BIRG
BIRG Bank of Ireland Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PRIS
PRIS PRIS
06:01
Market

Half-year Report

Open Terminal Source RNS
HSW
HSW Hostelworld Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MOTR
MOTR Motorpoint Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TCAP
TCAP TP ICAP Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PPET
PPET Patria Private Equity Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FUTR
FUTR Future PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HSX
HSX Hiscox Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HRI
HRI Herald Investment Trust
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FGEN
FGEN Foresight Environmental Inf…
06:01
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
OMG
OMG Oxford Metrics plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ACSO
ACSO Accesso Technology Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
PIN
PIN Pantheon International PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CVSG
CVSG CVS Group Plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
VTY
VTY Vistry Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RCP
RCP RIT Capital Partners
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
UKW
UKW Greencoat UK Wind PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ORIT
ORIT Octopus Renewables Infra Tr…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GAMA
GAMA Gamma Communications PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
IMI
IMI IMI PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SEQI
SEQI Sequoia Econ Infrastructure
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
FEVR
FEVR Fevertree Drinks Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EXPN
EXPN Experian PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
SCP
SCP Schroder UK Mid Cap Fund PLC
06:01
Market

Half-year Report

Here is a summary of the text provided: Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly c…

Here is a summary of the text provided
Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly continuation vote, and a more active buy-back policy. The portfolio NAV saw a negative return of 9.3%, underperforming the Benchmark, but the Company NAV has since outperformed the Benchmark by 2.1 percentage points. The Board announced an interim dividend of 6.3 pence per share, reflecting the ongoing recovery in portfolio income. The discount of the Companys share price to NAV narrowed to 7.9% as of March 31, 2025. The Companys net gearing ratio was 9.5%, and the Board remains confident in the UK mid-cap markets attractiveness and potential for correction in valuation dislocation. The outlook for the Company is positive, with experienced portfolio managers and attractive valuations. The report also includes details on investment and share price performance, dividend, discount management, gearing, and an investment managers review.
YearRevenueCapitalTotalNet AssetsNet Gearing
2025£3,944£(24,100)£(20,156)£215,4239.5%
2024£3,158£18,365£21,523£228,342N/A
2023£8,737£31,395£40,132£242,966N/A
Open Terminal Source RNS
DRX
DRX Drax Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
AT.
AT. AT.
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
KGF
KGF Kingfisher PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TST
TST Touchstar plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
JSG
JSG Johnson Service Group Plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HICL
HICL HICL Infrastructure Company…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KNOS
KNOS Kainos Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HET
HET Henderson European Focus Tr…
06:01
Market

Results for the half-year ended 31 March 2025

<mark style="background-color:yellow"></mark>

<mark style="background-coloryellow"></mark>
Open Terminal Source RNS
WIX
WIX Wickes Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BA.
BA. BA.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CHRY
CHRY Chrysalis Investments Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
HVPE
HVPE HarbourVest Global Private …
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
QQ.
QQ. QQ.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TRIG
TRIG Renewables Infrastructure G…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BBH
BBH Bellevue Healthcare Trust P…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MRO
MRO Melrose Industries PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RICA
RICA Ruffer Investment Company L…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ROR
ROR Rotork PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
KGH
KGH Knights Group Holdings plc
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
MGAM
MGAM Morgan Advanced Materials p…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
RR.
RR. RR.
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
COST
COST Costain Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
ULTP
ULTP Ultimate Products Plc
06:01
Market

Transaction in Own Shares and Total Voting Rights

Open Terminal Source RNS
APAX
APAX Apax Global Alpha Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EMVC
EMVC EMV Capital plc
06:01
Market

Office move and Related Party Transaction

Open Terminal Source RNS
ICON
ICON Iconic Labs Plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
PHE
PHE PowerHouse Energy Group Plc
06:01
Market

Completion of FEED for NH2

Open Terminal Source RNS
MACF
MACF Macfarlane Group PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
INPP
INPP International Public Partne…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
CREO
CREO Creo Medical Group PLC
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
BMK
BMK Benchmark Holdings Plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
ECEL
ECEL Eurocell PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
EJFZ
EJFZ EJF Investments Limited
06:01
Market

Cancellation of trading of 2025 ZDP Shares

Open Terminal Source RNS
RWS
RWS RWS Holdings PLC
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
JSG
JSG Johnson Service Group Plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
PINT
PINT Pantheon Infrastructure PLC
06:01
Market

Publication of Sustainability Report

Open Terminal Source RNS
RKW
RKW Rockwood Realisation PLC
06:01
Market

Issue of Equity and TVR

Open Terminal Source RNS
INDV
INDV Indivior PLC
06:01
Market

Indivior Announces Inclusion in US Russell Indexes

Open Terminal Source RNS
PAY
PAY PayPoint plc
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
GBG
GBG GB Group plc
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
450
450 450 PLC
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
ESO
ESO EPE Special Opportunities L…
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
SSPG
SSPG SSP Group PLC
06:01
Market

Total Voting Rights

Open Terminal Source RNS
ACSO
ACSO Accesso Technology Group PLC
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
HEMO
HEMO Hemogenyx Pharmaceuticals P…
06:01
Market

Total Voting Rights

Open Terminal Source RNS
AFC
AFC AFC Energy plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
FCM
FCM First Class Metals PLC
06:01
Market

Total Voting Rights

Open Terminal Source RNS
TEEG
TEEG Telecom Egypt Company S.A.E
06:01
Market

FS prepared in accordance with IFRSs ended31-12-24

Open Terminal Source RNS
SUP
SUP Supreme PLC
06:01
Market

Total Voting Rights

Open Terminal Source RNS
MF95
MF95 MF95
06:01
Market

Publication of MGL DIP Final Terms

Open Terminal Source RNS
AS94
AS94 AS94
06:01
Market

Publication of Final Terms XS2736736526

Open Terminal Source RNS
VEIL
VEIL Vietnam Enterprise Investme…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
VOF
VOF VinaCapital Vietnam Opportu…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
TTST
TTST Tata Steel Limited
06:01
Market

Disclosure under Reg 30 of SEBI Listing Regulation

Open Terminal Source RNS
WG.
WG. WG.
06:01
Market

Extension of PUSU deadline

Open Terminal Source RNS
IHG
IHG InterContinental Hotels Gro…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
OXIG
OXIG Oxford Instruments PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
BOY
BOY Bodycote PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
MDZ
MDZ MediaZest plc
06:01
Market

Half-year Report

MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million …

MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million and a 61% increase in gross profit, resulting in a return to profitability at the EBITDA and pre-tax levels. This positive trend is expected to continue in the second half of the financial year due to recent project wins and new business activity. The basic and diluted profit per share was 0.0031 pence, compared to a loss per share of 0.0092 pence in the previous period. The companys long-term client base remains consistent and continues to generate new opportunities, including digital signage solutions for Pets at Home and new dealership experiences for Hyundai and KIA. MediaZest also completed work for Lululemon Athletica and ArcTeryx, featuring LED technology. A significant new contract was won to deliver audio-visual experiences in airports worldwide. The Groups recurring revenue streams continue to expand, generating over £1 million per annum. The Board believes the outlook for MediaZest is encouraging and well-positioned for continued growth, with a positive start to H2 FY25 and a strong pipeline for FY26 and beyond.
Financial MetricsH1 FY25H1 FY24Change
Revenue£1,906,000£1,173,00063% increase
Gross Profit£1,127,000£701,00061% increase
Gross Margin59%60%1% decrease
EBITDA£197,000£(28,000)Positive change
Profit/(Loss) after tax£53,000£(141,000)Positive change
Profit/(Loss) per share (pence)0.0031(0.0092)Positive change
(Bank overdraft) / Cash in hand(£7,000)£14,000Negative change

The table above compares the financial metrics of MediaZest Plc for the first half of the financial year 2025 (H1 FY25) with the same period in the previous year (H1 FY24). The company has shown significant improvement in revenue, gross profit, EBITDA, and profit after tax. However, there was a slight decrease in gross margin and a negative change in cash position.

Debt MetricsH1 FY25H1 FY24Change
Invoice discounting facility£39,000£227,000Repaid £188,000
Short-term funding agreementUp to £60,000N/ANew agreement
Interest-bearing loans and borrowings (current liabilities)£1,359,000£1,524,000Decrease of £165,000
Interest-bearing loans and borrowings (non-current liabilities)£456,000£7,000Increase of £449,000

Regarding debt, MediaZest Plc has made significant changes. They have repaid a substantial amount of their invoice discounting facility and entered into a short-term funding agreement. There has been a decrease in interest-bearing loans and borrowings under current liabilities, while there is a notable increase in such borrowings under non-current liabilities.

Open Terminal Source RNS
0A9X
0A9X KR1 PLC
06:01
Market

Financial Update (May '25)

Open Terminal Source RNS
FGP
FGP FirstGroup PLC
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
THRG
THRG Throgmorton Trust Plc
06:01
Market

Total Voting Rights

Open Terminal Source RNS
AMRQ
AMRQ Amaroq Minerals Ltd.
06:01
Market

Closing of Fundraising and Admission

Open Terminal Source RNS
FSG
FSG Foresight Group Holdings Li…
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
OSB
OSB OneSavings Bank PLC
06:01
Market

Transaction in own shares

Open Terminal Source RNS
MTC
MTC Mothercare PLC
06:01
Market

Change of Nomad

Open Terminal Source RNS
NBPE
NBPE NB Private Equity Partners …
06:01
Market

NBPE Announces Transaction in Own Shares

Open Terminal Source RNS
PSH
PSH Pershing Square Holdings Ltd
06:01
Market

Transaction in Own Shares

Open Terminal Source RNS
NFG
NFG Next 15 Group PLC
06:01
Market

Change of Nominated Adviser

Open Terminal Source RNS
TFG
TFG Tetragon Financial Group Ltd
05:56
Market

Statement re: Monthly Factsheet

Open Terminal Source RNS
EDV
EDV Endeavour Mining Corp
05:31
Market

Transaction in Own Shares

Open Terminal Source RNS

Digested News

The ticker catalyst tape is rendered as native mobile cards. Articles and ticker links stay clickable.

CYN logo
Latest RNS 17:21
CYN

Holding(s) in Company

CQS Natural Resources Growth and Income plc

TR1 Buy
['Bank of America Corporation', '5.420847', 0]
CLAI logo
Latest RNS 17:16
CLAI

Director's Dealings

Cel AI PLC

<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
BVA logo
Latest RNS 16:33
BVA

BBVA's decision on the takeover bid for Sabadell

Banco Bilbao Vizcaya Argentaria S.A

Banco Bilbao Vizcaya Argentaria (BBVA) has released a statement regarding its voluntary tender offer to acquire the entire share capital of Banco de Sabadell. The Spanish Council of Ministers has authorized the economic concentration resulting from the offer, with an additional condition to BBVAs previously submitted commitments. Despite having the right to withdraw the offer due to the additional condition, BBVA has decided not to withdraw and will proceed with the offer as planned. The merger control procedure in Spain is now complete, and the offer remains in effect.
Takeover
SBDS logo
Latest RNS 16:14
SBDS

Final Results for the year ended 31 December 2024

Silver Bullet Data Services Group PLC

Silver Bullet Data Services Group PLC, a provider of AI-driven digital transformation services and products, released its audited results for the year ended December 31, 2024. The company reported a 12% increase in revenue to £9.37 million, with a gross profit of £7.13 million, representing a 12% increase. The companys services revenue increased by 8% to £6.0 million, while its 4D revenue grew by 20% to £3.37 million, driven by US demand. US and globally operating clients now account for over 60% of total group revenues. Silver Bullet also reported a positive EBITDA during Q4 of FY24 and a strong start to 2025. The company raised £3.3 million through the issue of new convertible loan notes and restructured its existing CLNs, simplifying its capital structure and aligning financing with its growth plans.
YearRevenueGross ProfitLoss Before TaxLoss Per Share
2024£9.37m£7.13m£3.04m£0.17
2023£8.36m£6.36m£3.45m£0.20
PR1 logo
Latest RNS 15:23
PR1

Half-year Report

Pri0r1ty Intelligence Group PLC

Pri0r1ty Intelligence Group PLC, an AI-driven professional growth services provider for SMEs, has released its interim results for the six months ended March 31, 2025. The company was acquired three months into this period, so the report reflects only three months of Pri0r1ty trading. During this time, they generated £37,000 in revenue, with 40 customers using their products and 20% paying for services. They also formed strategic partnerships, developed new revenue-generating products, and successfully integrated cryptocurrency payments. The company expects to see increased platform adoption in the second half of 2025 and remains on track to onboard at least 100 paying users by the financial year-end. The financial statements include details on the companys financial position, changes in equity, and cash flows for the period.
Financial YearRevenue (£)Cost of Sales (£)Gross Profit (£)Other Expenses (£)Earnings Before Interest, Tax, Depreciation, and Amortization (£)Interest Expenditure (£)Loss Before Taxation (£)Income Tax (£)Profit/ (Loss) for the Year (£)
31 March 2025 (unaudited)37,000037,000570,436-860,2670-860,2670-860,267
31 March 2024 (unaudited)000151,301-151,3010-151,3010-151,301

| Debt | 31 March 2025 (Unaudited) | 31 March 2024 (Unaudited) | | --- | --- | --- | | Trade and Other Payables (£) | 400,397 | 68,842 |
BBH logo
Latest RNS 15:17
BBH

Holding(s) in Company

Bellevue Healthcare Trust PLC

TR1 Buy
['Saba Capital Management, L.P.', '0.873177', '1.088320']
80M logo
Latest RNS 15:16
80M

Final Results for the year ended 31 December 2024

80 Mile Plc

80 Mile Plc, formerly Bluejay Mining Plc, released its final results for the year ended December 31, 2024. The company reported a loss of £9,561,414 for the year, compared to a loss of £1,809,374 in the previous year. The companys revenue remained nil, while its cost of sales decreased to £35,887 from £213,523 in the previous year. 80 Mile Plcs administrative expenses increased to £2,262,385 from £1,629,273 in the previous year. The companys impairment of intangible assets decreased to £4,902,058 from £3,535,254 in the previous year. 80 Mile Plcs share of losses from joint ventures increased to £18,114 from £13,779 in the previous year. The companys other losses increased to £2,259,088 from a gain of £2,962,769 in the previous year. 80 Mile Plcs finance expense decreased to £1,663 from a finance income of £7,039 in the previous year. The companys other income increased to £116,844 from £320,925 in the previous year. As of December 31, 2024, 80 Mile Plcs total assets decreased to £34,153,950 from £40,520,554 in the previous year. The companys total liabilities decreased to £1,187,350 from £1,143,927 in the previous year. 80 Mile Plcs net assets decreased to £32,966,600 from £39,376,627 in the previous year.
YearFinancialsDebt
2024£34,153,950£1,187,350
2023£40,520,554£1,143,927
BRSC logo
Latest RNS 14:58
BRSC

Portfolio Update

Blackrock Smaller Companies Trust PLC

Here is a summary of the provided text
BlackRock Smaller Companies Trust PLC released an update on its portfolio performance as of May 31, 2025. The companys net asset value per share increased by 6.5% to 1487.95p on a total return basis, while the benchmark index returned 7.3%. The share price performance was positive for the month, but underperformed the broader market. The largest detractors from performance were Bloomsbury Publishing, Ashtead Technology, and Tatton Asset Management due to stock-specific issues. However, holdings in Chemring, Boku, and Alpha Group International contributed positively to the portfolio.
The update also includes a commentary on the markets by Roland Arnold, representing the Investment Manager. Arnold notes that global financial markets experienced a strong rebound in May, with a boost in risk sentiment and easing geopolitical tensions. While the US Federal Reserve maintained its policy rate, the Bank of England cut rates citing domestic disinflation. Despite this, UK inflation surprised to the upside in April.
Arnold also provides an outlook for the UK equity market, highlighting several positive factors including falling mortgage rates, positive real wage growth, and a recovery in the housing market. Additionally, the pace of M&A activity remains robust, and UK SMID stocks are considered undervalued compared to large-cap stocks. The update concludes by expressing optimism about the attractiveness of the UK market for investors, given the uncertainty in the US equity market.
Financial MetricsOne MonthThree MonthsOne YearThree YearsFive Years
Net Asset Value6.5%3.7%-8.6%-7.2%24.5%
Share Price6.1%4.3%-10.6%-3.8%17.3%
Benchmark7.3%6.4%1.1%1.1%38.9%
Net Asset Value (Capital Only, Debt at Par Value)1,409.19p
Net Asset Value (Capital Only, Debt at Fair Value)1,473.13p
Net Asset Value incl. Income (Debt at Par Value)1,424.01p
Net Asset Value incl. Income (Debt at Fair Value)1,487.95p
Share Price1,296.00p
Discount to Cum Income NAV (Debt at Par Value)9.0%
Discount to Cum Income NAV (Debt at Fair Value)12.9%
Net Yield3.4%
Gross Assets£678.5m
Net Gearing including Income (Debt at Par)7.0%
WIZZ logo
Latest RNS 14:57
WIZZ

Holding(s) in Company

Wizz Air Holdings PLC

TR1 Buy
['The Capital Group Companies, Inc.', '8.058573', '9.951957']
JARA logo
Latest RNS 14:50
JARA

Final results for the year ended 28 February 2025

Jpmorgan Global Core Real Assets Ltd

Here is a summary of the text provided
JPMorgan Global Core Real Assets Limited has released its final results for the year ended February 28, 2025, announcing a managed wind-down of the company and a shift in its investment objective. The companys continuation vote failed to pass at the 2024 AGM, leading to a new strategy that involves liquidating assets and returning capital to shareholders. As of February 28, 2025, the company has realized its holdings in the Listed Real Assets Strategy, with the exception of Home REIT plc, and has made significant progress in redeeming its holdings in other strategies. The Board expects to have realized and returned over 55% of assets to shareholders by the end of 2025 and over 80% by the end of 2026. The companys return on net asset value was 5.2% for the year, while the return to shareholders was 36.8%. The Board has taken steps to reduce costs, including reducing directors fees and disbanding certain committees. The companys sixth AGM will be held on August 28, 2025, and the Board encourages shareholders to vote in advance. The Board acknowledges the challenges faced by the company since its launch in 2019 but remains focused on liquidating assets and returning proceeds to shareholders efficiently.
YearFinancialsDebt
2025£162,311,000£35,260,000
2024£196,411,000£3,682,000
CCH logo
Latest RNS 14:33
CCH

Director/PDMR Shareholding

Coca Cola HBC AG

<mark style="background-coloryellow">PURCHASE</mark> OF ORDINARY SHARES FOLLOWING THE RE-INVESTMENT OF DIVIDENDS PAID ON THE EMPLOYEES SHARES HELD UNDER THE COMPANYS EQUITIES PLANS
EAAS logo
Latest RNS 14:19
EAAS

Final Results

Eenergy Group PLC

eEnergy Group plc, a net zero energy services provider, has released its audited financial statements for the year ended December 31, 2024. The company reported a record revenue of £25.1 million, a 71% increase from the previous year, and transitioned into profit with an Adjusted EBITDA of £0.6 million. The companys net debt was reduced to £2.4 million, and it was awarded a solar installation contract worth £5.2 million with Spire Healthcare. The companys outlook for FY2025 is optimistic, with a strong contracted forward order book and increased sales pipeline. The company expects to be cash positive in H1 2025 and further cash generative in H2 2025.
<>eEnergy Group Financials
YearRevenueAdjusted EBITDANet DebtCash
2024£25.1 million£0.6 million£2.4 million£2.3 million
2023£14.7 million-£6.4 million£8.0 million£0.6 million
HAYD logo
Latest RNS 14:15
HAYD

Holding(s) in Company

Haydale Graphene Industries

TR1 Buy
['Octopus Investments Limited', '9.720000', '10.920000']
VLG logo
Latest RNS 14:14
VLG

Final Results for year ended 31 December 2024

Venture Life Group PLC

Venture Life Group PLC, a leader in product innovation, development, and commercialization within the global consumer healthcare sector, has released its audited financial results for the year ended December 31, 2024. The company reported strong growth in its core business, with a revenue increase of 18.9% to £26.6 million and an underlying growth of 14.9% excluding acquisitions. The gross profit increased by 31.1% to £12.2 million, and the gross margin improved to 45.8%. The adjusted EBITDA rose by 26.1% to £6.2 million, and the adjusted profit before tax increased to £4.3 million. The company also announced the sale of its contract development and manufacturing operations and certain non-core products for €62 million in cash. The Board expects to complete the sale of its oral care brands, which are now considered non-core, by the end of 2025.
YearRevenueGross ProfitMarketing CostsAdjusted EBITDAAdjusted Profit Before TaxAdjusted EPSFree Cash FlowGroup Net LeverageGroup Net Debt
2024£26.6 million£12.2 million6.1%£6.2 million£4.3 million3.37p£4.3 million1.83x£18.7 million
2023£22.4 million£9.3 million3.9%£4.9 million£2.8 million2.60p£2.7 million1.30x£13.7 million
VRS logo
Latest RNS 14:04
VRS

Interim Results

Versarien PLC

Versarien PLC, an advanced engineering materials group, released its unaudited interim results for the six months ended March 31, 2025. The company reported a loss before tax of £1.49 million and cash reserves of £0.85 million as of March 31, 2025. Versariens strategy is to monetize its intellectual property and know-how by licensing its technology and brands as commercial traction for graphene develops. The company has a pipeline of commercial opportunities worth £2.1 million and is seeking additional funding to continue as a going concern. Versarien is also simplifying its corporate structure and seeking strategic partners for its 3D Construction Printing business. The Board expects the Groups ongoing costs to reduce with the simplified structure.
Financial MetricsFY 2025FY 2024Change
Group revenues£1.47 million£1.34 million10.45% increase
Graphene revenues£0.21 million£0.28 million25% decrease
Grant income£0.23 million£0.20 million15% increase
Adjusted LBITDA£0.77 million£0.67 million14.93% increase
Loss before tax£1.49 million£1.61 million7.45% decrease
Cash as of 31 March£0.85 million£0.15 million466.67% increase

Debt MetricsFY 2025FY 2024Change
Innovate UK Loan£5 million£4.5 million11.11% increase
Long-term borrowings£285£47539.99% decrease
Total debt£5,285£4,9756.23% increase
TBCG logo
Latest RNS 13:41
TBCG

Holding(s) in Company

TBC Bank Group PLC

TR1 Buy
['Allan Gray Proprietary Limited', '2.993000', '3.886100']
EQT logo
Latest RNS 13:27
EQT

Final Results

EQTEC plc

EQTEC plc announces its audited results for the year ended 31 December 2024.
YearRevenueOperating LossNet LossNet Assets
2024€2.2 million€3.6 million€19.4 million€13.7 million
2023€2.5 million€3.5 million€23.5 million€21.2 million
OPT logo
Latest RNS 12:48
OPT

Holding(s) in Company

Optima Health plc

TR1 Buy
['Octopus Investments Limited', '10.620000', '9.210000']
WATR logo
Latest RNS 11:01
WATR

Audited Results for Year Ended 31 December 2024

Water Intelligence plc

Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions, has released its full audited results for the year ended December 31, 2024. The companys revenue increased by 10% to $83.3 million, with statutory profit before tax growing 2% to $6.4 million and statutory EBITDA growing by 11% to $13.1 million. The companys balance sheet remains strong, with cash of $12.1 million and a Total Net Debt to EBITDA Adjusted ratio of 1.1. The companys critical mass of sales and technology-driven foundation establish a scalable Technology Enabled Services (TES) platform. Between Q4 2024 and Q1 2025, Water Intelligence completed three strategic transactions, including reacquiring its Dallas franchise and establishing it as the headquarters for its core American Leak Detection business, forming a partnership with Chubb insurance and its StreamLabs Water business, and reaffirming its capital allocation guidance with acquisitions. The companys TES platform enables it to provide recurring Preventive Maintenance solutions and efficiently offer proprietary, technology-driven solutions to its customers. Based on its competitive strategy and the Dallas Template, the company expects to deliver higher organic revenue and profit trajectory.
YearRevenueProfit Before TaxNet Debt to EBITDA Adjusted Ratio
2024$83.3 million$6.4 million1.1
2023$76 million$6.2 millionN/A
PAG logo
Latest RNS 10:34
PAG

Director/PDMR Shareholding

Paragon Banking Group PLC

<mark style="background-coloryellow">Purchase</mark> of shares pursuant to the Companys Salary in Shares remuneration arrangements.
APN logo
Latest RNS 09:36
APN

Holding(s) in Company

Applied Nutrition Plc

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '0.000000', '5.065098']
LABS logo
Latest RNS 09:09
LABS

Holding(s) in Company

Life Science REIT PLC

TR1 Buy
['Legal & General Group Plc (Group)', '3.990000', '4.000000']
EARN logo
Latest RNS 08:52
EARN

Holding(s) in Company

EARNZ plc

TR1 Buy
['UBS Group AG - Investment Bank & Global Wealth Management', '6.773980', '0.000000']
ENET logo
Latest RNS 08:36
ENET

Results for the Year Ended 31 December 2024

Ethernity Networks Ltd

Ethernity Networks Ltd, a leading supplier of data processing and PON semiconductor technology, announces its audited results for the year ended 31 December 2024. The company experienced a 63% decrease in revenue compared to 2023, with a gross profit decrease of 46%. However, the gross margin percentage increased to 92.1% in 2024 from 61.9% in 2023, reflecting a 30.2% improvement. The operating loss decreased by 4%, and the EBITDA loss decreased by 10%. The company raised net cash funds of $1.86 million during the year and had cash and cash equivalents of $0.05 million at the end of December 2024. Despite challenges, the company successfully exited the Temporary Suspension of Proceedings process and initiated a strategic transition to leverage its Universal Edge Platform development. The companys Chairman and CEO provided statements highlighting the companys achievements and expressing optimism for the future.
YearRevenueGross ProfitOperating LossEBITDA LossNet CashCash Equivalents
2024$1.38 million$1.3m$5.1 million$3.48 million$1.86 million$0.05 million
2023$3.78 million$2.3m$5.3 million$3.86 millionN/A$1.99 million
HCM logo
Latest RNS 08:31
HCM

China Approval based on Phase III SACHI Trial

HUTCHMED China Ltd

HUTCHMED (China) Limited announces that the New Drug Application for the combination of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) has been approved by the China National Medical Products Administration for treating advanced non-small cell lung cancer with MET amplification after progression on EGFR inhibitor therapy. The approval is based on the positive results of the SACHI Phase III trial, which showed a significant improvement in progression-free survival for patients treated with the combination compared to chemotherapy. ORPATHYS® is an oral MET inhibitor, and TAGRISSO® is a third-generation EGFR inhibitor. This approval provides a new treatment option for lung cancer patients in China and triggers a US$11 million milestone payment from AstraZeneca, which markets both drugs in the country.
Approvals
OSB logo
Latest RNS 08:30
OSB

Holding(s) in Company

OneSavings Bank PLC

<mark style="background-coloryellow">TR1</mark> Buy
['City and country of registered office (if applicable) London, United Kingdom', '', 0]
MLVN logo
Latest RNS 07:33
MLVN

Holding(s) in Company

Malvern International

<mark style="background-coloryellow">TR1</mark> Buy
['8 KPG Limited', '2,140,630', 0]
KOD logo
Latest RNS 07:31
KOD

Bougouni Lithium Project Off-Take Agreement

Kodal Minerals PLC

Kodal Minerals Plc has signed an off-take agreement with Hainan Mining Co. Ltd for its Bougouni Lithium Project in Southern Mali. The agreement grants Hainan exclusive rights to purchase 100% of the spodumene concentrate produced by the projects DMS processing plant for four years, with an annual review of quantities and floor price. The price is referenced to the Shanghai Metals Market and will be subject to adjustments based on grade, quality, and delivery terms. The agreement includes a "take or pay" clause, with LMLB supplying spodumene exclusively to Hainan, who must purchase the agreed-upon quantity. The DMS processing plant has already produced over 40,000 tonnes of spodumene concentrate, and the company is working to secure an export license from the Mali government. The first phase of the project is expected to produce 100,000-120,000 tonnes per year of lithium concentrate with a yield of more than 5.5% Li2O.
Agreement
VOD logo
Latest RNS 06:28
VOD

Vodafone Group Plc launches Cash Tender Offers

Vodafone Group PLC

Vodafone Group Plc has launched a tender offer to purchase multiple series of outstanding notes with an aggregate principal amount of up to €2,000,000,000. The offer includes U.S. dollar and sterling-denominated notes with maturity dates ranging from 2043 to 2059. The company has set a maximum tender amount and acceptance priority levels for each series of notes. The tender offer is subject to certain terms and conditions, including a financing condition related to the issuance of new sterling-denominated notes. The company has retained Merrill Lynch International and Deutsche Bank AG as dealer managers and Kroll Issuer Services Limited as the tender and information agent for the offer. The offer period includes key dates such as the early tender deadline, price determination date, and settlement dates. The offer is subject to applicable laws and regulations in various jurisdictions, including Italy, the United Kingdom, France, and Belgium. The company also provides forward-looking statements and information about its purpose and commitment to environmental sustainability.
Launch
0A3D logo
Latest RNS 06:11
0A3D

Net Asset Value

iShares VII Public Limited Company - iShares Core S&P 500 UCITS ETF

TEAM logo
Latest RNS 06:07
TEAM

Half-year Report

TEAM plc

Here is a summary of the text provided
TEAM PLC, a wealth, asset management, and financial services group, released its interim results for the first half of 2025, showing significant growth and progress. The company reported a 41% increase in revenues to £5.8 million, with total client assets surpassing £1.1 billion. TEAM also successfully raised £2.96 million through equity and convertible loan instruments, and had £2.16 million in cash reserves as of March 31, 2025.
The companys operational highlights include growth in total client assets across its divisions, a successful group-wide cost reduction program, and the upcoming launch of the TEAM UCITS fund. The outlook for the remainder of the financial year remains positive, with a continued focus on migrating client assets to MPS and expanding the international advisory network.
Mark Clubb, Executive Chairman of TEAM, expressed confidence in the companys trajectory and mid-term targets, which include annual revenue of £20 million, an EBITDA margin exceeding 30%, and Assets Under Advice/Management of £4 billion. The company is focused on execution, with the UCITS fund launch being central to driving growth and achieving profitability.
The financial review highlights the companys improved financial position and continued revenue growth, with the goal of achieving month-on-month profitability. The segmental analysis shows the performance of the Groups three principal operating segments: Investment and Fund Management, Advisory and Consultancy, and International.
Overall, the results demonstrate TEAM PLCs strong performance and positive trajectory, with a focus on growth and achieving financial targets.
| | HY 25 | HY 24 | |---|---|---| | Revenues | £5.8m | £4.1m | | Total client assets | £1.112bn | £0.9bn | | Cash in bank | £2.16m | £1.5m | | Total Equity Raised | £1.96m | - | | Convertible Loan Notes | £1m | - | | Gross Total Raised | £2.96m | - | | Underlying loss before tax | £796k | £992k | | Loss before tax | £1.757m | £1.013m | | Loss for the period | £1.757m | £1.010m | | Loss per share | 3.6 pence | 3.5 pence |
CRTA logo
Latest RNS 06:02
CRTA

Holding(s) in Company

Cirata plc

<mark style="background-coloryellow">TR1</mark> Buy
['GEORGE WALTER LOEWENBAUM', '5.40', 'n/a']
SSTY logo
Latest RNS 06:01
SSTY

Lease agreement to operate hostel in Naples

Safestay PLC

Safestay plc, a leading European hostel group, has signed a 12-year lease agreement with Italian property developer Ma Creo srl to operate a 300-bed hostel in Naples, Italy. The lease agreement marks the beginning of a strategic partnership between the two companies, with plans to expand into other key Italian cities. The Naples hostel, set in a former monastery, is expected to open in August 2025 and will offer guests a range of amenities, including ancillary services. This expansion aligns with Safestays growth strategy and goal to double its portfolio size in the medium term.
Agreement
NAH logo
Latest RNS 06:01
NAH

Holding(s) in Company

NAHL Group PLC

<mark style="background-coloryellow">TR1</mark> Buy
['Colebrooke Partners IM Limited', 'Less than 3', '3.27']
MLVN logo
Latest RNS 06:01
MLVN

Holding(s) in Company

Malvern International

<mark style="background-coloryellow">TR1</mark> Buy
['Edward Roskill', '2,064,567', 0]
ROQ logo
Latest RNS 06:01
ROQ

Director/PDMR Shareholding

Roquefort Investments PLC

<mark style="background-coloryellow">Purchase</mark> of 72,507 ordinary shares
CRTX logo
Latest RNS 06:01
CRTX

Placing

CRISM Therapeutics Corporation

APTA logo
Latest RNS 06:01
APTA

Liver fibrosis breakthrough with Optimer® platform

Aptamer Group PLC

Aptamer Group plc, a leading developer of next-generation synthetic binders, has made a significant breakthrough in its liver fibrosis treatment research. The companys innovative Optimer® platform has successfully identified and validated a novel molecular target for targeted gene therapy delivery to specific liver cells that drive scarring. This advance positions Aptamer for strategic licensing discussions with global pharmaceutical partners in the $20 billion fibrosis market.
The Optimer® technology acts as a magic bullet, precisely targeting a protein in scarred livers and delivering siRNA gene therapy to hepatic stellate cells (HSCs), which cause liver scarring. In laboratory <mark style="background-color:yellow">test</mark>s, the Optimer®-siRNA system significantly reduced processes that mimic scar tissue formation and slowed the harmful activity of HSCs.
Aptamers unique approach to target identification has led to the discovery of a specific protein marker for HSCs, setting their technology apart for precision medicine. The Optimer® platform is compatible with various RNA-based medicines, making it highly versatile.
The company is now planning outsourced in vivo studies to evaluate the platforms performance in animal models and is in discussions with major pharmaceutical companies for parallel studies. These efforts aim to confirm the efficacy and safety of the Optimer® platform, paving the way for human trials and strategic collaborations in the multi-billion-dollar fibrosis market.
Breakthrough
CLCO logo
Latest RNS 06:01
CLCO

Interim Results

Cloudcoco Group PLC

Here is a summary of the provided text
CloudCoCo Group plc, an e-commerce and IT procurement business, has released its interim results for the six months ended March 31, 2025. The companys financial highlights include a revenue of £3.4 million, with 89% generated from e-commerce sales, stable gross profit of £228k, and improved gross margin to 7%. Trading Group EBITDA was £26k, and administrative expenses were reduced by 13%. The sale of legacy businesses resulted in a cash inflow of £7.9 million, enabling the repayment of MXC loan notes and strengthening the balance sheet. The companys operational highlights include adding 10 new business customers, introducing enhanced automation, onboarding new vendor distribution partners, and forming strategic partnerships. Simon Duckworth, Non-Executive Chairman, expressed confidence in the companys transformation and future growth prospects. The company aims to drive top-line growth, deliver excellent service, maintain cost discipline, and explore new opportunities.
Would you like me to generate a more in-depth summary?
Financial YearRevenue (£)Gross ProfitGross MarginEBITDAPLC Costs (£)Administrative Expenses (£)Cash Balance (£)Debt
H1 20253,383,000228,0007%26,000198,000489,000818,000Minimal debt
H1 20244,335,000228,0005%21,000251,000563,0001,042,0006,200,000 loan notes
SBTX logo
Latest RNS 06:01
SBTX

Croda Commercial Launch Progressing as Expected

SkinBioTherapeutics PLC

Here is a summary of the news article
SkinBioTherapeutics plc, a life science company focused on skin health, announces that the commercial launch of ZenakineTM by Croda Beauty is progressing as expected. ZenakineTM is a neuroactive ingredient designed to counteract the effects of stress on the skin and improve overall well-being by enhancing melatonin production and improving sleep quality. The company has a long-standing commercial and manufacturing agreement with Croda plc, and due to the competitiveness of the industry, SkinBioTherapeutics is under a strict confidentiality agreement regarding sales and market forecast information. The company also announces an upcoming investor presentation on July 3, 2025, regarding a recently signed commercial agreement with Superdrug. SkinBioTherapeutics is a consolidator in the skin health market, making acquisitions in complementary areas and expanding its distribution, geographical reach, and manufacturing capabilities. The companys proprietary platform, SkinBiotix®, is based on discoveries made by the translational dermatology team at the University of Manchester.
Launch
OBD logo
Latest RNS 06:01
OBD

Interim Results

Oxford Biodynamics PLC

Oxford BioDynamics Plc, a precision clinical diagnostics company, released its interim results for the six-month period ended March 31, 2025. The company reported a revenue of £587k, an increase from £327k in the same period last year. The operating loss was £5.88m, a slight improvement from £5.99m in H1 2024. Cash and term deposits as of March 31, 2025, were £4.26m, up from £1.2m in the previous year.
The company highlighted several corporate and operational highlights, including the appointment of Iain Ross as Executive Chairman and the growth in sales of the EpiSwitch PSE test. They also announced an agreement with Bupa UK to cover the EpiSwitch PSE test.
The financial highlights included an equity placing, subscription, and retail offer, raising gross proceeds of £7.35m in January 2025.
In his comments, Iain Ross, the Executive Chairman, emphasized the importance of "doing deals" for the commercial success and non-dilutive funding of the business. He also acknowledged that while they are in commercial discussions with third parties, no substantive deals have been finalized yet, and there is no guarantee within the current cash runway.
The text also includes an executive chairmans review, financial review, and detailed financial statements, providing insights into the companys performance and financial position.
YearRevenueOperating LossCash and Term DepositsEquity Placing
2025£587k£5.88m£4.26m£7.35m
2024£327k£5.99m£1.2mN/A
DKL logo
Latest RNS 06:01
DKL

2024 Final Results and Financing Update

Dekeloil Public Ltd

Dekel Agri-Vision Plc, a West African agribusiness company, released its financial results for the year ended December 31, 2024, highlighting stable Group EBITDA at €2.6 million. The Palm Oil Operation contributed a positive EBITDA of €3.9 million, while the Cashew Operation reported an improved EBITDA loss of €1.3 million. The company also announced a financial restructuring, including equity fundraising and debt facility revisions, strengthening its balance sheet. The outlook for 2025 is positive, with expectations of enhanced results driven by the ongoing turnaround of the Cashew Operation and rebounding CPO prices.
YearPalm Oil Operation RevenuePalm Oil Operation Gross MarginPalm Oil Operation Gross Margin %Palm Oil Operation EBITDACashew Operation RevenueCashew Operation EBITDAGroup EBITDA
2024€28.2m€5.1m18.1%€3.9m€1.8m€(1.3)m€2.6m
2023€37.2m€6.5m17.5%€4.8m€1.1m€(2.2)m€2.6m
% change-24.2%-21.5%3.4%-18.7%63.6%40.9%No change
ADVT logo
Latest RNS 06:01
ADVT

Final Results for Year Ending 28 February 2025

AdvancedAdvT Ltd

Advanced AdvT Limited, an international software solutions provider, released its financial results for the year ending February 28, 2025, with a focus on business solutions, compliance, and human capital management sectors. The company reported strong financial performance, including revenue from operations of £43.3 million and recurring revenue of £34.8 million, representing 80.3% of total revenues. The adjusted EBITDA from operations was £11.3 million, ahead of management expectations, and the pre-tax profit from continuing operations was £11.3 million. Cash and cash equivalent assets were reported as £109.5 million. The company also highlighted its proforma financial performance, with organic revenue growth of 17.8% and adjusted EBITDA growth of 90.0% on acquired businesses.
During the period, Advanced AdvT Limited made several acquisitions, including Celaton Limited, HFX Limited, and GOSS Technology Limited, strengthening their position in the market. The companys Chairperson, Vin Murria, emphasized the groups focus on digital transformation and their commitment to supporting customers strategic delivery. The companys CFO, Gavin Hugill, provided additional insights into the financial highlights and operational review.
The Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Consolidated Statement of Changes in Equity, and Consolidated Statement of Cash Flow provided detailed financial information for the year ending February 28, 2025, and the previous eight-month period ending February 29, 2024. The report also included critical accounting judgments, alternative performance measures, and segment information. Overall, Advanced AdvT Limited demonstrated strong financial performance and a commitment to growth through acquisitions and digital transformation.
Financial YearRevenue from Operations (£)Recurring Revenue (£)Adjusted EBITDA from Operations (£)Pre-tax Profit from Continuing Operations (£)Basic EPSCash and Cash Equivalents (£)
Year Ending 28 Feb 202543.3 million34.8 million11.3 million11.3 million8p109.5 million
Period Ending 29 Feb 2024 (8 months)21.1 million16.3 million4.4 million5.1 million5p102.9 million
VRCI logo
Latest RNS 06:01
VRCI

Final Results

Verici Dx Plc

Verici Dx plc, a developer of advanced clinical diagnostics for organ transplants, has released its audited financial results for the year ended December 31, 2024. The company reported record revenues of US$3.3 million, up from US$1.0 million in 2023, primarily due to a commercial contract with Thermo Fisher for the PTRA (Pre Transplant Risk Assessment) test. The adjusted EBITDA loss for the year was US$5.4 million, an improvement from US$7.6 million in 2023. Verici Dx also conducted an equity fundraise in February 2024, raising US$8.2 million in gross proceeds.
Operational highlights include the successful transfer of urine samples to Thermo Fisher, triggering milestone payments, and a collaboration with The Westmead Institute for Medical Research in Australia. The company received CLIA certification and CAP accreditation for its clinical laboratory, enabling testing for patients across 51 US states.
Post-period highlights include securing Medicare coverage for Verici Dxs Tutivia™ assay and a strong acceleration in Tutivia™ testing orders in Q1 2025. The company is proposing an equity fundraising to extend its cash runway and achieve commercial objectives for Tutivia™.
The directors believe that additional funding can be obtained to enable the company to continue operations for at least the next 12 months. However, there is uncertainty regarding the timing and quantum of cash receipts from revenue, and the directors are taking steps to secure funding arrangements.
<>Verici Dx Plc Financials and Debt Year on Year
YearRevenue (in millions)Adjusted EBITDA (in millions)Cash Balance (in millions)Net Proceeds from Equity Fundraising (in millions)
2024$3.3-$5.4$4.1$7.5
2023$1.0-$7.6$2.6N/A
MPL logo
Latest RNS 06:01
MPL

Full Year Results

Mercantile Ports & Logistics Ltd

Mercantile Ports & Logistics Ltd. (MPL), a company that operates and develops a port and logistics facility in Navi Mumbai, Maharashtra, India, released its preliminary financial results for the fiscal year ended December 31, 2024. Despite facing challenges such as reduced activity due to government elections and procedural issues, the company generated revenues of £4.35 million. The companys focus for the year was on resolving its outstanding debt obligations, and it remains optimistic about reaching a favorable agreement with lenders. MPL expects to diversify its revenue streams, expand its service offerings, and enhance operational efficiency in 2025. The companys long-term prospects remain positive, and it continues to receive strong support from its major shareholder, Hunch Ventures.
YearRevenueCost of SalesGross MarginAdministrative ExpensesOther IncomeDepreciationImpairment LossOperating LossFinance IncomeFinance CostNet Financing CostLoss Before Tax
20244,3522,3302,0222,8419214,7406,77211,410347,2917,25718,667
20235,4622,4173,0453,2665905,5819,85315,065256,2256,20021,265
CRTA logo
Latest RNS 06:01
CRTA

$700K Multiyear Data Integration Contract Renewal

Cirata plc

Cirata plc, a company listed on the London Stock Exchange, has secured a significant $700,000 contract renewal for its data integration software, Live Data Migrator (LDM), with a top-five Canadian bank. The two-year deal underscores the banks confidence in Ciratas data migration, synchronization, and disaster recovery capabilities. This contract will be facilitated through the Google Marketplace, and the announcement is considered inside information per the UK Market Abuse Regulation. The companys CEO, Stephen Kelly, is responsible for the announcements release. The contact details for Cirata, its financial advisors, and brokers are provided for further inquiries. The London Stock Exchanges news service, RNS, disseminates this information, and users are responsible for adhering to its terms and conditions.
NewContract
OPTI logo
Latest RNS 06:01
OPTI

Final Results

OptiBiotix Health Plc

OptiBiotix Health plc, a life sciences company, released its audited financial results for the year ended December 31, 2024. The company reported strong sales growth and progress in its strategic objectives, including increasing partners and sales in key markets like the USA and India. The order book for Q1 2025 surpassed sales achieved in H1 2024, and there were multiple product launches and new partnerships across various regions. The companys investments in sales and marketing are delivering returns, and it expects all parts of the business to become profitable as it reduces costs and grows its top line. OptiBiotix ended 2024 with a strong balance sheet and cash position, and it anticipates continuing its upward trajectory. The Chairmans and Chief Executive Officers reports provide further insights into the companys performance and future outlook.
YearRevenueCost of SalesGross ProfitSelling CostsR&D and Patent CostsOther Operating CostsTotal Administrative ExpensesOperating LossFinance IncomeShare of Loss from AssociateGain/Loss on InvestmentsProfit/Loss Before TaxTotal Comprehensive Income
2024870k539k331k651k294k1,605k2,597k2,266k1k350k486k1,866k1,805k
2023644k324k320k125k223k1,662k2,016k1,696k1k323k513k2,043k2,039k
CPX logo
Latest RNS 06:01
CPX

Global Distribution Agreement with RS Group plc

CAP-XX Limited

CAP-XX Limited, a developer of high-performance supercapacitors, has entered into a global distribution agreement with RS Group plc, a renowned distributor of industrial and electronic components. This agreement expands CAP-XXs global reach by making their prismatic, cylindrical, and hybrid supercapacitors more accessible through RS Groups extensive logistics network. With RS Groups presence in over 30 countries and a customer base that includes industrial OEMs and automation engineers, this partnership will enhance CAP-XXs ability to meet the rising global demand for their products. This agreement is part of CAP-XXs strategy to strengthen its global distribution network, which also includes partnerships with Farnell and Digi-Key, positioning the company to support a wide range of applications across various industries. The companys high-performance supercapacitors are known for their high-power density and energy storage capacity, making them valuable in consumer electronics, industrial automation, and renewable energy sectors.
Agreement
SKA logo
Latest RNS 06:01
SKA

Annual Results for the year ended 31 December 2024

Shuka Minerals Plc

Shuka Minerals Plc, an African-focused mine operator and developer, released its audited results for the year ended December 31, 2024. The company continued its transition in terms of management, with a refocus on future strategy, board changes, and the appointment of Richard Lloyd as the new CEO. Shuka Minerals faced production and output challenges at its Rukwa coal mine in Tanzania but expects a restart in mining operations soon. The company entered into a funding commitment with Gathoni Muchai Investments (GMI) for an unsecured, non-convertible, interest-free loan of £500,000, with an additional £1.5 million extension subject to due diligence. Shuka Minerals also agreed to acquire 100% of Leopard Exploration and Mining Limited (LEM), the registered holder of a large-scale mining license for the Kabwe Lead-Zinc-Silver-Vanadium mine in Zambia. The companys financial statements were audited by PKF Littlejohn LLP, who highlighted a material uncertainty related to going concern and emphasized the need to operationalize the 16% Government of Tanzania non-dilutable free carried share interest.
YearRevenueCost of SalesGross LossAdmin ExpensesGroup Operating LossFinance IncomeFinance CostsLoss on Operations
20242,305198,2611,799,5841,997,8452,3519,4332,004,927
2023194,346244,5311,424,1201,668,6513,25616,1331,681,528
RVRG logo
Latest RNS 06:01
RVRG

2025 Half-year Report

River Global Plc

River Global PLC released its half-year report for the six months ended March 31, 2025, announcing a loss of £1.6 million and a change in nominated adviser to Panmure Liberum Limited. The report highlights the challenging market conditions for the active asset management industry, with geopolitical turmoil and economic uncertainties impacting investor confidence. Despite these challenges, River Global has made progress in consolidating its asset management business and joint ventures. The A Ordinary Shares business interest reported a loss before taxation of £2.8 million, while the B Shares business interest, representing the companys structured equity interest in Parmenion, reported a profit of £1.2 million. The companys chairman, Martin Gilbert, remains optimistic about the future, focusing on cost-cutting measures and driving efficiencies. The report also includes details on the share reorganization, business review, financial statements, and segmental analysis.
YearLoss on EBITDATotal LossA Ordinary SharesB Shares
2025£0.2m£1.6m-£1.5m£1.3m
2024£1.3m£3.0m-£2.9m£1.2m
WSG logo
Latest RNS 06:01
WSG

£680,000 New Contract Awards

Westminster Group Plc

Westminster Group Plc, a UK-based security solutions provider, has announced two new significant contract awards totaling £680,000. The first contract involves providing a Parliamentary Broadcast System to an East African Parliament, including a sophisticated audio-visual system for broadcasting and recording debates. The second contract is with a worldwide broadcaster for advanced security screening systems in their UK operations. Westminsters CEO, Peter Fowler, highlights the potential for expansion and the importance of these contracts, especially the East African Parliament project. The company specializes in technology-based security solutions and managed services, with a focus on surveillance, detection, and tracking technologies, and has a global presence in over 50 countries. The Westminster Group Foundation, the groups CSR arm, aims to support communities through poverty relief, education, and healthcare initiatives.
NewContract
PRV logo
Latest RNS 06:01
PRV

Interim Results

Porvair plc

Porvair PLC, a specialist filtration, laboratory, and environmental technology group, released its interim results for the six months ended May 31, 2025. The Groups revenue increased by 3% to £97.7 million, with a 5% growth on a constant currency basis. Adjusted operating profit was 1% higher at £12.6 million, while operating profit increased by 3% to £11.9 million. The Group also saw improvements in adjusted profit before tax, profit before tax, adjusted basic earnings per share, and basic earnings per share. Porvairs closing cash balance was £17.1 million, and the interim dividend was increased by 0.1 pence per share.
The Groups performance was mixed across its end markets, with strength in certain industrial businesses and laboratory instruments offsetting softness in aerospace and foundry, along with foreign exchange headwinds. The Group continues to monitor the macro-economic uncertainty and tariff environment, noting that its manufacturing footprint primarily serves local customers.
Hooman Caman Javvi, Chief Executive, highlighted the Groups underlying growth trends, including tightening environmental regulation, the growth of analytical science, the need for clean water, and the development of carbon-efficient transportation. The Groups return on capital employed was 14%, and the Board remains confident in the Groups capabilities based on its long-term growth record.
The Groups strategy remains focused on developing specialist filtration, laboratory, and environmental technology businesses, with consistent earnings growth and selected ESG measures as key success indicators. Porvairs businesses are characterized by their specialist design, engineering, and commercial skills, mandated product use, and long-life-cycle systems.
The Board understands the importance of responsible business development and highlights that most of Porvairs products are used for environmental benefits. The Group published a full ESG report in February 2025, outlining its ESG management framework, goals, and metrics.
The Groups divisions, Aerospace & Industrial, Laboratory, and Metal Melt Quality, showed varied performances. Aerospace & Industrial revenue increased by 10%, while Laboratory revenue grew by 1%. Metal Melt Quality revenue decreased by 6%, impacted by lower industrial demand.
The Groups cash flow and cash position improved, with cash generated from operations at £10.2 million and net cash of £17.1 million. The Group continues to invest in capital expenditure and acquisitions, focusing on markets with long-term growth potential and geographic presence aligned with its end markets.
Overall, Porvair PLCs performance for the first six months of 2025 was in line with expectations, and the Group remains well-positioned to benefit from global trends and its long-term growth drivers.
Financial YearRevenueOperating ProfitAdjusted Operating ProfitProfit Before TaxAdjusted Profit Before TaxEarnings Per ShareAdjusted Earnings Per ShareNet Cash
H1 2025£97.7 million£11.9 million£12.6 million£11.3 million£12.0 million19.0 pence20.0 pence£17.1 million
H1 2024£94.6 million£11.6 million£12.5 million£10.6 million£11.5 million18.1 pence19.5 pence£4.1 million
Growth3%3%1%7%4%5%3%N/A
SCP logo
Latest RNS 06:01
SCP

Half-year Report

Schroder UK Mid Cap Fund PLC

Here is a summary of the text provided
Schroder UK Mid Cap Fund PLC released its half-year report for the six months ended March 31, 2025. The report highlights include a reduction in management fees, the introduction of a three-yearly continuation vote, and a more active buy-back policy. The portfolio NAV saw a negative return of 9.3%, underperforming the Benchmark, but the Company NAV has since outperformed the Benchmark by 2.1 percentage points. The Board announced an interim dividend of 6.3 pence per share, reflecting the ongoing recovery in portfolio income. The discount of the Companys share price to NAV narrowed to 7.9% as of March 31, 2025. The Companys net gearing ratio was 9.5%, and the Board remains confident in the UK mid-cap markets attractiveness and potential for correction in valuation dislocation. The outlook for the Company is positive, with experienced portfolio managers and attractive valuations. The report also includes details on investment and share price performance, dividend, discount management, gearing, and an investment managers review.
YearRevenueCapitalTotalNet AssetsNet Gearing
2025£3,944£(24,100)£(20,156)£215,4239.5%
2024£3,158£18,365£21,523£228,342N/A
2023£8,737£31,395£40,132£242,966N/A
MDZ logo
Latest RNS 06:01
MDZ

Half-year Report

MediaZest plc

MediaZest Plc, a creative audio-visual solutions provider, has released its unaudited interim results for the six months ended March 31, 2025, showing significant improvement. The company reported a 63% increase in revenue to £1.9 million and a 61% increase in gross profit, resulting in a return to profitability at the EBITDA and pre-tax levels. This positive trend is expected to continue in the second half of the financial year due to recent project wins and new business activity. The basic and diluted profit per share was 0.0031 pence, compared to a loss per share of 0.0092 pence in the previous period. The companys long-term client base remains consistent and continues to generate new opportunities, including digital signage solutions for Pets at Home and new dealership experiences for Hyundai and KIA. MediaZest also completed work for Lululemon Athletica and ArcTeryx, featuring LED technology. A significant new contract was won to deliver audio-visual experiences in airports worldwide. The Groups recurring revenue streams continue to expand, generating over £1 million per annum. The Board believes the outlook for MediaZest is encouraging and well-positioned for continued growth, with a positive start to H2 FY25 and a strong pipeline for FY26 and beyond.
Financial MetricsH1 FY25H1 FY24Change
Revenue£1,906,000£1,173,00063% increase
Gross Profit£1,127,000£701,00061% increase
Gross Margin59%60%1% decrease
EBITDA£197,000£(28,000)Positive change
Profit/(Loss) after tax£53,000£(141,000)Positive change
Profit/(Loss) per share (pence)0.0031(0.0092)Positive change
(Bank overdraft) / Cash in hand(£7,000)£14,000Negative change

The table above compares the financial metrics of MediaZest Plc for the first half of the financial year 2025 (H1 FY25) with the same period in the previous year (H1 FY24). The company has shown significant improvement in revenue, gross profit, EBITDA, and profit after tax. However, there was a slight decrease in gross margin and a negative change in cash position.

Debt MetricsH1 FY25H1 FY24Change
Invoice discounting facility£39,000£227,000Repaid £188,000
Short-term funding agreementUp to £60,000N/ANew agreement
Interest-bearing loans and borrowings (current liabilities)£1,359,000£1,524,000Decrease of £165,000
Interest-bearing loans and borrowings (non-current liabilities)£456,000£7,000Increase of £449,000

Regarding debt, MediaZest Plc has made significant changes. They have repaid a substantial amount of their invoice discounting facility and entered into a short-term funding agreement. There has been a decrease in interest-bearing loans and borrowings under current liabilities, while there is a notable increase in such borrowings under non-current liabilities.

CUSN logo
AI Chartist

CUSN

Today News812
Pulse--
AI Net0
Ticker AI

CUSN

AI sentiment, signals and catalyst scoring — loaded fresh from the site engine for the selected ticker.

Market AI · 2025-06-30

LONDON MARKET CLOSE: European stocks wilt but S&P 500 hits fresh high

European stocks struggled on Monday, with the FTSE 100, FTSE 250, and major European indexes closing in the red, despite gains on Wall Street. The yield on the US 10-year Treasury remained unchanged, while the …

Market AI · 2025-06-30

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

London stocks were mixed, with the FTSE 100 and 250 indices down while the AIM All-Share was up. UK GDP grew as expected in the first quarter of 2025, according to the Office for National Statistics. The po…

Market AI · 2025-06-30

LONDON BROKER RATINGS: Babcock International price targets raised

Here is the text formatted as bullet points in HTML: London-Listed Shares Analyst Recommendations London-Listed Shares Analyst Recommendations As of 30th June 2025, 09:38 FTSE 100 Ber…

Market AI · 2025-06-30

LONDON MARKET OPEN: FTSE 100 fades as UK GDP in line with expectations

London's FTSE 100 opened down on Monday, with a 0.1% decrease, while the FTSE 250 and AIM All-Share also saw losses. UK GDP grew as expected in the first quarter of 2025, with a 0.7% increase, according to the …

Market AI · 2025-06-30

LONDON MARKET EARLY CALL: London called higher on possible tax hikes

London's FTSE 100 is predicted to open with a slight gain of 0.1% on Monday, despite warnings of potential UK tax rises in the autumn. The index closed up 0.7% on Friday, and futures indicate a modest increase …

🤖
AI Intel
Sentiment scoring · good/bad/net · catalyst intensity · AI groups
Select a ticker above
Nexus Signal

Market Pulse

--pulse
Up
0
Down
0
News812
AI Net0
Movers1
📡
Nexus Signal
Price geometry · AI sentiment · short pressure · catalyst density fused into one read
Select a ticker above
Fundamentals

CUSN

MarketALL-MARKETS
RNS Today812
AI Score—
Business readCatalyst first, then balance-sheet — revenue quality, recurring income and debt maturity are the key filters after a major RNS.
Risk readWatch dilution risk, covenant headroom and customer concentration. Ask whether today's RNS changes the re-rating case.
🔭
Fundamentals
Market cap · broker target · float · valuation ratios · sector context
Select a ticker above
Financials

CUSN

Earnings lensCheck if today's RNS changes revenue timing, cash conversion or funding pressure — then confirm against historical trend.
Balance-sheet lensPrioritise net cash position, debt covenants, working capital and capex direction before acting on price momentum.
Forecast lensRevenue quarterly table, EPS, PE ratios, enterprise value multiples and analyst revisions load with the selected ticker.
📊
P&L / Financials
Revenue · income · cash flow · leverage · EPS · PE ratios
Select a ticker above
Structure DNA

CUSN

MarketALL-MARKETS
Up Count0
RNS Today812
Float structure Ownership pattern TR1 flow Re-rating potential
🧬
Structure DNA
Float · shares out · long/short interest · ownership concentration
Select a ticker above
RNS Today812
Up0
Down0
💎
Capital Radar
Broker targets · director dealing · TR1 flow · institution holders · market position
Select a ticker above
Short Data

CUSN

RNS Today812
MarketALL-MARKETS
AI Net0
Short pressure lensShort data matters most when it conflicts with fresh catalysts — high short interest plus a positive RNS is a squeeze candidate. Low short interest plus bad news has less bounce risk.
🎯
Short Data
Holder positions · % float shorted · borrow cost · squeeze candidates
Select a ticker above
Volatility Lab

CUSN

Movers1
News812
Up0
Execution lensATR defines stop width. Use it to judge whether today's RNS triggered a clean breakout or noise within the daily range.
Volume confirmsVolume expansion on catalyst day is the key signal — high volume on break through resistance confirms the move; low volume warns of fade.
⚡
Volatility Lab
ATR · realized range · volume profile · reaction zones · breakout confirmation
Select a ticker above
🧠
Ask AI
Chart context · RNS news · support/resistance · MACD · catalyst risk — all live
Target path News risk Invalidation Capital flow